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ABSTRACT 
The investigations presented in this thesis represent an effort to understand 
the regulated expression of cytoskeletal proteins in differentiating cell systems. 
Vimentin is an intermediate filament protein whose expression is regulated during 
the differentiation of a variety of cell types. I have isolated DNA probes specific 
for chicken vimentin and utilized them for the study of vimentin gene regulation. 
The single chicken vimentin gene encodes multiple mRNAs that differ in the 
lengths of their 3' untranslated regions. These mRNAs are differentially 
expressed in a tissue-specific manner. Furthermore, vimentin mRNA increases to 
high levels during chicken embryonic erythropoiesis, underlying similar changes in 
vimentin protein accumulation. 
Unlike nucleated avian erythrocytes, mammalian erythrocytes are devoid of 
intermediate filaments. I show that cultured murine erythroleukemia (MEL) cells 
repress the levels of vimentin mRNA during inducer-mediated differentiation, 
resulting in a subsequent loss of vimentin filaments. The expression of vimentin in 
these cells reflects the disappearance of vimentin filaments during mammalian 
erythropoiesis in vivo. To examine the molecular basis for divergent vimentin 
gene regulation in avian and mammalian erythropoiesis, I have studied the 
behavior of chicken and hamster vimentin genes introduced into MEL cells. 
During MEL cell differentiation, RNA encoded by transfected chicken vimentin 
genes significantly increases in abundance, whereas RNAs arising from either 
transf ected hamster vimentin genes or the endogenous mouse vimentin gene are 
repressed. The results suggest that the difference in vimentin expression in avian 
and mammalian erythropoiesis is due to a divergence of cis-linked vimentin 
sequences. 
vii 
Protein 4.1 is an extrinsic membrane protein that facilitates the interaction 
of spectrin and actin in the erythroid membrane skeleton. Previous studies have 
shown that chicken protein 4.1 exists as a multiplet of related polypeptides that 
are differentially expressed during erythropoiesis. I have isolated cloned cDNA 
probes for chicken protein 4.1, and have found that a single protein 4.1 gene 
encodes multiple mRNAs by differential processing; the ratios of protein 4.1 
mRNAs change during erythroid development. In vitro translation experiments 
demonstrate that while the expression of protein 4.1 polypeptides is specified 
initially at the mRNA level by RNA processing, the ultimate expression of 
protein 4.1 variants is further determined trans la tionally. 
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CHAPTER 1: 
INTRODUCTION 
2 
Patterns of cytoskeletal protein expression have provided several model 
systems in which to study the regulation of gene expression and morphogenesis 
during cellular differentiation. In multicellular organisms, the maturation of 
distinct cell lineages yields differentiated cell and tissue types capable of 
performing specialized functions. The functional specificity of any given cell is 
necessarily a reflection and manifestation of its structure and organization. For 
example, the force-generating capability of a striated muscle cell is due to a 
highly ordered arrangement of multiple units of the fundamental contractile 
apparatus, the sarcomere. Similarly, the capacity of erythrocytes to carry oxygen 
to systemic tissues through narrow and tortuous capillary beds is facilitated by 
their cell membranes' deformability and high tensile strength. An advantage of 
studying differentiating cell systems is presented in the opportunity to correlate 
changes in gene expression with changes in cell structure and function. Through 
genetic and molecular manipulations, such correlates can be tested directly by 
altering the developmental expression of genes that would be otherwise regulated 
as part of a differentiation program. In this thesis, I have examined the 
developmentally-regulated expression of two cytoskeletal protein components. 
The first, vimentin, is one member of the intermediate filament protein family, 
which by morphological criteria appears to play a structural role in the cytoplasm 
of higher . eukaryotic cells. The second, protein 4.1, is a component of the 
submembranous network of proteins initially and extensively characterized in 
erythroid cells, and has been shown to facilitate and modulate the interaction of 
other components in this network. I will highlight here the relevant information 
that has served as the foundation for the investigations presented in this thesis. 
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Intermediate Filaments 
Intermediate filament proteins comprise a heterogeneous family of 
cytoskeletal proteins that display a characteristic 10 nm-diameter filament 
morphology. By immunological, biochemical, and protein and DNA sequence 
criteria, five distinct classes of cytoplasmic intermediate filament proteins have 
been defined in higher vertebrates. The keratins are expressed in epithelial cells, 
desmin in smooth and striated muscle, glial fibrillary acidic protein (GF AP) in 
glial cells, neurofilaments in neuronal cells, and vimentin in a wide variety of cell 
types, and often in immature stages of cell differentiation (reviewed by Lazarides, 
1982; and Steinert et al., 1985). All intermediate filament subunit types share a 
highly conserved a-helical central rod domain structure of 310-340 amino acid 
residues, flanked by variable subunit-specific non-helical head- and tail-pieces 
(Geisler and Weber, 1982; Hanukoglu and Fuchs, 1982, 1983; Quax et al., 1983, 
1985; Lewis et al., 1984; Lewis and Cowan, 1985; Steinert et al., 1985; Zehner 
et al., 1987). The characteristic l 0 nm filament array is believed to be due to the 
polymerization of subunits via a tetrameric organization of the conserved central 
rod domains in coiled-coiled dimers (Geisler et al., 1982; Geisler and Weber, 1982; 
Hanukoglu and Fuchs, 1982; Aebi et al., 1983; Steinert et al., 1983), which 
probably is influenced by the variable non-helical domains (Geisler and Weber, 
1982). The presumed cell type-specific functions of intermediate filament 
sub uni ts, inferred by their tissue-specific expression, most likely reside in the 
variable non-helical flanking domains, which probably are disposed radially at the 
peripheries of the filament structure (Fraser and MacRae, 1983; Steven et al., 
l 983a,b). 
A specific intermediate filament subunit often is induced as part of the 
terminal differentiation program in a variety of cell lineages. For example, 
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vimentin is expressed as the major intermediate filament protein in fibroblasts 
(Franke et al., 1978), lens fibers (Bradley et al., 1979; Ramaekers et al., 1980), and 
avian erythrocytes (Granger et al., 1982). In other cases, vimentin is present 
during immature stages and precedes the appearance of the cell type-specific 
subunit. During terminal differentiation, the particular subunit may partially or 
completely replace vimentin as the major intermediate filament protein. In 
developing chick spinal cord, neurof ilament protein is expressed in lieu of 
vimentin during the terminal differentiation of neurons (Tapscott et al., 
198la,b). In chicken myogenesis, vimentin is co-expressed with desmin, whose 
synthesis is induced following fusion of myoblasts in the formation of 
multinucleate myotubes (Bennett et al., 1979; Gard and Lazarides, 1980); the co-
expression of vimentin and desmin persists in adult chicken skeletal muscle 
(Granger and Lazarides, 1979). Heterogeneity of intermediate filament 
composition within a cell type is also exhibited in certain mouse retinal neurons, 
where vimentin co-exists with neurofilament protein (Drager, 1983), and in 
astrocytes, where GF AP and vimentin are both present (Tapscott et al., 198 lb; 
Yen and Fields, 1981; Schnitzer et al., 1981). Interestingly, the 70,000 dalton core 
neurofilament polypeptide (NF70) has been found in sub-stoichiometric quantities 
relative to vimentin in erythrocytes from chicken embryos and young chicks 
(Granger and Lazarides, 1983). The coexistence of vimentin with desmin, GFAP, 
or neurofilament protein results in a heteropolymeric intermediate filaments 
(Gard et al., 1979; Gard and Lazarides, 1980; Steinert et al., 1981; Quinlan and 
Franke, 1982, 1983; Sharp et al., 1982; Ip et al., 1983; Granger and Lazarides, 
1983). 
The cell type-specific expression of intermediate filaments suggests that 
each subunit type performs a specialized function tailored to the requirements of 
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the differentiated cell. Studies of intermediate filament protein expression and 
intracellular localization suggest a structural role for these elements. During 
chicken skeletal myogenesis in vitro, there is an induction of desmin synthesis and 
accumulation upon fusion of immature myoblasts into multinucleate myotubes 
(Gard and Lazarides, 1980). This induction is manifested by the appearance of 
cytoplasmic desmin-containing filaments (Bennett et al., 1979; Gard and 
Lazarides, 1980). During later stages of myogenic differentiation, desmin 
redistributes from a cytoplasmic filamentous pattern to a sarcomeric Z-line 
association at a time when adjacent sarcomeres become aligned (Bennett et al., 
1979; Gard and Lazarides, 1980). In adult chicken skeletal muscle, desmin is 
localized at the peripheries of Z-discs (Granger and Lazarides, 1978). One 
interpretation of these observations is that desmin or desmin-containing filaments 
initially facilitate, and subsequently maintain the cross-striated sarcomeric 
registry m skeletal muscle by redistributing to the Z-disc peripheries and 
interlinking adjacent myofibrils across the myocyte cytoplasm (Granger and 
Lazarides, 1978, 1979; Gard and Lazarides, 1980). Vimentin follows the same 
redistribution pattern as desmin during myogenesis, but is present in mitotic and 
post-mitotic myoblasts, as well as in fusing and post-fusion myotubes (Granger and 
Lazarides, 1979; Gard and Lazarides, 1980). 
The mechanism by which intermediate filament redistribution occurs during 
myogenesis is unknown. Desmin and vimentin may associate preferentially with 
Z-discs due to the de novo appearance of binding sites at these structures. 
Another possibility involves the developmentally-regulated expression of Z disc-
specific desmin and vimentin mRNAs, whose products would localize only at Z-
discs. Posttranslational modifications of desmin and vimentin also may affect 
their subcellular localizations and interactions. Lastly, the ratio of vimentin to 
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desmin may influence intermediate filament distribution. To distinguish among 
these possibilities, studies were carried out to examine the accumulation of 
desmin mRNA (Capetanaki et al., 1984) and vimentin mRNA (Capetanaki et al., 
1983 [Chapter 2 of this thesis]) during myogenesis in vitro, using cloned DNAs as 
probes. The major increase in desmin mRNA accumulation occurred during the 
time of the major onset of myoblast fusion, coinciding with the time of increased 
desmin protein synthesis (Gard and Lazarides, 19&0; Capetanaki et al., 1984). The 
specific expression of desmin during and subsequent to myoblast fusion therefore 
appears to be regulated primarily at the level of mRNA abundance. The induction 
of desmin mRNA levels and desmin synthesis parallels the induction of other 
muscle-specific mRNAs and proteins at the time of fusion (Devlin and Emerson, 
1979; Shani et al., 1981; Moss and Schwartz, 1981). Vimentin mRNA and vimentin 
protein synthesis were maintained at fairly constant levels during myogenesis 
(Gard and Lazarides, 1980; Capetanaki et al., 1983 [Chapter 2]). Since both 
desmin and vimentin each exist as a single copy per haploid avian or mammalian 
genome (Zehner and Paterson, 1983; Capetanaki et al., 1984; Quax et al., 1983, 
1985), each producing only one protein-coding sequence, it seems unlikely that a 
switching of desmin or vimentin mRNAs (and hence, the respective protein 
products) occurs. The relatively constant levels of vimentin and desmin protein at 
the time of myogenic intermediate filament redistribution renders unlikely the 
possibility that changing ratios of subunit composition affect localization. It is 
possible that the filament redistribution in fact is mediated solely by a specificity 
conferred by desmin, and that vimentin passively co-localizes in desmin-vimentin 
heteropolymeric filaments. 
Both vimentin and desmin are substrates for cAMP-dependent protein 
kinases (O'Connor et al., 1981; Gard and Lazar ides, 1982), and at the time of 
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myogenic intermediate filament redistribution, the sensitivities and sites for these 
kinases change (Gard and Lazarides, 1982). Furthermore, Oanto and Fischman 
(1984) have characterized a monoclonal antibody that recognizes desmin in adult 
cardiac and skeletal muscle, but not in cultured cardiac muscle cells or certain 
regions of embryonic myocardium. The differential reactivity to this antibody 
presumably reflects conformational differences or differential masking, which 
only allows this epitope to be reactive in adult muscle (Oanto and Fischman, 
1984). Together these results suggest that the redistribution of desmin- and 
vimentin-containing filaments during myogenesis is effected either by 
posttranslational modifications of these proteins, by the elaboration of a 
vimentin- or desmin-specific Z-disc receptor, or both. However, the levels of 
desmin and vimentin accumulation appear to be determined primarily at the level 
of mRNA abundances. 
The highly ordered striations of cardiac and skeletal muscle cells, quite 
obvious to the microscopist's eye, is perhaps an extreme example of cytoplasmic 
organization. The observations discussed above suggest that desmin- and 
vimentin-containing intermediate filaments play a role in establishing and 
maintaining this organization. Intermediate filaments have also been implicated 
in nuclear anchorage and nuclear centration. In cultured human fibroblasts, 
intermediate filaments appear to span the cytoplasm and interact directly with 
the nuclear laminar residue following detergent extraction (Lehto et al., 1978). 
Centrifugal enucleation of cultured fibroblasts reveals a residual connection of 
intremediate filaments between the extruding nucleus and the presumptive 
cytoplast, further suggesting an anchoring role for these filaments (Laurila et al., 
1981). However, other studies have shown that a disruption of intermediate 
filaments by microinjection of monoclonal antibodies has no obvious effects on the 
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morphology of cultured fibroblasts (Lin and Feramisco, 1981). The relevance of 
this observation to other cell types and differentiating cell systems remains to be 
determined. In the nucleated erythrocyte of non-mammalian vertebrates, the 
centrally-located nucleus appears to be anchored by a filamentous network (Harris 
and Brown, 1971; Cohen, 1978). The filaments of this system are 10 nm in 
diameter, and appear to span the cytoplasm and attach to the plasmalemma and 
nucleus (Harris and Brown, 1971; Virtanen et al., 1979; Woodcock, 1980; Granger 
and Lazarides, 1982). Immunological and biochemical analyses have demonstrated 
that the transcytoplasmic filaments in avian erythrocytes are composed of 
vimentin (Granger et al., 1982). 
The question arises as to what vimentin binds on the nuclear and 
plasmalemmal surfaces. Georgatos and Marchesi (1985) have demonstrated that 
vimentin binds to the human erythrocyte membrane via a specific interaction with 
ankyrin, a component of the membrane skeleton. The relevance of this 
observation to the present discussion is equivocal for two reasons. First, since 
vimentin filaments are not present in the mature mammalian erythrocyte (see 
below), the physiological significance of vimentin-ankyrin binding is unknown. It 
is possible that vimentin instead binds to the plasma membrane via ankyrin m 
earlier stages of mammalian erythropoiesis, or alternatively may bind to some 
other membrane skeletal receptor, which may be present only during early stages 
of erythropoiesis. Second, non-mammalian ankyrin and vimentin may not be 
capable of binding to each other, and so the plasmalemmal association of 
intermediate filaments in nucleated erythrocytes would not be due to such an 
interaction. Direct binding studies using avian vimentin and avian membrane 
skeleton components will be needed to resolve this issue. 
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How do intermediate filaments attach to the nucleus? Ultrastructural 
examination of membrane-extracted fibroblasts have shown an attachment of 
intermediate filaments with the residual nuclear laminar material (Lehto et al., 
1978). Interestingly, McKeon et al. (1986) have discovered a surprising sequence 
and structural homology between the nuclear lamins A and C and all other classes 
of intermediate filaments. Lam ins A and C both contain the a-helical central rod 
domain characteristic of cytoplasmic intermediate filaments. These results 
suggest that the nuclear lamina is assembled via coiled-coiled oligomerization of 
the nuclear lamins, and furthermore that the nuclear lamins represent a sixth 
class of intermediate filament protein (McKeon et al., 1986). It will be interesting 
to see if nuclear lamins can form hetero-oligomers or heteropolymers with 
cytoplasmic intermediate filaments via coiled-coiled interactions. The structural 
homology between nuclear lamins and cytoplasmic intermediate filaments 
presents exciting new possible mechanisms for the attachment of intermediate 
filaments to nuclei. 
As an approach to understanding the developmental and tissue-specific 
regulation of intermediate filaments, as well as the functional consequences of 
their expression, I have chosen erythropoiesis as a model system in which to study 
the expression of the vimentin gene. In Chapter 2 I present data demonstrating 
the isolation and identification of cloned DNAs specific for chicken vimentin, and 
an analysis of vimentin mRNAs in different chicken tissues and cells. Vimentin 
mRNA accumulates to high levels in chicken definitive erythroid cells, and this 
accumulation appears to underlie the synthesis and accumulation of vimentin 
filaments (Granger et al., 1982; Blikstad and Lazarides, 1983). In contrast to the 
avian erythrocyte, the anucleate mammalian erythrocyte contains no intermediate 
filaments. Immunof luorescence microscopy studies have shown that vimentin 
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expression is lost during the erythroblastic stages of human erythropoiesis in vivo 
(Dellagi et al., 1983). In Chapter 3 (Ngai et al., 1984) I demonstrate that vimentin 
expression is diminished upon chemically-induced differentiation of murine 
erythroleukemia (MEL) cells in vitro, and that the observed loss of vimentin 
filaments is due to a rapid decrease in vimentin mRNA levels. Differentiating 
MEL cells therefore provide an excellent model system in which to study vimentin 
gene regulation during cellular differentiation. The striking contrast in vimentin 
expression in avian and mammalian erythropoiesis led to a speculation that the 
loss of vimentin filaments during mammalian erythroid terminal differentiation is 
necessary to facilitate enucleation (Ngai et al., 1984 [Chapter 3]). What is the 
molecular basis for the divergent regulation of vimentin expression in avian and 
mammalian erythropoiesis? Have the factors governing vimentin gene regulation 
during erythropoiesis changed since the divergence of birds and mammals, or 
alternatively, have vimentin sequences themselves diverged, rendering the 
present-day patterns of erythropoietic vimentin expression? In Chapter 4 I have 
addressed these questions by studying the behavior of transfected vimentin genes 
in differentiating MEL cells. Based on these results, I present a mechanism to 
explain the divergent regulation of vimentin in avian and mammalian 
erythropoiesis. 
Protein 4.1 and the Erythrocyte Membrane Skeleton 
A mesh-like protein network lines the inner surface of the mammalian 
erythrocyte plasma membrane, and is believed to confer upon this membrane its 
properties of strength and elastic ity, and to influence the lateral mobility of 
membrane proteins (reviewed by Branton et al., 1981, Cohen, 1983, and Marchesi, 
1985). The major proteins of this network, termed the membrane skeleton, are a-
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and s-spectrin, which form an (a,s)2 tetramer and complex with actin to form a 
two-dimensional protein network. This spectrin-actin-based complex is bound to 
the plasma membrane primarily via a high affinity interaction with ankyrin, which 
in turn is bound to a subset of transmembrane anion transporter molecules 
(Bennett and Stenbuck, l 979a,b, 1980; Luna et al., 1979; Yu and Goodman, 1979; 
Hargreaves et al., 1980). Protein 4.1 facilitates the interaction of spectrin and 
actin by forming a ternary complex with these two components (Ungewickell 
et al., 1979; Fowler and Taylor, 1980; Cohen and Korsgren, 1980; Ohanian et al., 
1984). Protein 4.1 also has been demonstrated to interact directly with two 
intrinsic membrane proteins, glycophorin (Anderson and Lovrien, 1984) and anion 
transporter (Pasternack et al., 1985), as well as with membrane phospholipid (Sato 
and Ohnishi, 1983). Protein 4.1 therefore plays an important role in the 
maintenance of the membrane skeleton. 
The major membrane skeletal components of the mammalian erythrocyte 
have been identified in chicken erythrocytes (Chan, 1977; Weise and Chan, 1978; 
Repasky et al., 1982; Jay, 1983; Granger and Lazarides, 1984; Nelson and 
Lazarides, 1984). Protein 4.1 exists as a set of structurally related polypeptides in 
avian erythroid cells (Granger and Lazarides, 1984). In chicken erythrocytes, 
there are seven major protein 4.1 variants of 77, 87, 100, 115, 150, 160, and 
175 kDa, with the 100 and 115 kDa polypeptides found in highest abundances 
(Granger and Lazarides, 1984, 1985). In immature mitotic erythroblasts, the 77 
and 87 kDa protein 4.1 variants predominate, and as the cells undergo terminal 
differentiation, the 100 and 115 kDa polypeptides accumulate to higher levels 
(Granger and Lazarides, 1985). Hence, the expression of multiple protein 4.1 
variants is developmentally regulated during chicken erythropoiesis. A kinetic 
analysis of protein 4.1 synthesis and assembly onto the membrane skeleton 
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indicates that protein 4.1 variants do not arise by posttranslational processing 
pathways (Granger and Lazarides, 1984; Staufenbiel and Lazarides, 1986). The 
complexity of protein 4.1 expression in chicken erythrocytes raises the question as 
to how these multiple variants are generated. Several lines of evidence have 
given preliminary indications that multiple protein 4.1 polypeptides are the 
product of a single gene. First, turkey erythrocytes contain protein 4.1 variants 
similar to those found in chickens, but each variant is consistently -3 kDa smaller 
(Granger and Lazar ides, 1984). It would be difficult to reconcile these consistent 
interspecies differences with the presence of multiple protein 4.1-encoding 
genes. Second, a human patient presenting a mutant form of erythroid protein 4.1 
has been described, wherein the mutation yielded an 8.5 kDa truncation of both of 
the proteins which comprise the normal protein 4.1 doublet in humans (Alloisio 
et al., 1982). A single genetic locus apparently was responsible for this mutation 
(Alloisio et al., 1981). 
In Chapter 5 (Ngai et al., 1987) I present data showing the isolation and 
characterization of cDNA clones specific for chicken erythroid protein 4.1. I have 
used these cDNAs as probes in a preliminary investigation of the mechanisms 
governing the production of multiple protein 4.1 variants. 
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Summary 
We have isolated chicken cDNA and genomic clones 
for the intermediate filament subunit vimentin and 
show that the gene for this protein, which exists in 
a single copy in the haploid chicken genome, is 
transcribed into two mature mRNA species with ap-
proximate lengths of 2.0 and 2.3 kb. We have found 
cell-specific regulation in the expression of these 
two mRNAs; whereas both mRNA species are pre-
sent in muscle cells, fibroblasts, spinal cord and 
lens, erythroid cells from 10- and 15-day-old chicken 
embryos express predominantly the lower molecular 
weight RNA. The difference between these two 
mRNAs is due to different lengths of their 3' untrans-
lated regions, suggesting that the cell-specific reg-
ulation of their expression occurs either by specific 
termination of transcription or by differential post-
transcriptional processing of the 3' untranslated re-
gion. Additionally, a remarkable induction (40· to 50· 
fold) in the abundance of the vimentin mRNA is 
observed in erythroid cells as chicken development 
proceeds from 4 to 15 days, which suggests that the 
level of expression of vimentin during erythroid de-
velopment is regulated at the transcriptional level. 
Introduction 
The expression of intermediate filament subunits repre-
sents an attractive model system for studying regulation 
of gene expression during development and differentiation 
in higher eukaryotic organisms. The five major classes of 
subunits identified to date share a number of structural 
and biochemical similarities and generally exhibit specificity 
of expression in certain cell types: keratins are expressed 
in epithelial cells, neurofilaments in neurons, glial filaments 
in glial cells and desmin in muscle cells. A major exception 
is the intermediate filament subunit vimentin ; even though 
it is the predominant subunit expressed in certain mesen-
chymally-derived cell types, its expression is more gener-
alized (for reviews see Lazarides, 1980, 1982). Certain 
terminally differentiating cells substitute a cell-type specific 
subunit for vimentin upon their commitment to differentiate 
(e.g. neurons; Tapscott et al., 1981 ), while in others expres-
sion of vimentin persists through the fully differentiated 
state. In the latter case, vimentin can be the sole subunit 
expressed which is best exemplified in chicken erythro-
cytes (Granger et al., 1982). Alternatively, vimentin is coex-
pressed with a cell type-specific subunit [e.g. chicken 
skeletal muscle (Granger and Lazarides, 1979), certain 
mouse retinal neurons (Drager, 1983), and chicken and rat 
astrocytes (Tapscott et al., 1981 ; Yen and Fields, 1981)]. 
The modulation of the ratio of vimentin and the cell-type 
specific subunit may be a function of their differential 
synthesis and turnovers. Whether indeed this heterogene-
ity in the composition of certain intermediate filament 
systems is regulated by the differential abundance in the 
mRNAs of the two subunits is presently unknown. 
In addition, intermediate filaments exhibit a rearrange-
ment in their cytoplasmic distribution in cultured myogenic 
cells, where a cytoplasmic filament-type distribution is 
replaced with a sarcomere Z-line association (Gard and 
Lazarides, 1980). This rearrangement is presumed to re-
flect a functional property of these filaments in muscle 
morphogenesis (Granger and Lazarides, 1978; Gard and 
Lazarides, 1980; Lazarides, 1980). How this morphoge-
netic redistribution is regulated during the terminal stages 
of muscle differentiation is also undetermined. 
To probe the above observations and to further define 
the modes of expression of the various intermediate fila-
ment subunits, we have examined the expression of vi-
mentin mRNA in a variety of tissues and in different stages 
of differentiation of certain cell types by the use of recom-
binant clones of chicken vimentin. We show that the 
vimentin gene, which is represented only once in the 
chicken genome (Zehner and Paterson, 1983), spans at 
least 8 kb of DNA and is transcribed into two distinct 
mRNA species which exhibit cell specificity in their expres-
sion. The difference in the lengths of the two mRNAs is 
primarily due to different lengths of their 3 ' untranslated 
regions, suggesting that the expression of the two mRNAs 
is regulated by cell-type specific termination of transcription 
or by differential post-transcriptional processing (but not 
splicing) of the 3' untranslated region . Furthermore, we 
show that the accumulation of vimentin filaments during 
terminal differentiation of erythrocytes is regulated mainly 
at the transcriptional level or by RNA stabilization. 
Results 
Isolation and Characterization of Vimentin Gene 
Recombinant Clones 
Recombinant DNA clones containing vimentin gene se-
quences were isolated by a combination of two strategies 
carried out independently. First, we have used the following 
mixed 16-fold degenerate, 14-nucleotide-long synthetic 
probe, 
3' T T G C A G T T C T A C C G 5' 
A C T 
A 
T 
deduced from the amino acid sequence of chicken vimen-
tin (Geisler and Weber, 1981), 
61 64 
... Asn-Val-Lys-Met-Ala 
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Figure 1. Positive Hybrid-Selected Translation of Vimentin mRNA 
Hybrid-selected translations were performed as described in Experimental 
Procedures, and the resulting translation products and immunoprecipitates 
were resolved on a 12.5% SDS-polyacrylamide gel and detected by 
fluorography. For a given in vitro translation reaction, an equivalent aliquot 
of non-precipitated lysate was loaded as was used for immunoprecipitation. 
Lane 1, endogenous activity of lysate; lane 2, translation products from 
unfractionated 2·week-old chicken spinal cord poly(At RNA; lane 3, the 
corresponding immunoprecipitation with anti-vimentin; lane 4, translation 
products selected by p5C5 plasmid DNA and lane 5, immunoprecipitation 
with anti-vimentin; lane 6, translation products selected by pBR322 and 
lane 7, immunoprecipitation with anti-vimentin. Note that the amount of 
vimentin synthesized from spinal cord poly(At RNA is just detectable at 
these loadings. NF. 70 kd neurofilament subunit, Tb, tubulins, V, vimentin, 
G, glial fibrillary acidic protein, A, actin. 
to screen two genomic equivalents of a partial Haelll-Alul 
chicken genomic DNA Charon 4A library (Dodgson et al., 
1979). This sequence is 76 amino acids from the carboxyl 
terminus. Only three clearly positive recombinant DNA 
clones were obtained; each had a distinct restriction map 
and did not cross-hybridize with the others. 
Simultaneously, we isolated a vimentin cDNA clone from 
a chicken spinal cord cDNA library in the following manner. 
The cDNA library first was screened with 32P-labeled 
cDNAs synthesized from size-fractionated chicken spinal 
cord poly(At RNA, as described in Experimental Proce-
dures. Clones which hybridized preferentially with probes 
generated from a vimentin-enriched fraction were sub-
iected to further analysis by positive hybrid-selected trans-
lation. Figure 1, lane 4 shows the in vitro translation product 
from RNA which bound specifically to one recombinant 
cDNA plasmid, p5C5. The identity of this translation prod-
uct as vimentin was confirmed by immunoprecipitation 
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Figure 2. Restriction Map Analysis of the Vimentin Gene 
(A) Comparison of the vimentin gene isolates. Representative phage clones 
of the seven insert size-distinct classes containing the following number of 
isolates per group: .\V1, 1, .W3, 5; .W4, 4; .\VB, 6; .W12, 1; .W19, 6; .W30, 
1 (B) Detailed restriction maps of three pBR322 subclones containing the 
vimentin gene. EcoR1-Bam HI and Barn HI fragments of XVB were sub-
cloned in pBR322. The origins of the subclones are noted below the 
corresponding X VB fragments. The thick line designates the vimentin gene. 
Flanking sequences are shown by thin straight lines. The direction of 
transcription found by hybridization of the 3' synthetic probe to DNA blots 
of different restriction fragments is also indicated and the position where 
the synthetic probe hybridizes is noted as well(-~-) . The EcoRI fragment 
V8M2 is not represented in these three subclones. B, Barn HI; H, Hind Ill; 
R, EcoR1; S, Sac I. 
with an anti-chicken vimentin antiserum (lane 5), and by 
two-dimensional electrophoresis (data not shown). Lanes 
6 and 7 represent translation products from RNA selected 
by pBR322 and the corresponding immunoprecipitation 
with anti-vimentin, respectively; the amount of vimentin 
mRNA bound to pBR322 under these conditions is below 
the detection limit of our procedures. From these experi-
ments we conclude that p5C5 is a vimentin cDNA plasmid. 
By hybridizing p5C5 with the three genomic clones 
selected by the synthetic oligonucleotide probe, we estab-
lished that only one of them contains vimentin gene se-
quences. Screening four more genomic equivalents of the 
same library with p5C5 yielded 24 independent vimentin 
gene-containing phages. Restriction analysis of these vi-
mentin isolates showed that they all share several identical 
restriction fragments and represent seven insert size-dis-
tinct classes as shown in Figure 2A [multiple isolates of 
most recombinants were obtained, probably due to plate 
growth amplification (Dodgson et al., 1979)]. Further re-
striction analysis of representative clones suggested that 
they all contain overlapping fragments of the same vimen-
tin gene. Genomic DNA blot analysis as well as genomic 
reconstitution experiments demonstrated the existence of 
a single vimentin gene in the chicken genome (data not 
shown), confirming the data of Zehner and Paterson 
( 1983), reported while this work was in progress. 
Expression of the Vimentin Gene 
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The orientation of transcription within these segments 
was established by hybridization of the 3' end-specific 32P-
labeled synthetic oligonucleotide probe to DNA blots of 
restricted vimentin genomic clones (data not shown). The 
approximate position of the synthetic sequence is shown 
in Figure 2B. This position is at least 400 bp away from 
the one predicted both from the location of the peptide 
from which this synthetic probe was deduced and from 
further data of the map of the gene (see below), implying 
the existence of an intron close to the end of the translated 
region of the vimentin gene. On the other hand, hybridi-
zation of the p5C5 clone to similar DNA blots of restricted 
vimentin phage DNA indicates that the cDNA insert corre-
sponds to the 5' end of the vimentin gene and that the 
gene extends more than 2 kb upstream from the EcoRI 
fragment V8M2 as shown in Figure 2A. Furthermore, the 
p5C5 hybridization pattern reveals that this area of the 
vimentin gene is interrupted by another intron containing 
both the 2 kb V8M1 and the 0.65 kb V8M2 fragments (Fig. 
2A), as p5C5 hybridizes to the gene both left and right of 
these segments, but not to them (data not shown). 
Since the EcoRI sites are near the middle of the gene, 
we considered the X V8 clone, shown in Figure 2A, as the 
most representative, and subcloned it in pBR322. The 
chimeric plasmids were constructed by ligation of EcoRl-
BamHI-, BamHI-, and Hindlll-digested fragments of the 
genomic X V8 clone with pBR322 plasmids, and were used 
to transform E.coli HB101 (see Experimental Procedures). 
In this way we obtained subclones of all possible EcoRl-
BamHI, BamHI, and Hindlll fragments of the X V8 genomic 
clone. A detailed restriction map of three subclones, pV8L, 
pV8M1 , and pV8R, corresponding to most of the W8 
insert is shown in Figure 2B. The 5' - and 3' -boundaries of 
the vimentin gene were approximated by hybridization of 
different pV8 restriction fragments to RNA blots (data not 
shown). In the case of the 5' end, the 32P-labeled left end 
of the H3b fragment was protected by RNA from S1 
nuclease (data not shown), whereas hybridization of RNA 
blots with sequences 5' to the H3b fragment was negative. 
Assuming that these sequences are not within an intron, 
the initiation of transcription of the vimentin gene must be 
located within -50 bp 5' to the left Hindlll site of the H3b 
fragment as shown in Figure 2. Our approximation of the 
5' end of the vimentin gene does not agree with that 
recently reported by Zehner and Paterson ( 1983); these 
authors located the 5 ' end of the gene near one of the 
internal EcoRI sites. However, the position of the 3' end 
border, as shown in Figure 2, agrees with the one predicted 
by the sequence data of Zehner and Paterson (1983). 
Two Different Size mRNAs are Transcribed from 
the Single Vimentin Gene with Cell-Specificity in 
their Expression 
To investigate the expression of the vimentin mRNA in 
different cell types, during myogenesis and during eryth-
roid development, the following experiments were carried 
out. Total and/or polyadenylated RNA from gizzard, skel-
etal muscle, spinal cord, lens fibers, 10-day-old embryos, 
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chicken embryo fibroblasts , myogenic cultures at different 
stages of differentiation, and erythroid cells from different 
stages of chicken embryonic development were fraction-
ated by electrophoresis in agarose gels containing form-
aldehyde and transferred to nitrocellulose paper. The im-
mobilized RNA was then hybridized with a nick-translated 
probe synthesized either from the entire pV8R (Figure 2) 
or portions therefrom. The results of such experiments are 
shown in Figures 3 and 4. Two distinct size classes of 
vimentin mRNA can be identified, with molecular lengths 
of 2.0 and 2.3 kb, as shown by Zehner and Paterson 
(1983) for myogenic cells. Both mRNA species are present 
in muscle cells, fibroblasts , spinal cord and lens at similar 
concentrations. However, from Figure 3A it is evident that 
with the exception of skeletal muscle, in the other tissues 
the 2.3 kb RNA is 1 .5-2 times more prevalent than the 2.0 
kb species. Both mRNA species were detected in 14-day 
embryonic muscle polysomal poly(At RNA (data not 
shown), indicating that both are mature mRNAs. 
Surprisingly, erythroid cells obtained from 10- and 15-
day-old embryos express predominantly the lower molec-
ular weight vimentin mRNA (Figure 3 A; Figure 4 A and B) ; 
comparatively very low amounts of the 2.3 kb RNA 
species are present in both cases. At the same level of 
exposure, no vimentin RNA band could be detected in 
total or poly(At RNA from 4-day embryonic erythroid cells 
(Figure 4, A and B) Prolonged exposure of this blot (- ?X) 
reveals the presence of very low levels of vimentin mRNA 
and a lower difference in the intensities of the two mRNA 
bands. The increase in vimentin mRNA from 4- to 10-day 
cells is approximately 30-fold , whereas there is a smaller 
increase (less than two times) from 10- to 15-day cells. 
Comparison of total and poly(At erythrocyte RNA blots 
(Figure 4, A and B) demonstrates a smaller increase in the 
prevalence of the 2.0 kb RNA species in the poly(At RNA 
population from 10- to 15-day cells. This might arise from 
a higher degree of vimentin RNA polyadenylation in the 
10-day as compared to the 15-day erythroid cells. 
Two main conclusions emerge from the observations 
described above. First, there is specific expression of 
predominantly the lower molecular weight vimentin RNA 
species in erythroid cells from 10- and 15-day chicken 
embryos (Figures 3 and 4) . Second, there is a remarkable 
(40- to 50-fold) increase in the level of expression of this 
2.0 kb RNA in erythroid cells as development proceeds 
from the 4th to the 15th day (Figure 4). 
Figure 3B shows RNA blot analysis of cultured myogenic 
cells at 6, 12, and 64 hr after plating . There is an almost 
equimolar representation of the two RNA species through-
out myogenesis with a slight increase in the relative con-
centration of the 2.0 kb RNA as differentiation proceeds. 
With regard to the level of vimentin expression in the 
different tissues or cells tested, cultured myogenic cells 
and chicken embryo fibroblasts contain the highest levels 
of vimentin RNA Additionally, it is evident that the amount 
of vimentin RNA in gizzard is -50-fold lower than in 10-
day-old total embryo and 10-fold lower than in skeletal 
muscle (Figure 3). 
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Figure 3. Expression of Vimentin RNA in Different Chicken Cell and Tissue Types and During Myogenesis In Vitro 
(A) Total polyadenylated RNA isolated from different sources was fractionated by electrophoresis on 1.3% agarose gels containing 2.2 M formaldehyde, 
transferred to nitrocellulose filters and hybridized to nick-translated probe synthesized from either the entire pV8R or part of it. Lane 2, 10-day-old embryo (1.5 
µg): lane 3, 1-week-old skeletai muscle, (3 µg): lane 4, 1-week-old gizzard smooth muscle, (5 µg); lane 5, 2-week-old spinal cord , (3 µg); lane 6, 1-week-old 
lens, (3 µg); lane 8, 15-day-old embryonic ery1hrocytes. (3 µg). The quantities of the RNA used were intentionally unequal due to high prevalence differences. 
Lane 7 is a three-fold longer exposure of the gizzard lane (4). Lane 1 shows a blot similar to lane 2 hybridized with the synthetic oligonucleotide probe as 
described in Experimental Procedures. 
(B) Similar RNA blots carried out as (A) using 10 µg total RNA from different stages of cultured myogenic cells 6 hr (1), 12 h (2). and 64 h after plating (3), 
and chicken embryo fibroblasts (4) hybridized to p5C5. The positions of 27S and 18S rRNA were obtained by ethidium bromide staining of 5 µg total chicken 
muscle RNA from adjacent lanes. 
The Two Size Classes of Vimentin mRNAs Differ in 
the Lengths of Their 3' Untranslated Regions 
The data presented so far demonstrate that the single 
vimentin gene is transcribed into two different size classes 
of mRNA with cell-specific expression. Unmodified chicken 
vimentin synthesized in vivo migrates as one major 52,000 
dalton protein in both one- and two-dimensional gel elec-
trophoresis (see Lazarides, 1980, 1982). This is also the 
result of our hybridization selection experiments where in 
vitro translation of the selected RNA and immunoprecipi-
tation of the translated products give only one size protein 
(Figure 1 ), thus suggesting that the -300 nucleotide 
difference between the two vimentin mRNAs is not due to 
large differences in protein coding regions but arises pre-
dominantly from differences in untranslated sequences. In 
an attempt to find the segment of the gene that encodes 
only one of the two mRNAs we hybridized RNA blots to a 
series of probes from different regions near the 5' end 
and 3' end of the vimentin gene. All probes hybridized to 
both RNAs (e.g. see Figure 5, fragment Hindlll-Hincll), 
except the Hincll-Hindlll fragment from the 3' end of the 
gene, shown in Figure 5, which hybridized only to the 
longer mRNA species. The preferential expression of the 
lower molecular weight mRNA in 15-day erythrocytes is 
shown once more by this experiment. The DNA probe 
containing the rest of the 3' sequences of the pV8R insert 
(Figure 5) did not hybridize to either mRNA. These data 
demonstrate that the difference between the two size 
classes of vimentin mRNA lies mainly in the len~ths of their 
3' untranslated regions and is not due to differential splic-
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Figure 4. induction in the Expression of Vimentin mRNA during Ery1hroid 
Development 
RNA blots similar to those described in Figure 3 were pertormed with either 
10 µg ery1hrocyte total RNA (A) or 3 µg ery1hrocyte poly(A)' RNA (B) 
obtained from 4-day-old (4 d), 10-day-old (10 d) and 15-day-old (15 d) 
embryos, as designated. 4d• is a 7-fold longer exposure of lane 4d. The 
positions of 27S and 18S rRNA were obtained as described in Figure 3. 
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ing at the 3' end of the gene. While this work was in 
progress, Zehner and Paterson ( 1983) reported the se-
quence of the 3' untranslated region of the vimentin gene 
which revealed two sets of tandemly repeated putative 
polyadenylation sites approximately 250 nucleotides apart. 
The Hincll site we have used to generate the 3' segment 
of the gene that hybridized only to the larger RNA species 
is located between these tandem polyadenylation sites, 90 
bp 3' to the second site of the first set (Figure 5). We have 
searched further for any possible differences in the tran-
scription of the 5' end of the vimentin gene by S1 nuclease 
mapping using both embryonic and erythrocyte RNA; no 
differences could be detected at our level of resolution 
(-50 bp) (data not shown). 
Discussion 
Transcription of the Single Vimentin Gene into Two 
mRNAs with Cell-Specificity in Their Expression 
We report here the isolation, characterization, and pattern 
of expression of the chicken vimentin gene. Restriction 
map analysis and genomic DNA blot experiments con-
firmed the observation that vimentin is present as a single 
copy in the haploid chicken genome (Zehner and Paterson, 
1983). Experiments by Dodemont et al. (1982) also have 
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Figure 5. Localization of the 3' Untranslated Se-
quence Responsible for the Size Ditterences of 
the Two Vimentin mRNAs 
The lower part of the figure shows blots of RNA 
from 10-day-old embryos and 15-day erythrocytes 
hybridized to ditterent fragments of the 3' end 
and beyond the 3' end of the vimentin gene, as 
designated. The upper portion of the figure shows 
the restriction map of the 3' end of the gene and 
the fragments used for these hybridizations. The 
450 bp Hind Ill· Hine II fragment and the 1150 bp 
Hine II-Hind Ill fragments were isolated from low-
melt agarose gels, from the 1.6 kb Hind Ill fragment 
H3e and after labeling by nick-translation were 
hybndied to RNA blots. The 2.8 kb Hind Ill-Barn HI 
fragment beyond the 3' end was isolated from the 
pV8R subclone and labeled as described above. 
The asterisks (") show the two polyadenylation site 
sets derived from the sequence data of the 3' 
end of the gene (Zehner and Paterson, 1983) . 
suggested the presence of a single vimentin gene in the 
hamster genome. We show that the single chicken vimen-
tin gene is transcribed into two different size mRNA spe-
cies of 2.0 kb and 2.3 kb with cell-specific regulation in 
their expression. Whereas both mRNA species are repre-
sented in chicken muscle cells, fibroblasts, spinal cord, 
and lens, predominantly the lower molecular weight mRNA 
is expressed in erythroid cells obtained from 10- and 15-
day-old chicken embryos. Erythroid cells from 4-day-old 
embryos, however, express both mRNAs in comparatively 
low amounts and with a much smaller difference in the 
relative abundance of the two species. 
Blood cells from 4-day-old embryos are a mixture of 
early and late polychromatophilic primitive erythroblasts, 
whereas cells from 10-day-old embryos are -25% primi-
tive cells, -35% mid to late polychromatophilic definitive 
erythroblasts, and -35% mature definitive erythrocytes; 
approximately 60-70% of the cells from 15-day-old em-
bryos are mature definitive erythrocytes, with the remainder 
being late polychromatophilic definitive erythroblasts 
(Bruns and Ingram, 1973). We do not know which of these 
cells synthesize vimentin or the relative quantities of vi-
mentin produced by each cell type. Nevertheless, since 
primitive and definitive erythrocytes arise from different 
erythroid cell lines, the induction of accumulation of the 
2.0 kb vimentin mRNA found between 4 and 10 days of 
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development should be considered as lineage-specific. 
Furthermore, the low abundance 2.3 kb vimentin mRNA in 
1 o- and 15-day-old cells most likely doesnot derive from 
pnmrtive series cells, as these cells comprise only a small 
percentage of the 10-day population, and are virtually 
absent in 15-day-old embryo blood. 
The tremendous induction in the 2.0 kb vimentin mRNA 
expression from 4- to 15-day embryonic erythroid cells 
underlies similar changes at the protein level (Blikstad and 
Lazarides, unpublished results), strongly suggesting pri-
marily transcriptional and/or posttranscriptional, but not 
translational control in the expression of vimentin during 
erythroid development. Transcriptional and/or posttran-
scriptional control in the level of vimentin expression may 
apply to the rest of the cell and tissue types studied as 
well, as comparative abundances in vimentin mRNA gen-
erally correlate with the observed respective protein levels. 
This is best exemplified in the case of gizzard, where the 
low levels of vimentin detected (Granger and Lazarides, 
1980), reflect similarly low levels of vimentin RNA. 
The Two Vimentin mRNAs have Unequal Lengths in 
Their 3' Untranslated Regions 
By hybridizing RNA blots from both erythrocytes and 
embryos to different fragments of the vimentin gene (Fig-
ure 5), we have shown that the difference between the 
two size classes of vimentin mRNA, transcribed from a 
single gene, is due to different lengths of their 3' untrans-
lated regions. Hence, it is clear that during erythroid de-
velopment erythrocytes regulate vimentin expression either 
by differential termination of transcription or by differential 
processing of the 3' end. At present we have no evidence 
supporting either of these two possibilities. An answer to 
this question will require short time periods of labeling and 
detection of the vimentin primary transcripts. In vitro tran-
scription studies have shown continuous transcription of 
the mouse /)-major globin gene extending 1400 nt beyond 
the poly(A) addition site (Hofer and Darnell, 1981 ), sug-
gesting the necessity of an endonucleolytic cleavage of a 
primary transcript followed by polyadenylation in the proc-
ess of creating the 3' end of this mRNA, as has been 
demonstrated for the adenovirus and SV40 transcription 
units studied (Nevins and Darnell, 1978; Ford and Hsu, 
1978; Lai et al., 1978; Faser et al., 1979; Nevins et al., 
1980). We therefore cannot exclude a precursor-product 
relationship in which the 2.3 kb mRNA is cleaved and 
secondarily polyadenylated, thus giving rise to the 2.0 kb 
mRNA. The size heterogeneity in the 3' untranslated re-
gions of mRNAs derived from a single vimentin gene 
resembles those reported for the mouse dihydrofolate 
reductase gene which codes for four mRNAs (Setzer et 
al., 1980), as well as the mouse /32-microglobulin (Parnes 
and Robinson, 1983), and a-amylase genes (Tosi et al., 
1981), both of which code for two mRNAs. Since the 
biological functions of 3' untranslated regions is unknown, 
the significance of variations in their lengths is unclear. The 
important implication of our data, however, is directly 
related to this question. The tissue-specific differences in 
the relative distribution of the two size classes of vimentin 
mRNA imply that the presence and usage of multiple 
poly(A) addition sites are biologically significant. It is pos-
sible that the differences in the 3' untranslated region 
somehow affect the subcellular compartmentation of the 
mRNA (and consequently the fate of the translated pro-
tein), the relative stabilities of the two mRNAs, or both. 
Functional Implications of the Induction of Vimentin 
mRNA Accumulation During Erythroid Development 
Preliminary studies from this laboratory have shown that 
the primitive series of erythroid cells in the chicken contain 
and synthesize very low levels of vimentin (Blikstad and 
Lazarides, unpublished observations). However, there is a 
dramatic increase in the synthesis and accumulation of 
vimentin when the definitive series of erythroid cells ap-
pears in the blood of the animal (Blikstad and Lazarides, 
1983), with a concomitant appearance of clearly identifia-
ble intermediate filaments (Granger and Lazarides, 1982). 
The observed increase in the accumulation of vimentin 
mRNA in the definitive series erythroid cells (Figure 4) 
argues that this accumulation of vimentin is regulated either 
at the level of transcription or by RNA stabilization. How 
this induction in the transcription or accumulation of vimen-
tin mRNA is regulated during the switch of the organism 
from the production of the primitive series to the production 
of the definitive series of cells is unknown. One possibility 
is that the level of induction is influenced by hemopoietic 
microenvironments at the sites of production of the defin-
itive series cells. Alternatively, the level of vimentin expres-
sion may be a function of stem cell heritage. Nevertheless, 
the large induction in vimentin synthesis suggests that 
vimentin filaments are an essential part of the terminal 
differentiation program of these cells. The increased ac-
cumulation of vimentin in definitive erythroid cells should 
be contrasted and compared with the expression of inter-
mediate filaments in other terminally differentiating cells 
such as neurons and muscle cells. In these cases the cells 
substitute the pre-existing vimentin filaments with a cell 
type-specific intermediate filament subunit, either com-
pletely, as in the case of the neurofilament subunit in 
neuronal differentiation (Tapscott et al., 1981), or partially 
as in the case of desmin in muscle differentiation (Gard 
and Lazarides, 1980). Since, at least in the case of eryth-
roid cells, regulation of vimentin expression occurs pre-
dominantly at the level of mRNA abundance, such partial 
or complete changes in the composition of intermediate 
filaments during terminal differentiation in other cell types 
also may be regulated at the mRNA level. 
Implications for the Regulation of Vimentin 
Distribution During Myogenesis 
Developing myogenic cells exhibit a striking redistribution 
of vimentin- and desmin-containing filaments which occurs 
during the terminal phases of differentiation (Kelly, 1969; 
Bennett et al., 1979; Gard and Lazarides, 1980). In the 
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initial stages of myogenesis vimentin and desmin assemble 
into cytoplasmic intermediate filaments. However, after the 
assembly of functional, contractile sarcomeres, vimentin 
and desmin begin to associate with the myofibril Z-discs 
(Gard and Lazarides, 1980), where they surround and link 
them laterally to each other and to other cytoplasmic 
organelles (Granger and Lazarides, 1978, 1979). Since 
vimentin filaments exhibit slow turnover in vivo (McTavish 
et al., 1983; Blikstad and Lazarides, 1983), the redistribu-
tion of vimentin could be regulated at the transcriptional 
level by the activation of a Z-disc specific vimentin gene, 
posttranslationally by a specific chemical modification of 
vimentin, and/or by the elaboration of a specific Z-disc 
vimentin receptor which induces these filaments to rear-
range and bind to the peripheries of Z-discs. The first 
possibility is unlikely, as we and others (Zehner and Pater-
son, 1983) have shown that vimentin is present as a single 
gene in the chicken genome, and moreover, the major 
difference between the two mRNA species appears to lie 
in the 3' -untranslated regions. This is in accordance with 
previous studies from this laboratory which show that the 
vimentin protein exhibits no detectable changes in its 
electrophoretic mobility or isoelectric point before and after 
transition to the Z-line (Gard and Lazarides, 1980). How-
ever, we have observed that vimentin (and desmin) be-
come susceptible to changes in their phosphorylation by 
cAMP-dependent protein kinases at a time which coincides 
with the onset of this redistribution to the Z-line (Gard and 
Lazarides, 1982). Collectively these observations suggest 
that the redistribution of vimentin filaments during the 
terminal phases of myofibril assembly is regulated primarily 
posttranslationally and/or by the appearance of a specific 
Z-disc vimentin receptor(s). 
Experimental Procedures 
Isolation of RNA 
Gizzards, skeletal muscle, and lens fibers were isolated from 1-week-old 
chicks and spinal cords from 2-week-old chicks. Chicken embryo ery1hroid 
cells were isolated from 4-, 10-, and 15-day-old embryos as previously 
described (Granger et al. , 1982). Cultures of embryonic myogenic cells and 
chicken embryo fibroblasts were prepared from 10- to 11-day-old chicken 
embryos as previously described (Gard and Lazarides, 1980). Total RNA 
was isolated essentially according to the method described by Chirgwin et 
al. ( 1979). Pulverized frozen tissue or cell pellets were homogenized in 5 M 
guanidinium thiocyanate, 50 mM Tris, pH 7.5, 50 mM EDTA, 5% 2-
mercaptoethanol, and 3% sodium lauryl sarcosine using a Dounce homog-
enizer. The homogenates (-30 ml) were layered over 8 ml 5.7 M Cscl 
cushions and centrifuged at 39,000 rpm for 20 hr in a Beckman 60 Ti rotor. 
The pellets were dissolved in water and precipitated with ethanol twice. 
Polyadenylated RNA was isolated by oligo( dT)·cellulose chromatography 
essentially as described by Aviv and Leder ( 1972). 
Construction and Screening of the Spinal Cord cDNA Library 
Synthesis of cDNA from 2-week-old chicken spinal cord poly(At RNA was 
essentially performed as outlined by Efstratiadis and Villa-Komaroff (1979) 
using oligo(dT), 2_, 8 as a primer. Second strand synthesis was carried out 
with DNA polymerase I. The resulting double stranded cDNA was digested 
with nuclease S1 and chromatographed on a Biogel A150 m column. 
Leading fractions were pooled, yielding cDNAs with lengths of 0.5 to > 1.6 
kb. This cDNA was homopolymerically tailed with dCTP by incubation with 
terminal transferase (Rowekamp and Firtel, 1980); Pstl-digested, gel purified 
pBR322 was similarly reacted with dGTP. Approximately equimolar amounts 
30 
of dCMP-tailed cDNA and dGMP-tailed vector were annealed and used to 
transform E.coli HB101 (Cohen et al., 1972). 
32P-labeled cDNAs generated from size-fractionated spinal cord poly(At 
RNA were utilized as probes in a preliminary screening of the cDNA library. 
Poly(At RNA from spinal cords of 2-week·old chickens was electropho-
resed in the presence of methylmercury hydroxide (Bailey and Davidson, 
1976) on a preparative 1% low melting point agarose gel. The gel was 
soaked in 0.2 M potassium acetate (pH 5.0), 1 mM EDTA, 13 mM DTI, 
and then sliced repetitively perpendicular to the direction of electrophoresis. 
A volume of the above buffer approximately equal to that of each gel slice 
was added to each fraction, the gels were melted at 60°C, and RNA was 
purified by extraction with phenol (Weislander, 1979). 
To determine the mRNA composition of each fraction, aliquots were 
used to direct protein synthesis in a nuclease-treated rabbit reticulocyte 
lysate (Pelham and Jackson, 1976) containing 35S·methionine. The resulting 
translation products were subjected to both one- and two·dimensional gel 
electrophoresis (Laemmli, 1970; O'Farrell, 1975; Hubbard and Lazarides, 
1979); the gels were impregnated with Enhance (New England Nuclear), 
dried and exposed to Kodak XAR film . 
Fractions which were determined by in vitro translation to be enriched 
in vimentin mRNA served as substrates for reverse transcriptase in the 
presence of a-32P·labeled deoxynucleotides, using sheared denatured calf 
thymus DNA as primer (Taylor et al., 1976). Filters bound with DNA of 
colonies bearing recombinant plasmids were hybridized with -2 x 106 
cpm probe/ml for 48 hr at 42°C (Grustein and Hogness, 1975). To identify 
and reduce the number of non·vimentin positives, the library wak counter· 
screened in a similar fashion using 32P-labeled cDNAs synthesized from 
RNA fractions depleted of vimentin mRNA, as well as from gizzard poly(At 
RNA. 
Positive Hybrid-Selected Translation 
Complementary DNA clones which hybridized differentially with the vimen-
tin-enriched 32P·labeled cDNA probe were pooled in groups of up to 6 and 
further tested by positive hybrid-selected translation (Ricciardi et al., 1979). 
Twenty micrograms of EcoRl-restricted, denatured plasmid DNA, was 
spotted on nitrocellulose (Kafatos et al., 1979) with the aid of a Hybridot 
Manifold (Bethesda Research Laboratories) . Filters were washed with 1 M 
NH40Ac and 1X SSC (1X SSC is 150 mM NaCl, 15 mM Na-citrate), and 
baked at 70°C under vacuum. Prior to hybridization. filters were boiled in 
H20 and prehybridized in 50% formamide, 0.1 M PIPES, 0.6 M NaCl, pH 
6.4, 50 µg/ml poly(A) for 2 hr at 54°C. Nine micrograms of 2-week·old 
chicken spinal cord poly(At RNA was hybridized for 3 hr with each filter in 
30 µI of the above buffer minus poly(A) at 54°C. Filters were then washed 
ten times with 1XSSC, 0.5% SOS at 65°C, twice with 10 mM Tris-HCI, 2 
mM EDTA, pH 8.0 at room temperature, and once with 10 mM Tris-HCI, 
pH 7.5 at room temperature . Bound RNA was eluted by boiling the filters 
for 60 sec in 100 µI H20 and quenching in a dry ice/ethanol bath. Three 
micrograms of carrier beef liver tRNAs and 10 µI 2 M NH.OAc were added, 
and the samples were precipitated and washed twice with 70% ethanol. 
The RNA pellets were then used to direct protein synthesis in a rabbit 
reticulocyte lysate as described in the previous section. lmmunoprecipita-
tions were carried out using a high-titer rabbit anti·chicken vimentin antise-
rum (Granger and Lazarides, 1979) essentially according to method B of 
Blikstad et al. (1983) , except that all immunoprecipitation buffers contained 
0.25% 2·mercaptoethanol to reduce background. lmmunoprecipitates as 
well as non-precipitated samples were electrophoresed on 12.5% SDS-
polyacrylamide gels, impregnated with Enhance and subjected to fluorog-
raphy. 
Synthesis of a Mixed Oligonucleotide Probe 
The mixed oligonucleotide probe 
3' -T T G C A G T T C T A C C G-5', 
A C T 
A 
T 
derived from the amino acid sequence, Asn-Val-Lys-Met-Ala, which is 
located 76 amino acids from the carboxyl terminus of chicken vimentin 
(Geisler and Weber, 1981), was synthesized by the solid phase triester 
procedure mainly as described by Miyoshi et al. ( 1980). The oligonucleo-
tides were purified by gel filtration. followed by gel electrophoresis in 20% 
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or 25% polyacrylamide-urea gels. The probes were labeled with [ -y-32P)A TP 
using bacteriophage T 4 \QOlynucleotide kinase. The sequences of the 
oligonucleotides were conlirmed by DNA sequencing using a modification 
of the Maxam-Gilbert technique (1980), in combination with 5' end nucleo-
tide determination by thin layer chromatography of S 1 nuclease-treated 32P-
labeled oligonucleotides. 
Screening of the Chicken Genomic Library 
The chicken Charon 4A genomic DNA library used was prepared by 
Dodgson et al. ( 1979) by partial digestion with Hae Ill and Alu I restriction 
enzymes. as described by Maniatis et al. (1978). 
A. Screening wilh Synthetic Oligonuc/eotide Probes 
Duplicate nitrocellulose filters representing 9 x 105 pfu's were prepared as 
described by Benton and Davis ( 1977) and prehybridized at 65°C for 3 hr 
in a solution containing 6X SET buffer (1X SET is 0.15 M NaCl, 30 mM Tris, 
pH 7.5, 1 mM EDTA), 5X Denhardt's solution (1X Denhardt's solution is 
0.02% BSA. 0.02% Ficoll, 0.02% polyvinyl pyrrolidone (Oenhardt, 1966)) 
0.5% NP-40 and 100 µg/ml sheared single stranded salmon testis DNA. 
Hybridization was carried out at 25°C for 48 hr in 6X SET buffer, 2X 
Oenhardt's solution, 250 µg/ml tRNA, containing 4 x 1()6 cpm 32P-labeled 
oligonucleotide probe per ml. Filters were washed four times at room 
temperature in 6X SSC for 20 min each and then twice at 25°C in 6X SSC 
for 30 min each. Filters were air-dried and exposed to Kodak XAR film with 
Dupont Lightening Plus intensifying screens. 
8. Screening wilh the Vimentin cDNA 
4 x 1()5 pfu's of the genomic DNA library were screened using nick-
translated (Rigby et al., 1977) insert of the p5C5 vimentin cDNA clone. 
Filters were prepared and hybridized to 32P·labeled insert according to 
Benton and Davis (1977). 
DNA Isolation 
Phage DNA was isolated essentially as described by Yamamoto et al. 
(1970). Plasmid DNA was isolated either as described by Clewell and 
Helinski (1972) or by Holmes and Quigley (1981). High molecular weight 
DNA was prepared from liver nuclei by a modification of the method 
described by Firtel and Bonner (1972). Restriction enzyme-generated DNA 
fragments were isolated from low melting temperature agarose gels mainly 
as described by Weislander (1979), or from normal agarose gels according 
to Brown et al. (1976). Oligonucleotides were isolated from 20% or 25% 
polyacrylamide-urea gels by the method described by Maxam and Gilbert 
(1977). 
Subcloning of Genomic Vimentin Sequences into pBR322 
Plasmids containing genomic vimentin sequences were constructed ac-
cording to Mertz and Davis (1972) and Cohen et al. (1973) by ligation of 
EcoRl-BamHI-, BamHI-, and Hind Ill-digested fragments of the genomic :W8 
clone with pBR322 which had been digested with the appropriate enzymes 
to generate complementary ends. The recombinant plasmids were then 
used to transform E. coli HB101 (Cohen et al., 1972). Nick-translated 
vimentin-spec1fic sequences were used to select clones containing the 
desired fragments (Hanahan and Meselson, 1980). 
Restriction Endonuclease Mapping 
Restriction endonuclease cleavage sites were determined either by single 
and double digests with various restriction endonucleases or by partial 
digestion of end-labeled fragments according to Smith and Birnstiel (1976). 
Digestion products were resolved in conventional horizontal agarose gels. 
RNA Blotting and Hybridization 
RNA electrophoresis under denaturing conditions in the presence of form-
aldehyde was carried out according to Lehrach et al. (1977) as modified 
by Capetanaki et al. (1982). Gels were soaked in 20X SSC for 30 min and 
transferred to nitrocellulose with 1 OX SSC for 10-15 hr, using the transfer 
system described by Southern ( 1975). 
Hybridizations of -5 x 105 cpm/ml 32P-labeled nick-translated probes 
(Rigby et al.. 1977) to filter-bound RNA were performed as described by 
Wahl et al. (1979) at 42°C for 15 hr. Following hybridizations, filters first 
were washed three times at room temperature with 2X SCC, 0.2% SOS, 
for 15 min each and then four times at 50°C with 0.2 x sec. 0.2% sos 
for 30 min each. Filters were dried and exposed to Kodak XAR film with 
intensifying screens. RNA hybridizations using the synthetic oligonucleotide 
probes were performed as described for the genomic library screening. 
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Differentiation of Murine Erythroleukemia Cells Results 1n 
the Rapid Repression of Vimentin Gene Expression 
JOHN NGAI, YASSEMI G. CAPETANAKI, and ELIAS LAZARIDES 
Division of Biology, California Institute of Technology, Pasadena, California 9 7 7 25 
AssTRAcT We show that vimentin filaments are present in undifferentiated Friend murine 
erythroleukemia cells, but are lost progressively to undetectable levels by 96 h of dimethyl 
sulfoxide-mediated differentiation. The amount of newly synthesized cytoskeletal vimentin is 
decreased dramatically by 24 h of induction, and is paralleled by a rapid loss of vimentin 
mRNA (-25-fold reduction at 96 h). Hence, disappearance of vimentin filaments in these cel ls 
appears to be regulated at the level of vimentin mRNA abundance. On the other hand, the 
levels of actin synthesis and actin mRNA remain essentially unchanged. The kinetics of 
vimentin mRNA reduction during dimethyl sulfoxide-mediated differentiation, and the levels 
of vimentin mRNA observed in the presence of hexamethylene-bisacetamide or hemin as 
inducers suggest that the cessation of vimentin expression precedes, but may be associated 
with commitment to terminal differentiation. Our results demonstrate the dynamic regulation 
of vimentin expression in mammalian erythropoiesis. 
Elucidation of the events occurring in mammalian erythro-
poiesis has been facilitated by the study of murine erythroleu-
kemia cell differentiation in vitro. Friend murine erythroleu-
kemia (MEL) 1 cells originally were derived from Friend leu-
kemia virus-infected tumor _implants and proliferate rapidly 
in culture ( 13). Exposure to a variety of chemical agents, such 
as dimethyl sulfoxide (DMSO), hexamethylene-bisacetamide 
(HMBA), or butyric acid induces MEL cells to differentiate 
(14, 29, 48; for a review see reference 35). Among the char-
acteristic phenomena observed during terminal differentiation 
of MEL cells are a maturation from a basophilic erythroblastic 
appearance to an orthochromatophilic normoblastic pheno-
type ( l 4 ), a loss of proliferative capacity ( l 2, 2 l ), alterations 
in purine metabolism ( 46), increases in iron uptake and heme 
synthesis ( 14), an elevation of heme synthetic enzyme activi-
ties (10, 54), the induction of globin mRNAs ( 41,43,50), 
and the accumulation of hemoglobin (14). The tremendous 
induction of hemoglobin synthesis and accumulation in 
chemically-induced MEL cells, a distinctive feature of eryth-
roid terminal differentiation in vivo, is effected by transcrip-
tional activation of globin genes (2, 34, 44 ); the relative 
accumulation of globin mRNAs also may be modulated by 
the stabilization of these messages and/or by the destabiliza-
tion of nonglobin mRNAs (2, 32, 56, 60). 
1 Abbreviations used in this paper: DMSO, dimethyl sulfoxide; 
HMBA, hexamethylene-bisacetamide; MEL, Friend murine erythro-
leukemia; TX-100, Triton X = I 00. 
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Studies from this laboratory have demonstrated that vimen-
tin is the major intermediate filament subunit in chicken 
erythrocytes ( l 9). We have shown further that during chicken 
embryonic development, the expression of vimentin in cir-
culating erythroid cells is regulated at the level of transcription 
and/ or mRNA stabilization (5). An approximately SO-fold 
increase in the accumulation of vimentin mRNA is observed 
between 4-d primitive series cells and l 5-d definitive series 
cells, and this increase appears to underlie similar changes at 
the protein level (5 ). In contrast, Dellagi et al. (7) have shown 
by immunofluorescence microscopy that vimentin is lost 
during human erythropoiesis in vivo. However, the loss of 
vimentin could not be correlated with a particular stage of 
erythroid development, as the presence of vimentin was var-
iable in both early and late erythroblastic cells. 
To define the mechanisms that regulate vimentin expres-
sion during mammalian erythropoiesis, we have examined 
the pattern of expression of this intermediate filament subunit 
in differentiating MEL cells. We have found that vimentin 
filaments disappear from the cytoplasm of DMSO-treated 
MEL cells, and that this disappearance results from a rapid 
decrease in vimentin synthesis. Furthermore, we demonstrate 
that the observed change in vimentin synthesis during induc-
tion is caused by a rapid and dramatic decrease in the amounts 
of steady state vimentin mRNA, indicating that vimentin 
filament expression in differentiating MEL cells is regulated 
primarily at the mRNA level. Our data suggest that the 
cessation of vi men tin filament expression is an essential com-
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ponent of the terminal differentiation program in mammalian 
erythropoiesis. 
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Cell Culture: Friend murine erythroleukemia cells were obtained from 
Dr. Barbara J. Wold (California Institute of Technology, Pasadena, CA) and 
were maintained in Dulbecco's modified Eagle medium (DME) supplemented 
with 15% fetal calf serum and penicillin/streptomycin at 37°C in an atmosphere 
of95 % air/5% CO,. Cells were passaged every third day at dilutions of 1:100. 
For induction experiments, cultures were initiated at densities ranging from 5 
x I 04/ ml to 2 x IO' / ml, and incubated in the presence of 1.8% DMSO, 4 mM 
HMBA, or 75 µM bovine hemin (from a 10-mM stock solution, prepared as 
described by Ross and Sautner [51]) for the times indicated in each of the 
experiments. Inducers were added to culture media prior to the addition of 
cells. Cells from control cultures were harvested after 2-3 d. In general, cells 
were harvested while they were still in logarithmic growth (although cells 
induced in DMSO or HMBA for 96 h had just begun to reach plateau densities. 
as expected at this stage of MEL cell terminal differentiation [ 12. 21 ]). Growth 
kinetics were derived by estimation using a hemacytometer, and cell viability 
was confirmed by trypan blue exclusion. 
/mmunofluorescence Microscopy: Yimentin-containing inter-
mediate filaments were visualized using a rabbit anti-chicken vimentin anti-
serum ( 17). Although this antiserum displays weaker reactivity with mammal-
ian vimentin than with chicken vimentin. immunoprecipitation of [" S]labeled 
MEL cell proteins (method B of reference 4) indicates that vimentin is specifi-
cally recognized in this system (data not shown). 
MEL cells from different periods of induction were washed twice with Tris-
buffered saline ( 140 mM NaCl, 5 mM KCI, 10 mM Tris-Cl. pH 7.5), resus-
pended in Tris-buffered saline. and allowed to settle onto Alcian Blue-treated 
coverslips at 4"C ( 19). Adherent cells were fixed for 2 min at room temperature 
in 2% formaldehyde. 140 mM KC! , 5 mM MgCI,. I mM EGTA, I mM NaN 3• 
20 mM PIPES. pH 7.0, and rinsed and permeabilized in Tris-buffered saline 
plus 0.5 % Triton X-100 (TX-100) and I mM EDTA. Cells were reacted first 
with the rabbit anti-chicken vimentin antiserum at I :40 dilution. and then with 
fluorescein isothiocyanate-conjugated goat anti-rabbit lgG diluted I: I 50 (Miles-
Yeda Ltd. , Rehovot. Israel). Coverslips were mounted in Tris-buffered saline 
and viewed in a Leitz phase/ epifluorescence microscope using a 63 x objective. 
Metabolic Labeling with [3 5S]Methionine and Two-dimen-
sional Ce/ Electrophoresis: For each time point examined. 2 x 106 
cells were pelleted by centrifugation and washed in 5 ml Dulbecco's modified 
Eagle medium depleted of methionine and supplemented with 15% dialyzed 
fetal calf serum. with or without 1.8% DMSO. Cells were resuspended in 5 ml 
of this medium plus -100 µCi ["S]methionine (Amersham Corp. , Arlington 
Heights. IL. ca. 1.100-1.200 Ci/ mmol) and incubated at 37°C for I h. After 
labeling, cells were placed on ice. washed with Ca'•- and Mg'•-free Earle's 
balanced salt solution (EBSS). and resuspended in 100 µI 100 mM KC!, 300 
mM sucrose. 20 mM PIPES. 5 mM Mg acetate,, 5 mM EGTA, 0.5% TX-100, 
pH 6.8 (cytoskeleton buffer: 39). Lysis was allowed to proceed for 5 min at 
O"C. and insoluble "cytoskeletal" fractions were pelleted by centrifugation. 
After removal of detergent-soluble phases. pellets were resuspended in cyto-
skeleton buffer plus 2.5% 2-mercaptoethanol. saturated with urea. The TX-
100-insoluble residues are defined operationally as cytoskeletal fractions. TX-
100 fractionation is necessary for two-dimensional gel analysis of mammalian 
vimentin. as in our gel system the large quantities of tubulin (mostly soluble 
under these lysis conditions) obscures the identification of vimentin. TX-100 
insoluble "S-labeled vimentin therefore represents newly synthesized and newly 
assembled cytoskeletal vimentin (3. 39). 
Protein-incorporated 35S-radioactivity was determined from total lysates as 
well as from TX-100 soluble and insoluble fractions. Briefly, aliquots were 
incubated in I N NaOH, 4 mg/ml methionine. and 0.4 mg/ ml BSA at 37°C 
for 10 min to hydrolyze methionyl-tRNA complexes, precipitated with tricho-
loroacetic acid. and collected on Whatman GF/C filters (Whatman Laboratory 
Products. Inc., Clifton. NJ). Radioactivity was determined by liquid scintillation 
counting in Aquasol-2 (New England Nuclear, Boston, MA). Typically 12-
14% of protein-incorporated "S-radioactivity was found in the cytoskeletal 
fraction. For electrophoretic analysis, the amounts of sample used were nor-
malized to total cell lysate protein "S-radioactivity. 
Two-dimensional gel electrophoresis was performed as described by O'Far-
rell (42) and modified by Hubbard and Lazarides (23). Resolving gels in the 
second dimension contained 12.5% acrylamide and 0.1 % bisacrylamide. After 
electrophoresis, gels were fixed , impregnated with Enhance (New England 
Nuclear). and subjected to fluorograph y using preflashed Kodak XAR-5 film 
(26). "S-labeled vimentin was identified on the basis of its co-migration with 
purified bovine lens vimentin (40). 
RNA Isolation: Cells were harvested by centrifugation at appropriate 
times, washed twice with Ca2•- and Mg'•-free Earle's balanced salt solution, 
quickly frozen in liquid N,, and stored at -80-C. Total cellular RNA was 
isolated by the method ofChirgwin et al. (6). Frozen cell pellets (each containing 
up to -4-5 x 108 cells) were thawed into 27 ml 5 M guanidinium thiocyanate, 
50 mM Tris-Cl. pH 7.5. 50 mM EDTA, and 5% 2-mercaptoethanol. The 
resulting viscous DNA was sheared by at least 10 strokes in a Dounce homog-
enizer(with a tightly fitting pestle), and by 5 additional strokes after the addition 
of 3 ml 30% sodium lauryl sarcosine. Homogenates were layered over 8 ml 
cushions of 5.7 M CsCI. I mM EDTA. pH 8.0, and RNA was pelleted by 
centrifugation for 20-24 hat 39,000 rpm in a Beckman 60 Ti rotor (Beckman 
Instruments. Inc. , Palo Alto, CA) at 20"C. Pellets were resuspended in water. 
precipitated twice with ethanol. washed once with 70% ethanol, and dried. The 
recovery of RNA by this method is quantitative if care is taken to shear 
sufficiently the cellular DNA {which traps RNA): we find that recovery of RNA 
from cells at a given stage of induction is constant irrespective of cell number 
(between -1.5 x 108 and -4.5 x 108 cells/30 ml homogenization buffer). 
Poly(Ai+-enriched RNA was isolated by two rounds of oligo(dT)-cellulose 
chromatography (I). Within an induction experiment. the conditions of 
oligo(dT)-cellulose chromatography for each sample were maintained as iden-
tical as possible. In this manner, a constant fraction of total RNA was recovered 
as poly(Aj+ RNA (generally 2% recovery), regardless of the stage of MEL cell 
differentiation. 
RNA Electrophoresis, Blotting to Nitrocellulose, and Hy-
bridization: RNA was separated on I. I% agarose gels under denaturing 
conditions in the presence of formaldehyde (30). essentially as described by 
Goldberg ( 16). Following electrophoresis. gels were soaked in 20 x SSC (I x 
SSC is 150 mM NaCl. 15 mM Na-citrate) and transferred to nitrocellulose in 
10 x SSC according to the method of Southern (58). Filters were washed briefly 
in 2 x SSC. air dried. and baked in vacuo at 80-C for 2-3 h. 
"P-labeled DNA probes were utilized to detect specific filter-bound RNA 
sequences. For the detection of vimentin RNA, the -0.5 kilobase (kb) insert 
from p5C5. a chicken vimentin cDNA plasmid (5) was isolated (62) and nick-
translated (49) using a 32 P-labeled deoxynucleoside triphosphates (ca. 800 Ci/ 
mmol. New England Nuclear). Detection of /l-globin RNA sequences was 
facilitated by nick-translation of pMB-/lG2. a recombinant mouse /Jm*'-globin 
genomic plasmid (25), whereas actin sequences were identified using a "P-
labeled actin cDNA plasmid derived from chicken smooth muscle. This actin 
cDNA plasmid (containing a 1.9 kb-insert) was isolated by screening a chicken 
gizzard cDNA library with a sea urchin actin probe (55). Its identity as an actin 
cDNA was confirmed by positive hybrid-selected translation (data not shown). 
Filter-bound RNA was hybridized to 5 x IO' cpm/ml nick-translated probe 
at 42-44-C for 20-24 h, as described by Wahl et al. (61) in the absence of 
dextran sulfate. Filters then were washed twice in 2 x SSC. 0.2% SDS at room 
temperature for 20-30 min each. and four times in 0.1 x SSC, 0.2 % SDS at 
42-44-C for 30 min each. and air dried. Blots were exposed to preflashed 
Kodak XAR-5 film with DuPont Lightning-Plus intensifying screens. 
Quantitation of RNA Blot Hybridizations: The relative levels 
of specific RNA species during MEL cell differentiation were quantitated by 
determining densities of autoradiographic signals from RNA blot hybridiza-
tions. For this technique to be reliable and effective. however, a number of 
variables were controlled. First. for every experiment requiring quantitation. 
the RNA sample containing the highest amount of the sequence of interest was 
diluted and included in the same gel containing the other experimental samples. 
For example. vi men tin mRNA quantitation was standardized by using control 
RNA diluted to 1.0-, 0.5-. 0.25-. 0.1-. and 0.05-equivalents. For actin mRNA, 
control RNA was diluted to 1.0-. 0.8-, 0.6-. and 0.4-equivalents, whereas for 
globin mRNA quantitation. RNA from cells induced for 96 h in DMSO was 
diluted to 1.0-, 0.5-. 0.25-, 0.1-. and 0.05-equivalents. Hence. concentration 
standards were treated identically as the experimental samples were through 
electrophoresis, transfer. hybridization. washes. exposure. and photographic 
development. 
Second, deviations from linearity of film response to signal were taken into 
account. The inclusion of standards with each blot to be quantitated controlled 
for reciprocity failure at low intensity levels. However, hybridization bands that 
expose the film to or beyond saturation cannot be quantitated. The effects of 
nonlinear film response were minimized by preflashing film to an optical 
density of 0.15 at 540 nm (26), and by exposing films within linear range for 
several periods of duration. Autoradiograms were scanned with a densitometer, 
and peak areas were determined using a computer digitizer. 
Fig. I shows an example of a standardization for vimentin mRNA. The 
autoradiogram of Fig. I A was from the same blot (and same film) as the one 
of Fig. 4A. The graph in Fig. I B shows the relationship between peak area and 
relative level of vimentin mRNA. Although the overall response is not linear, 
this type of curve is typical. 
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RESULTS 
Disappearance of Vimentin Filaments from 
oMSO-induced MEL Cells 
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Indirect immunofluorescence microscopy using an antivi- . 
mentin antiserum revealed that vimentin filaments are lost 
from differentiating MEL cells. Cells were cultured in control 
medium or for 24, 36, 48, and 72 h in the presence of 1.83 
DMSO and prepared for immunofluorescence microscopy. 
Representative micrographs are shown in Fig. 2. MEL cells 
grown in control medium exhibit cytoplasmic vimentin fila-
ments. Upon incubation with DMSO, however, vimentin-
specific fluorescence progressively diminishes. After 24 h in 
DMSO, vimentin filaments are still visible in most cells, but 
their presence is more difficult to detect than in control cells. 
Longer periods of DMSO induction result in a further dimi-
nution of detectable vimentin, and filaments generally are not 
visible after 48 h of incubation. Diffuse cytoplasmic fluores-
cence is also observed in all cells; this is due to nonspecific 
staining, as it is observed when preimmune serum is used as 
the primary antibody (data not shown), and is present irre-
spective of the cellular vimentin content (see below). 
The loss of vimentin filaments in differentiating MEL cell 
cultures appears to be uniform; for a given time point, distinct 
subpopulations of vimentin-positive and vimentin-negative 
cells are not seen. The presence of apparently vimentin-
negative cells among positive cells (Fig. 2) is due primarily to 
· the positions of cells outside the plane of focus. However, 
visualization of cells exposed to DMSO for 48 or 72 h occa-
sionally reveals a cell displaying vimentin filaments (see Fig. 
2). These are rare cases (<I %), and most likely represent cells 
that did not respond to the inducer. By this qualitative assay, 
the disappearance of detectable vimentin filaments occurs in 
differentiating MEL cells between 24 and 48 h of DMSO-
mediated induction, a time that corresponds to the onset of 
significant hemoglobin accumulation (31 , 36; see also below). 
Analysis of Newly Synthesized Cytoskeletal 
Vimentin in Differentiating MEL Cells 
MEL cells differentiating in response to DMSO rapidly and 
extensively reduce the synthesis of vimentin, and conse-
quently cease the de novo assembly of vimentin filaments. 
Although 35S-labeled vimentin is present in cytoskeletons 
from control ME L cells (Fig. 3A), after 24 h of induction 
newly synthesized cytoskeletal vimentin is barely detectable 
(Fig. 3 B), and at 36 and 72 h of culture in DMSO (Fig. 3, C 
and D), remains at or below detection limits. Since de novo 
assembly of vimentin filaments ceases rapidly, the disappear-
ance of filaments in MEL cell differentiation may result from 
dilution by cell division (see Discussion). 
Immunoprecipitation of newly synthesized cytoskeletal vi-
mentin and subsequent one-dimensional gel analysis also 
yields a pattern similar to that seen in Fig. 3; we observe a 
slight decrease in 35S-labeled vimentin after 12 h of induction, 
and at 24 h and all subsequent time points vimentin was 
nearly or completely absent (data not shown). Examination 
of 35S-labeled vimentin from total cell lysates by immunopre-
cipitation revealed that vimentin synthesis is diminished at 
24 h of incubation in DMSO and thereafter (data not shown). 
Hence, the reduction in newly synthesized cytoskeletal vi-
mentin parallels the rapid and extensive repression of vimen-
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F1 GU RE 1 Standardi za ti on o f vimentin RNA hybridiza tion. (A) Au-
toradiogram o f an RNA b lot containing 4.0, 2.0, 1.0, 0.4, and 0.2 µg 
control MEL ce ll poly(At RNA, hybridized to the vimentin cDNA 
probe. (8) Q uantitati on o f th e blot in A. Vimentin mRNA peaks 
were scanned and integrated w ith a computer digit izer. Th e data 
are expressed as peak area vs . percent control, w ith 100% corre-
sponding to 4 µg poly(At RNA. 
tin synthesis. These observations are consistent with previous 
studies from this laboratory, which demonstrated that vimen-
tin assembly in chicken erythroid cells occurs rapidly and 
post-translationally from a saturable pool, but with assembly 
appearing not to be regulated at this level (3, 39). 
The data in Fig. 3 indicate that the reduction in newly 
synthesized cytoskeletal vimentin (and consequently the re-
duction in newly synthesized total cellular vimentin) is spe-
cific, even though overall protein synthesis is reduced in 
differentiating MEL cells (57). Several other 35S-labeled pro-
teins are present in fairl y constant amounts throughout the 
72-h induction period, most notably actin. 35S-labeled actin 
was also maintained at constant levels in total cell lysates 
(data not shown). 
Rapid Reduction in Vimentin mRNA Levels 
During the Maturation of MEL Cells 
The data presented thus far show that the disappearance of 
vimentin filaments in differentiating MEL cells is mediated 
by a decrease in vimentin synthesis. To analyze steady state 
vimentin mRNA levels during induction, we performed quan-
titative RNA blot analysis of poly(At RNA derived from 
cells undergoing DMSO-induced differentiation, using a 
chicken vimentin cDNA as probe. This cDNA probe, desig-
nated p5C5, corresponds to the 5' region of the chicken 
vimentin gene (5). When p5C5 was hybridized to RNA blots 
38 
F1cuRE 2 Disappearance of vimentin filaments during DMSO-induced MEL cell diffe rentiation. Vi mentin filaments in MEL cells 
were visualized by indirect immunofluorescence microscopy using an antivimentin antiserum . The left -most panel of the top row 
is a phase contrast image of the same field shown in th e control fluorescence panel. Cells were examined at 24, 36, 48, and 72 
h of induction in 1 .8% DMSO, as indicated. Note the presence of a rare vimentin-posi tive cell at 48 h of differentiation (see tex t). 
Bar, 10 µm. 
containing poly(At RNA from total l-d-old neonatal mice, 
only one species with an approximate molecular length of 2.1 
kb was detected (data not shown), in agreement with the data 
of others for the mature mammalian vimentin mRNA (8. 
45). 
MEL cells were cultured in the presence of 1.83 DMSO 
and were harvested after 12, 24, 36, 48, 72, and 96 h of 
induction; untreated cells were maintained in control me-
dium. Poly(At RNA was isolated from each sample and 
analyzed by RNA blot hybridization using p5C5 as probe. An 
autoradiogram of a representative RNA blot is shown in Fig. 
4A. A 2.1-kb RNA band corresponding to vimentin mRNA 
is clearly detected in poly(At RNA from control MEL cells. 
After 12 h of culture in DMSO, this band is somewhat 
reduced, and declines rapidly between 12 and 96 h of induc-
tion. Fig. 4B, which represents data derived from two inde-
pendent induction experiments, shows the quantitation of 
relative vimentin mRNA levels through 96 h of DMSO 
induction. After 12 h of exposure to inducer, vi men tin mRNA 
is - 703 of the control level, and falls rapidly thereafter to 
approximately 303 at 24 h, 103 at 48 h, and 43 at 96 h of 
differentiation. The results demonstrate that vimentin expres-
sion in differentiating MEL cells is regulated by the steady 
state level of vi men tin mRNA. 
The data of Fig. 4 show relative vimentin mRNA levels 
normalized to total cellular RNA, since the fraction of 
poly(At RNA that we recover from total RNA is constant 
throughout the induction period (see Materials and Methods). 
However, the amount of total RNA recovered per cell de-
creases as differentiation of MEL cells progresses. From con-
trol cultures, we obtain - l.5-l.8 mg RNA/ l 08 cells, and this 
value declines steadily to -0.4-0.5 mg RNA/ 108 cells after 
96 h of culture with DMSO. consistent with the results of 
others (33 , 57). Hence, the kinetics of vimentin mRNA re-
duction per cell is actually more rapid than shown in Fig. 4B, 
and the overall extent of this loss is greater (-1 3 control 
levels per cell at 96 h of induction). The - I 00-fold reduction 
in vimentin mRNA levels per cell therefore results from both 
a specific decrease in vimentin mRNA and a general decline 
in total cellular RNA. 
Quantitation of Actin and {3-C lobin mRNA Levels 
in Differentiating MEL Cells 
To characterize further the specific reduction in vimentin 
mRNA during DMSO-induced differentiation, we performed 
as controls quantitative RNA blots using probes for actin and 
/)-globin . As in Fig. 4.4, equivalent amounts ofpoly(At RNA 
from different time points of DMSO induction were electro-
phoresed and transferred to nitrocellulose. Fig. 5 A is an 
autoradiogram of a blot hybridized to a 32P-labeled chicken 
actin cDNA, and the quantitation of this blot is shown in Fig. 
5 B. From Fig. 5, A and B, it is clear that the abundances of 
actin mRNA in poly(At RNA from differentiating MEL cells 
remain essentially constant through 96 h of culture in the 
presence of DMSO. The results show that the constant level 
of actin expression in MEL cells is regulated at the mRNA 
level. 
NGAI ET AL. Vimentin Gene Expression 309 
39 
F1cuRE 3 Two dimensional gel analysis o f newly synthesized cytoskeletal vimentin during MEL cell differentiation. Control cells 
and ce lls cultured in the presence of 1.8% DMSO for 24, 36, or 72 h were pulse- labeled for 1 h w ith [35S]methionine. Cytoskeletal 
fractions were prepared and analyzed by two-dimensional gel el ectrophoresis and fluorography (see Materials and M ethods). (A) 
control ; (8) 24 h; (C) 36 h; and (0 ) 72 h. Arrowheads demarca te vimentin, as determined by its co-migration with a purified 
bovine vimentin standard . Tb, tubulins; Ac, actin. 
The kinetics of globin mRNA induction under our culture 
conditions was assessed by hybridizing RNA blots with a 32 P-
labeled recombinant plasmid containing mouse genomic 
,sm•i0 '-globin sequences (25). The results of such experiments 
are presented in Fig. 5, C and D. After a -24-h lag period, a 
significant increase in ,B-globin mRNA is observed between 
24 and 36 h of culture in the presence of DMSO, and there 
is an overall -20-fold increase of ,B-globin mRNA over the 
basal level at 96 h of induction. The pattern of ,B-globin 
mRNA induction observed in this study is similar to the 
patterns observed by other investigators (32-34, 41 , 51 ). The 
amount of ,B-globin mRNA in control MEL cells is reproduc-
ibly higher than in cells incubated for 12 or 24 h in DMSO, 
and most likely is due to the accumulation (after 2-3 d of 
culture) of a low percentage of spontaneously differentiating 
cells in our control cultures ( 14; see also reference 35). At 48 
h of DMSO-stimulated differentiation, ,B-globin mRNA in-
creases -5-fold over basal levels (see Fig. 5 D), whereas vi-
mentin mRNA already has fallen to approximately one-tenth 
of control amounts (Fig. 4B). The decrease in vimentin 
mRNA levels therefore precedes the major accumulation of 
,B-globin mRNA. 
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Effects of HMBA and Hemin on Vimentin mRNA 
Levels in MEL Cells 
A variety of chemical agents other than DMSO can induce 
MEL cells to differentiate. For example. HMBA is a particu-
larly potent inducer, and causes terminal differentiation of 
MEL cells. as does DMSO ( 48) . On the other hand, incubation 
of MEL cells with hemin causes the rapid accumulation of 
globin mRNA, but does not induce other changes character-
istic of terminal differentiation (22, 33, 51 ). We therefore 
tested the effects of these two agents on the levels of vimentin 
mRNA in MEL cells. 
After 96 h of exposure to 4 mM HMBA, MEL cells exhibit 
an extensive reduction in vimentin mRNA, as shown by RNA 
blot anal ysis (Fig. 6A). The levels at 96 h of HMBA-mediated 
induction are similar to those seen with 1.83 DMSO after 72 
h. Fig. 6 C is a control, showing the large induction at 96 h of 
,B-globin mRNA in response to HMBA. Hence, MEL cells 
dramatically decrease the steady state level of vimentin 
mRNA during both HMBA- and DMSO-mediated differen-
tiation . 
Incubation of MEL cells with 75 µM hemin for 72 h causes 
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F1 GuRE 4 Analysis of vimentin 
mRNA levels during MEL cel l d iffer-
entiation. 4 µg of poly(A j+ RNA from 
control cells or cells cultured in 
1 .8% DMSO for 12, 24, 36, 48, 
72, and 96 h were electroph oresed 
in the presence o f formaldehyde, 
transferred to nitrocellulose, and 
hybridized with a 32 P-labeled 
chicken vimentin cDNA probe. (A) 
Autoradiogram o f a representati ve 
blot. C denotes po ly(At RNA from 
contro l ce lls; numbers indicate 
hours of culture in the presence of 
1.8% DMSO from w hich poly(Aj+ 
RNA was deri ved . V marks the po-
sit ion of the 2. 1-kb mouse vimentin 
mRNA. (8) Quantitation of vimentin 
mRNA levels during induction. The 
data in this graph were derived from 
two independent experiments from 
blots using either 4.0 or 2.2 µg RNA 
per lane, and vimentin mRNA levels 
were quantitated as described in 
Materials and Methods . The va lues 
correspond to relative quantities o f 
vimentin mRNA normalized to eel-
~~~-~~-~~-~~~-~- lular poly(At RNA content (see 
10 20 30 40 50 60 70 80 90 100 tex t}, as compared wi th the control 
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FI GURE 5 Actin and ,6-globin 
mRNA in d iffe rentiating MEL cells . 
Poly(A)+ RNA from M EL cells was 
prepared fo r quantitative RNA blot 
hybrid iza tion as descr ibed in Mate-
rials and Methods. (A) Autoradi -
ogram o f a blot containing 3 µg of 
each poly(Aj+ RNA, w hich was hy-
bridized to a chicken act in cDNA 
probe. (8) Q uantitat ion o f actin 
mRNA leve ls from the RNA blo t 
shown in A. (C) Auto radiogram of 
a blot (4 µg poly(Aj+ RNA per lane) 
hybrid ized to a mouse ,6m''10'-globin 
probe. (0) Q uantitat ion of ,6-globin 
mRNA levels during M EL ce ll differ-
entiati on, expressed as percentages 
o f th e level observed at 96 h o f 
DMSO-med iated di ffe rentiation. 
Th e data in this graph we re deri ved 
from two independent experiments. 
C contro l cell poly(At RNA; 7 2, 24 , 
36, 48, 72, 96, hours o f culture in 
1.8% DMSO. A, actin mRNA; ,6C, /3-
globin mRNA. 
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a less extensive change in vimentin mRNA, as compared with 
the effects of HMBA or DMSO (Fig. 6 B). Quantitation of an 
RNA blot similar to the one shown in Fig. 6B indicates that 
vimentin mRNA is reduced to -503 of control amounts. 
Fig. 6 D demonstrates a -4- 5-fold increase in ,6-globin mR NA 
in response to hem in, as reported by others (33, 51 ). By 
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F1cuRE 6 Effec ts of HMBA 
and hemin on MEL cell vimen-
tin and l'i-globin mRNA levels. 
(A) Autoradiogram o f an RNA 
blot containing poly(At RNA 
(4 µg each lane) from cells cul-
tured in the absence (-) or 
presence(+) of 4 mM HMBA 
for 96 h, hybridized to the vi-
mentin cDNA probe. (8) RNA 
blot analysis o f vimentin 
mRNA from cells cultured in 
the absence (-) or presence 
(+) of hemin for 72 h (4 µg per 
lane). The hybridiza tion seen 
w ith RNA from hemin -treated 
cells represents - 50% of con-
trol vimentin mRNA levels 
(see text). (C) RNA blot as in 
A, hybridized to the tl-globin -
specific probe. (0) Detection 
of tl-globin mRNA in a blot 
similar to the one in 8, except 
that 2.2 µg poly(At RNA was 
used per lane, V, vimentin 
mRNA; tiG, l'i-globin mRNA. 
immunofluorescence microscopy, nearly all cells cultured in 
the presence of 75 µM hemin for 3 d possess vimentin 
filaments (data not shown), indicating that most, if not all 
cells are responding similarly to this inducer with regard to 
vimentin expression. The response observed with hemin sug-
gests that the more extensive reduction in vimentin mRNA 
observed in DMSO- and HMBA-treated cells is an event 
related to terminal differentiation (see Discussion). 
DISCUSSION 
Disappearance of Vimentin Filaments in 
Differentiating MEL Cells is Regulated at the 
mRNA Level 
In this study we demonstrate that vimentin filaments dis-
appear from differentiating MEL cells, and this disappearance 
is preceded by a rapid cessation of vimentin synthesis and 
assembly into the cytoskeleton (see below). Moreover, the 
level of vi men tin synthesis is regulated primarily by vimentin 
mRNA levels, as the pattern of newly synthesized cytoskeletal 
vimentin during differentiation is paralleled by a similarly 
dramatic decrease in vimentin mRNA. The expression of a 
number of other proteins. most notably actin, is constant 
during chemically-induced MEL cell differentiation, indicat-
ing that the rapid and extensive repression ofvimentin mRNA 
levels is a result of the specific regulation of vimentin gene 
expression. 
Vimentin mRNA is reduced -3-fold after 24 h of culture 
in 1.83 DMSO, and -25-fold after 96 h (Fig. 4). Normali-
zation of these values to cell number reveals that vimentin 
mRNA decreases to -1 3 control levels per cell at 96 h of 
induction. This reduction results in a rapid decrease in newly 
synthesized cytoskeletal vimentin (Fig. 3). However, by im-
munofluorescence microscopy vimentin filaments are still 
detectable (with weaker fluorescence intensity) through 36 h 
of differentiation (Fig. 2). Vimentin filaments have been 
shown to be stable cellular constituents in other systems (3, 
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38). For example, in Ehrlich ascites tumor cells, the half-life 
of vimentin is similar in magnitude to the population dou-
bling time (38) ; the decay of vimentin therefore is very slow 
compared with the mitotic rate of these cells. As the doubling 
time of MEL cells under our conditions of DMSO induction 
is 14-16 h, our data suggest that the loss of filaments is 
facilitated by a rapid turn-off of vimentin synthesis with 
continual dilution of ex isting filaments by cell division. It is 
also possible that the reduction in vimentin filaments during 
differentiation is accelerated by an increased rate of vi men tin 
turnover. 
Regulation of Vimentin Gene Expression 
Our data demonstrate a dramatic repression of vimentin 
mRNA levels during MEL cell maturation. However, we do 
not know as yet the relative contributions toward this phe-
nomenon by changes in vimentin gene transcription and post-
transcriptional processing and turnover. Reduced transcrip-
tion may result from both specific repression of the vi men tin 
gene and an overall reduction of RNA synthesis, as the 
synthesis and accumulation of RNA in DMSO-treated MEL 
cells decreases during differentiation (57). In vitro nuclear 
transcription studies (20, 37) and/ or pulse-labeling in vivo, 
with subsequent detection of newly synthesized vimentin 
transcripts are needed to demonstrate directly transcriptional 
regulation of the vimentin gene in this system. These studies 
also may detect any significant changes in transport of mature 
vimentin mRNA from the nucleus to the cytoplasm. The 
turnover rate of vimentin mRNA during inducer-mediated 
differentiation of MEL cells also may be increased, thereby 
accelerating the removal of vimentin mRNA from differen-
tiating cells. Pulse-chase studies should elucidate the kinetics 
of vi men tin mRNA turnover during MEL cell differentiation. 
We have shown previously a tremendous induction of 
vimentin mRNA accumulation during chicken embryonic 
erythropoiesis (5). In chicken erythroid cells, two vimentin 
mRNA species of 2.0 and 2.3 kb are expressed at low levels 
in 4-d primitive series cells, and a specific 40-50-fold higher 
level of the 2.0-kb mRNA is observed by 15 d of development 
in definitive series cells. The increase in steady state vimentin 
mRNA during chicken embryonic erythropoiesis underlies 
similar changes observed at the protein level (5). Hence, 
although vimentin expression in chicken erythropoiesis in 
vivo and mammalian erythropoiesis in vitro are both regu-
lated transcriptionally and/ or post-transcriptionally, in the 
nucleated erythroid cells of chickens the regulation is positive, 
whereas in differentiating MEL cells the regulation is negative. 
In both cases, however, the change in magnitude of steady 
state vimentin mRNA is large (-50- to I 00-fold). Such a 
comparison of vimentin mRNA levels during avian and 
mammalian ery1hropoiesis illustrates that vimentin gene 
expression can be dynamically regulated in both positive and 
negative fashions. The contrast between these two systems 
further suggests that the regulation of vimentin expression is 
an essential feature of each of the respective terminal differ-
entiation programs, and the differences observed indeed may 
reflect the functional requirements of these cells (see below). 
Relationship of Vimentin mRNA Repression to 
Commitment of MEL Cells to 
Terminal Differentiation 
After a defined period in inducer, MEL cells acquire the 
capacity to continue in their maturation program in the 
absence of chemical inducer; this characteristic represents 
commitment to terminal differentiation (12, 21 ). In the pres-
ence of DMSO. the major onset of MEL cell commitment 
appears to occur after 20-24 h of induction, at which time 
-30% of the cells are committed; the appearance of commit-
ted cells increases rapidly thereafter, and at 48 h of induction 
reaches a plateau level of -90% (21 ). Qualitatively similar 
results for DMSO-induced differentiation and commitment 
have been reported by others ( 41 ). By comparison, vi men tin 
mRNA levels are reduced rapidly very early in DMSO-me-
diated induction; a significant decrease (to - 70% control 
levels) is observed at 12 h, the earliest time point examined 
(Fig. 4 B). The kinetics of this repression indicates that the 
decline in vimentin mRNA precedes commitment of MEL 
cells to terminally differentiate, as vimentin mRNA levels are 
reduced -3-fold by 24 h (Fig. 4B), corresponding to a time 
when a detectable fraction of committed cells is only just 
beginning to appear in the population (21, 41 ). 
Two lines of evidence-suggest that the decrease in vimentin 
mRNA expression in MEL cells is an event associated with 
terminal differentiation, even though this reduction tempo-
rally appears to precede commitment. First, HMBA, an agent 
that induces commitment and terminal differentiation ( 11 ), 
also causes a large repression of vimentin mRNA (Fig. SA). 
Second, exposure to hemin for 72 h results in a comparatively 
smaller change in vimentin mRNA abundance (-503 of 
control, see Fig. 5 B). MEL cells treated with hemin display a 
rapid (within -6 h) increase in globin mRNA (22, 41, 51 ), 
but do not show changes characteristic of terminal differen-
tiation (22), such as limited proliferative capacity (i.e. , com-
mitment; 12, 21 ), induction of cytidine deaminase activity 
(46), or induction of the chromatin-associated protein, IP2s 
(24). Our observations show that the precipitous decline in 
vimentin mRNA is an early event in MEL cell differentiation, 
and this event precedes, but may be associated with commit-
ment to terminal differentiation. A conclusive answer to this 
subject awaits further experimentation with inhibitors of MEL 
cell differentiation (see reference 35) and the study of variant 
MEL cell lines resistant or hypersensitive to induction (for 
example, see reference 52). 
Inducer-mediated MEL Cell Differentiation as a 
Model System for Vimentin Expression in 
Mammalian Erythropoiesis 
Studies of human hematopoiesis in vivo have shown that 
vimentin expression is lost during erythropoiesis, although 
the stage at which this event occurs could not be ascertained 
(7). Furthermore, the loss of vi men tin during the erythroblas-
tic stages of erythropoiesis is maintained in the mature cir-
culating erythrocyte, and no other intermediate filament sub-
units are detected (7) . Intermediate filaments have never been 
described in the mature mammalian erythrocyte. Examina-
tion of the regulatory mechanisms involved in vi men tin gene 
expression during MEL cell differentiation should facilitate 
the understanding of this phenomenon in vivo. 
Since the function of intermediate filaments has not been 
determined directly (27, 28), the significance of the repression 
of vimentin expression in mammalian erythropoiesis is un-
clear. However, electron microscopic examination of nu-
cleated chicken erythrocytes reveals a transcytoplasmic net-
work of vimentin filaments that appears to anchor the cen-
trally located nucleus ( 18). We speculate that the loss of 
vimentin filaments during mammalian erythropoiesis facili-
tates en ucleation, as the presence of intermediate filaments at 
this late stage of development physically may hinder this 
process (for example, see reference 47). The repression of 
vimentin synthesis early in MEL cell differentiation may 
reflect the necessity in vivo of allowing a sufficient number of 
cell divisions to dilute existing filaments. 
Generalization of MEL Cell Regulation of 
Vimentin Expression to Other Terminally 
Differentiating Cells 
We have proposed previously that vimentin expression in 
terminally differentiating cells is regulated at the level of 
mRNA abundance (5). For example, neurons substitute vi-
mentin completely with the neuron-specific intermediate fil-
ament protein during their differentiation (59). In other cell 
types, vimentin is replaced only partially by the cell-specific 
intermediate filament protein, such as desmin in muscle 
differentiation ( 15), and may be co-expressed with a cell type-
specific intermediate fi lament subunit in the mature cell (e.g. , 
chicken skeletal muscle: desmin [ 17], rat and chicken astro-
cytes: glial fibrillary acidic protein [59, 63], some mouse 
retinal neurons: neurofilament protein [9]). Our observation 
that the loss of vimentin filaments in differentiating MEL 
cells is regulated primarily by mRNA abundance suggests that 
the complete or partial repression of vimentin expression in 
other differentiating cell types is also controlled at the mRNA 
level. 
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SUMMARY 
We have studied the expression of transfected chicken and hamster vimentin 
genes in murine erythroleukemia (MEL) cells. MEL cells normally repress the 
levels of endogenous mouse vimentin mRNA during inducer-mediated 
differentiation, resulting in a subsequent loss of vimentin filaments. The 
expression of vimentin in differentiating MEL cells reflects the disappearance of 
vimentin filaments during mammalian erythropoiesis in vivo. In contrast, chicken 
erythroid cells express high levels of vimentin mRNA and vimentin filaments 
during term inal differentiation. We demonstrate here that chicken vimentin 
mRNA levels increase significantly in differentiating transfected MEL cells, 
whereas similarly transfected hamster vimentin genes are negatively regulated. 
In conjunction with in vitro nuclear run-on transcription experiments, these results 
suggest that the difference in vimentin expression in avian and mammalian 
erythropoiesis is due to a divergence of cis-linked vimentin sequences that are 
responsible for transcriptional and posttranscriptional regulation of vimentin gene 
expression. Transfected chicken vimentin genes produce functional vimentin 
protein and stable vimentin filaments during MEL cell differentiation, further 
demonstrating that the accumulation of vimentin filaments is determined by the 
abundance of newly synthesized vimentin. 
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INTRODUCTION 
Intermediate filaments represent a family of cytoskeletal structures whose 
members are expressed in developmentally-regulated and tissue-specific patterns 
in vertebrate cells. Keratins are expressed in epithelial cells and cells of 
epithelial origin, desmin in smooth and striated muscle, glial fibrillary acidic 
protein in glial cells, neurofilaments in neuronal cells, and vimentin in a wide 
variety of both immature and differentiated cell types (reviewed by Lazarides, 
1982, and Steinert et al., 1985). The specificity of intermediate filament protein 
expression in developing cell lineages suggests that each intermediate filament 
protein type plays an important morphogenetic role in cellular differentiation. An 
interesting facet of the study of intermediate filament proteins indeed pertains to 
their patterns of developmental and tissue-specific regulation. Vimentin 
expression is both positively and negatively regulated during the differentiation of 
a variety of cell types. For example, in chicken spinal cord, vimentin is replaced 
by neurofilament protein during the terminal differentiation of neurons (Tapscott 
et al., 1981). In muscle, astrocytes, and certain retinal neurons, vimentin is co-
expressed with the cell type-specific intermediate filament protein (desmin, glial 
fibrillary acidic protein, and neurofilament protein, respectively) in the fully 
differentiated state (Granger and Lazarides, 1979; Tapscott et al., 198 L; Yen and 
Fields, 1981; Schnitzer et al., 1981; Drager, 1983). Fibroblasts, lens fibers, and 
avian erythrocytes express vimentin as the major intermediate filament protein 
subunit of the mature cell (Franke et al., 1978; Bradley et al., 1979; Ramaekers 
et al., 1980; Granger et al., 1982). 
The generality and diversity of vimentin expression suggests that its 
regulation is necessarily complex. This complexity is particularly evident from a 
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comparison of avian and mammalian erythropoiesis. The mature avian 
erythrocyte is a nucleated biconvex ellipsoidally-shaped cell. Ultrastructural 
analyses of avian red cells have revealed a network of intermediate filaments 
which spans the cytoplasm, and appears to anchor the centrally located nucleus 
(Virtanen et al., 1979; Woodcock, 1980; Granger and Lazarides, 1982). The major 
subunit protein of these filaments is vimentin (Granger et al., 1982). In contrast, 
the anucleate, biconcave disc-shaped mammalian erythrocyte contains no 
intermediate filaments. Studies of human hematopoiesis m vivo have 
demonstrated that vimentin is expressed early in erythroid differentiation, but is 
lost in the erythroblastic stages (Dellagi et al., 1983). 
In chicken erythroid cells, vimentin filaments are assembled rapidly and 
stably from a soluble pool of newly synthesized vimentin (Blikstad and Lazarides, 
1983; Moon and Lazar ides, 1983). The efficiency and rapidity of vimentin 
assembly in vivo suggests that the extent of vimentin filament formation is 
determined primarily by the amount of vimentin synthesized. We have shown that 
the expression of vimentin protein during erythropoiesis is determined primarily 
by mRNA abundance (Capetanaki et al., 1983; Ngai et al., 1984). In chicken 
embryonic erythropoiesis, vimentin mRNA is found at low levels in immature, 
mitotic primitive cells, and accumulates to increasingly higher levels during the 
terminal differentiation of the definitive erythroid lineage, apparently underlying 
similar changes at the protein level (Capetanaki et al., 1983). During 
differentiation of murine erythroleukemia (MEL) cells in vitro, vimentin mRNA 
levels rapidly and extensively decline (-25 fold reduction), rendering a 
concomitant decrease in vimentin synthesis and a subsequent loss of vimentin 
filaments (Ngai et al., 1984). The striking difference in the changes of viment in 
mRNA abundances (and ultimately, of vimentin filaments) during mammalian and 
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avian erythropoiesis presents an opportunity to study not only the factors 
responsible for the dynamic positive and negative regulation of the vimentin gene, 
but also the basis for the evolutionary divergence of the two erythropoietic 
programs with regard to vimentin expression. 
In the present study, we have addressed these issues by exammmg the 
behavior of transfected chicken and hamster vimentin genes in differentiating 
MEL cells. The utility of studying both resident and transfected genes during 
in vitro differentiation of MEL cells is well established (reviewed by Marks and 
Rifkind, 1978, and Chao, 1986). We demonstrate that in MEL cell lines harboring 
and expressing chicken vimentin genes, chicken vimentin mRNA levels either 
increase two to ten fold or remain constant during DMSO-mediated 
differentiation, whereas the resident mouse vimentin mRNA levels decline 
extensively (l 0-20 fold). Expression of mRNA from transfected hamster vimentin 
genes is reduced significantly in differentiating MEL cells. These results suggest 
that the divergence in vimentin expression in mammalian and avian erythropoiesis 
is due to a divergence of elements linked to vimentin sequences in cis. Our results 
further suggest the existence of general erythroid- specif ic trans-acting factors 
which have been functionally conserved from birds to mammals, and interact with 
chicken vimentin regulatory sequences in murine erythroid cells in a manner 
appropriate for chicken vimentin sequences in a chicken erythroid environment. 
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RESULTS 
Transfection of MEL Cells with the Chicken Vimentin Gene 
We constructed a plasmid, designated pAV2 l, specifically for the introduction of 
chicken vimentin gene sequences into adenine phosphoribosyl transferase (aprt) 
deficient cells (Figure la). pAV21 contains the entire 7.7 kb chicken vimentin 
gene coding sequence (Capetanaki et al., 1983; Zehner et al., 1987), with 2.5 kb 5' 
flanking and 2.5 kb 3' flanking sequences, plus a 4.0 kb hamster genomic DNA 
fragment containing the hamster aprt gene (Lowy et al., 1980). In this 20 kb 
plasmid, the hamster aprt gene resides in the same or ientation as the chicken 
vimentin gene, and its point of RNA initiation (Nalbantoglu et al., 1986, 1987) is 
approximately 3.2 kb downstream from the vimentin gene's 3' terminus. pAV21 
was linearized with Asp 718 and introduced into an aprt- MEL cell line, 
Faprt-585-S (Deisseroth and Hendrick, 1978; Chao et al., 1983) by calcium 
phosphate precipitation (Wigler et al., 1979) or by poly-1-orn ithine-mediated 
transfection (Bond and Wold, 1987). Fifty-two independent aprt + MEL cell clones 
were isolated and expanded for analysis. + Of these aprt transformants, 28 
possessed intact chicken vimentin gene sequences, as judged by genomic DNA 
blotting (data not shown). Using either method of transfection, the copy numbers 
of chicken vimentin genes ranged from one copy to - 10-20 copies per cell (data 
not shown; see Table I). 
Analysis of Chicken Vimentin mRNA Expression in Differentiating MEL Cells 
MEL cell lines harboring intact chicken vimentin sequences either were grown in 
the absence of chemical inducer ("undifferentiated" cells), or were induced to 
differentiate by culturing in the presence of 1.8% DMSO (Friend et al., 1971) for 
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4-5 days, and total cellular RNA was isolated. Chicken vimentin RNA was 
detected by quantitative RNase protection of a homogeneously-labeled l. 9 kb 
32P-RNA probe specific for the first and second exons (see Figure 2b). Figure 2a, 
lane 2 demonstrates protection of portions of the RNA probe corresponding to the 
632 nt first ex on and 61 nt second ex on sequences of vimentin RNA from chicken 
embryo fibroblasts. This probe apparently also hybridizes to mouse vimentin RNA 
sequences, rendering a 70 nt protected fragment (e.g., see Figure 2a, lane 3; 
compare with tRNA control). This 70 nt fragment is not detected in RNA from 
differentiated MEL cells (e.g., see Figure 2a, lane 4), and is absent from RNA 
preparations derived from other murine cell lines devoid of vimentin mRNA, such 
as the plasmacytoma MPC-11 (McTavish et al., 1983; data not shown). Ten MEL 
cell lines expressed correctly initiated chicken vimentin RNA at detectable levels 
(Figure 2a, lanes 5-24). Seven cell lines, MELCY-4, MELCV-5, MELCY-11, 
MELCV-26, MELCY0-2, MELCV0-12, and MELCV0-16, induced the expression of 
chicken vimentin RNA 2-10 fold during differentiation (Figure 2a; see Table I). 
With the exception of MELCV0-26, the remainder of chicken vimentin-expressing 
cell lines maintained relatively constant levels of chicken vimentin RNA during 
DMSO-mediated differentiation. MELCV0-26 cells expressed chicken vimentin 
RNA only at very low levels, and upon differentiation, these levels decreased by 
approximately 2-5 fold. The variations in levels of expression and induction are 
typical for transfected genes in this and other systems (e.g., see Chao, 1986). As 
an internal control, we observe that mouse vimentin RNA levels decreased by > l 0-
fold during differentiation of all MEL cell lines, as judged by the 70 nt fragment 
protected by mouse vimentin RNA sequences (Figure 2a). 
Among the cell lines which induced chicken vimentin RNA during DMSO-
mediated differentiation, MELCV-5, MELCV-26, and MELCY0-12 e xpressed the 
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chicken RNA after differentiation at levels comparable to or greater than the 
levels of endogenous mouse vimentin RNA found in undifferentiated cells 
(compare the 70 nt protected fragment of mouse vimentin with the 61 nt 
protected fragment of chicken vimentin in lanes 5 and 6, 11 and 12, and 15 and 
16). Experiments similar to the one shown in Figure 2a were performed several 
times, with results qualitatively similar to those shown here (data not shown). 
Analysis of a-Globin RNA Levels in Transfected MEL Cells 
To assess the extent of differentiation of each of the cell lines expressing chicken 
vimentin RNA, we analyzed the levels of s-globin RNA during differentiation of a 
selected subset of cell lines. A 345 nt 32P-labeled RNA, complementary to mouse 
smaJor globin sequences from the 5' end of the first intervening sequence 
(excluding the first 9 nt), to the 3' end of the second exon (excluding the last 
13 nt) was synthesized and used as a probe in RNase protection experiments 
(Figure 3b). A 209 nt protected fragment corresponding to exon II of the smaJor 
globin mRNA is induced 50-fold in the parent MEL cell line (Figure 3a, lanes 2 and 
. . 
3; Table I). Our smaJor globin probe also detects the presence of smmor globin 
transcripts, as evidenced by the protection of an 81 nt fragment, corresponding to 
homology with sequences between nucleotide positions 262 to 342 of smaJor globin 
(Konkel et al., 1979). The pattern shown in lanes 2 and 3 indicate that the parent 
MEL cell line used in this study, Faprt-585-S, exhibits a high ratio of sminor 
globin to smajor globin RNA, and expresses a significant amount of sminor globin 
RNA in the undifferentiated state; the induction of smmor glob in RNA in these 
cells is 3-4 fold. As a comparison, the induction pattern of s-globin RNA from 
another MEL cell line, Mel-Fl, is shown in Figure 3a, lanes 18 and 19. This MEL 
cell line produces mainly smaJor globin RNA upon differentiation with DMSO, and 
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comparatively little Bmmor globin RNA m either the undifferentiated or 
differentiated state. Variations in Bmajor globin and smmor globin ratios in 
different MEL cell lines have been described previously (Alter and Goff, 1978). 
Figure 3a, lanes 4-17 and Table I show that MELCV-5, MELCV-11, MELCV-26, 
MELCV-29, MELCV0-2, MELCV0-12, and MELCV0-16 all induce Bma;or globin 
RNA by 10-120 fold (mean= 43 fold), and sminor globin RNA by 2.5-7 fold 
(mean = 4 fold). Hence, the increases in chicken vimentin RNA in differentiating 
MEL cells are occurring in cells undergoing extensive differentiation, as judged by 
s-globin RNA induction. 
Analysis of Hamster aprt and Mouse y-Actin RNA Levels m Transfected MEL 
Cells 
The specificity of induction of chicken vimentin RNA levels in differentiating 
MEL cells was established by assaying levels of hamster aprt RNA. If the 
transfected vimentin and aprt genes are independently expressed in our cell lines, 
then we expect to find little or no correlation in the respective steady state 
mRNA levels during differentiation. We also measured endogenous y-actin RNA 
levels, since actin RNA levels are expected to exhibit little, if any changes during 
MEL cell differentiation (Ngai et al., 1984). MEL cell RNAs were hybridized to a 
mixture of two 32P-labeled RNA probes. The hamster aprt-specific probe is a 
0.9 kb RNA complementary to the 95 nt first exon and 111 nt second exon of the 
aprt transcript (see Figure 3d). The y-actin-specific probe is a complementary 
RNA derived from human y-actin 3' sequences, and protects an 80 nt fragment 
from mouse y-actin RNA (Enoch et al., 1986). Figure 3c shows RNase protection 
experiments which measure simultaneously the steady state levels of aprt and 
mouse y-actin RNAs. Quantitation of this gel is tabulated in Table I. A 
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comparison of hamster aprt RNA levels with chicken vimentin RNA levels reveals 
no direct correlation in either the amounts of RNA accumulated (compare 
Figures 2a and 3c) or in the ratios of RNAs in induced versus uninduced cells 
(Table I). Mouse y-actin RNA levels vary less than two-fold during MEL cell 
differentiation (Table I), and the differences observed · most likely reflect clonal 
variations of MEL cell isolates or variable levels of expression during particular 
DMSO inductions. 
Utilization of Chicken Vimentin Gene Polyadenylation Signals 
An interesting feature of the chicken vimentin gene is the occurrence and 
utilization of multiple polyadenylation sites (Zehner and Paterson, l 983a,b). Four 
consensus polyadenylation signals (5'-AA TAAA-3' [Proudfoot and Brownlee, 1976]) 
reside 250, 298, 533, and 554 nt downstream from the translation termination 
codon (Zehner and Paterson, l 983a); however, only the second through fourth 
polyadenylation signals are utilized in the chicken tissues examined (Zehner and 
Paterson, l 983b), producing mRNAs of -2.0 and -2.3 kb in length (Zehner and 
Paterson, l 983a; Capetanaki et al., 1983). The utilization of chicken vimentin 
polyadenylation sites is tissue specific; definitive erythroid cells accumulate 
predominantly the 2.0 kb mRNA, whereas other tissues and cell types accumulate 
more equivalent amounts of the 2.0 kb and 2.3 kb mRNAs (Capetanaki et al., 
1983). A comparison of hamster and chicken vimentin gene sequences at their 3' 
ends reveals that the mammalian vimentin gene retains only one functional signal, · 
corresponding to the second chicken polyadenylation site (Quax et al., 1983); both 
hamster and mouse cells produce -2.l kb vimentin mRNAs (Dodemont et al., 1982; 
Ngai et al., 1984). We therefore were interested if the mechanism by which the 
second polyadenylation signal is preferentially utilized in definitive chicken 
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erythroid cells has been conserved in mammals. To address this question, we 
analyzed chicken vimentin RNA from transfected MEL cells by performing RNase 
protection experiments using as probe a l kb RNA complementary to chicken 
vimentin 3'-terminal sequences, from 143 nt downstream of the translation 
termination codon, past the last polyadenylation signal (Figure 4b). Chicken 
vimentin RNAs with 3' termini generated from polyadenylation signals 2, 3, and 4 
protect 170, 41 O, and 430 nt fragments of the RNA probe (Figure 4a, lanes 3, 10 
and 11). The preferential utilization of polyadenylation signal 2 in 15-day old 
chick embryo erythroid cells (lanes 3 and 10) as compared to chicken spinal cord 
(lane 11) is demonstrated in this experiment, in agreement with previous findings 
(Capetanaki et al., 1983). Total RNA from MEL cells expressing transfected 
chicken vimentin genes contains chicken vimentin RNAs with ratios of 3' termini 
similar to those found in chicken non-erythroid cells. MELCV-26 and MELCV-29 
cells accumulate similar ratios of chicken vimentin RNAs in both the 
undifferentiated and differentiated states (lanes 4-7; compare with chicken 
definitive erythroid RNA [lanes 3 and 10] and chicken spinal cord poly(A)+ RNA 
[lane 11 ]). All MEL cell lines that express detectable chicken vimentin RNA 
display 3' terminal patterns identical to those shown here for MELCV-26 and 
MELCV-29 (data not shown). Mouse fibroblastic L cells transfected with pAV21 
also accumulate similar ratios of chicken vimentin transcripts as transfected MEL 
cells (data not shown). The RNAs exhibiting these 3' termini in MEL cells are 
bona fide polyadenylated transcripts, as they are greatly enriched in the poly(A)+ 
RNA fraction (compare 10 µg total RNA from induced MELCV-26 cells [lane 8] 
with 1 µg of poly(A)+ RNA derived from the same total RNA preparation 
[lane 9]). From these experiments we conclude that MEL cells do not discriminate 
the multiple chicken vimentin polyadenylation sites in a manner specific to 
chicken definitive erythroid cells. 
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Transfected Chicken Vimentin Genes Produce Functional mRNAs and Vimentin 
Filaments in Differentiating MEL Cells 
We examined one MEL cell line, MELCV-26, for the synthesis and stabilization of 
vimentin protein. MELCV-26 cells contain high levels of chicken vimentin RNA, 
which increase approximately three-fold after differentiation in the presence of 
DMSO (Figure 2a, lanes 11 and 12; Figure 4a, lanes 4 and 5). Cells were 
maintained in control medium or induced to differentiate in medium containing 
1.8% DMSO for 4 days, incubated with 35s-methionine for l hr, and fractionated 
with Triton X-100. Equivalent amounts of Triton X-100 insoluble protein-
incorporated radioactivity were analyzed by two-dimensional electrophoresis; this 
material represents newly synthesized, newly assembled cytoskeletal protein 
(Blikstad and Lazarides, 1983; Moon and Lazarides, 1983). Figure 5 demonstrates 
that even though newly synthesized and assembled mouse viment in is greatly 
reduced after differentiation in both the parent cell line (panels a and b) and in 
MELCV-26 cells (panels c and d), newly synthesized and assembled chicken 
vimentin is not only present in undifferentiated cells (panel c), but increases in 
abundance upon differentiation (panel d). Liquid scintillation counting of excised 
gel spots reveals that chicken vimentin radioactivity increases 5-6 fold at 4 days 
of differentiation in MELCV-26 cells, whereas mouse vimentin radioactivity 
decreases ?_4-5 fold in these cells, and 7-10 fold in the parent MEL cell line (data 
not shown). Cytoskeletal chicken vimentin accumulates to high steady state 
levels after DMSO induction of MELCV-26 cells, as judged by Coomassie blue 
staining of the gels (panels e and f) whose autoradiograms are shown in panels c 
and d. 
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To ascertain if the cytoskeletal chicken vimentin was present in a 
filamentous configuration, we performed indirect immunofluorescence microscopy 
on undifferentiated and differentiated MEL cells, using a vimentin-specific 
antiserum (Granger and Lazarides, 1979). Figure 6, b and d show that vimentin 
filaments are lost during differentiation of the parent MEL cell line, in 
accordance with our previous observations using another MEL cell line, MEL-Fl 
(Ngai et al., 1984). When we examined MELCV-26, however, we observed a 
striking array of intensely fluorescent vimentin filaments in both undifferentiated 
an differentiated cells (Figure 6, f and h). In several e xperiments, we have found 
that all MELCV-26 cells are vimentin-positive, both before and after DMSO-
induction, indicating that the transfected vimentin gene is expressed in all cells in 
the population. Since the composition of cytoskeletal vimentin in differentiated 
MELCV-26 cells is predominantly, if not exclusively, chicken vimentin, the array 
shown in Figure 6h is due to the presence of chicken vi men tin filaments. Hence, 
differentiating MELCV-26 cells accumulate filamentous chicken vimentin during 
differentiation while simultaneously losing mouse vimentin. The results of 
Figures 5 and 6 have also been confirmed in another cell line, MELCV-5; by both 
immunoblot and immunofluorescence analysis, we have found that chicken 
vimentin accumulates and forms filaments during differentiation of MELCV-5 
cells, whereas the endogenous mouse vimentin is lost (data not shown). 
Expression of Hamster Vimentin Genes in Differentiating MEL Cells 
The data presented thus far indicate that MEL cell lines transfected with 
chicken vimentin genes accumulate either increasing or constant amounts of both 
the chicken mRNA and protein during DMSO-media ted differentiation. However, 
we could not rule out the possibility that the induction (or lack of repression) of 
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chicken vimentin mRNA was due to aberrations of DNA transfection. We 
therefore transfected MEL cells with a cloned hamster vimentin gene. The 
plasmid construct used for this purpose, pAHY3, is analogous to pA Y21, the 
chicken vimentin plasmid. In pAHY3 we substituted the chicken genomic 
sequences and -400 bp of hamster aprt 5' flanking sequences with a 14.5 kb 
genomic DNA fragment containing the entire hamster vimentin gene (Quax et al., 
1983) (see Figure 1). The hamster vimentin gene lies in the same orientation 
relative to vector and aprt gene sequences as the chicken gene does in pA Y2 l, and 
is surrounded by -3 kb 5' flanking and -3' flanking sequences. pAHY3 DNA was 
linearized by Asp7 l 8 and introduced into Faprt-585-S cells by calcium phosphate 
transf ection. Seven independent cell lines containing intact hamster vimentin 
gene sequences were obtained and used for subsequent analysis. To assay hamster 
vimentin RNA levels, we performed quantitative primer extension analysis, using 
a 32P-labeled oligonucleotide complementary to hamster vimentin mRNA 37-56 nt 
downstream from the predicted cap site (Quax et al., 1983). Figure 7, lane l 
shows the expected 53-57 nt primer extension product using BHK-21 RNA as a 
source of hamster vimentin transcript (Gard et al., 1979; Tuszynski et al., 1979). 
Primer extension using Faprt-585-S RNA as template was negative (Figure 7, 
lanes 2 and 3). Three cell lines, MELAHY-6, MELAHY-9, and MELAHY-12, were 
found to express the hamster vimentin RNA at detectable levels, and all three 
showed significantly reduced levels of this RNA upon differentiation (lanes 4-9). 
Undifferentiated MELAHY-9 and MELAHY-12 cells accumulated hamster vimentin 
RNA at -5% of the levels found in BHK-21 cells. Upon differentiation, hamster 
vimentin RNA levels fell -2-fold in MELAHY-9 and 10-fold in MELAHV-12 
(Table II). The decrease in hamster vimentin RNA in MELAHY-6 was difficult to 
measure, as the levels in undifferentiated cells were low, and declined below our 
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limits of detection in differentiated cells; we estimate the decrease to be >5-
fold. Quantitation of aprt, y-actin, and B-globin RNA levels confirmed that the 
decline in hamster vimentin RNA was specific, and induction of B-globin RNA was 
extensive (Table II). 
Determination of Vimentin Gene Transcription Rates by In Vitro Nuclear Run-On 
Transcription Analysis 
Our observation that chicken vimentin RNA increases and the murine or hamster 
vimentin RNA decreases during MEL cell differentiation suggests that the 
differences are due to cis-acting sequences. To establish the contribution of RNA 
transcription rates toward vimentin RNA accumulation levels, we performed 
in vitro nuclear run-on transcription analysis (McKnight and Palmiter, 1979; 
Groudine et al., 1981). Nuclei were isolated from MEL cells cultured in the 
absence or presence of DMSO for 4 days, and incubated in the presence of a-[32P] 
UTP. 32P-labeled RNA was isolated and transcription rates were determined by 
hybridizing with excess filter-bound DNAs. In this assay, we assume that re-
initia tion of transcription does not occur, and the incorporated radioactivity 
detected therefore reflects the polymerase density on the gene of interest 
(however, see Discussion). To determine the utility of this technique for our 
system, we performed run-on transcriptions on nuclei isolated from a MEL cell 
line (Mel-Fl) whose endogenous vimentin, B-globin, and actin RNA accumulation 
kinetics have been determined previously (Ngai et al., 1984). In this cell line, 
steady state vimentin RNA falls to 30% of control levels at 24 hr of DMSO-
induced differentiation, 10% at 48 hr, and 4% at 96 hr of differentiation; actin 
mRNA levels remain constant through 96 hr of differentiation, whereas B-globin 
mRNA increases 3-5 fold at 48 hr, and 10-20 fold at 96 hr (Ngai et al. , 1984). 
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Figure 8a and Table III show the results of nuclear run-on transcriptions in nuclei 
obtained from MEL-Fl cells grown in control medium or in the presence of DMSO 
for 24, 48, and 96 hr. 6-globin transcription increased to a maximum of 12-fold 
over control levels at 96 hr, and actin transcription remained fairly constant, 
falling to only 74% after 96 hr of differentiation. Surprisingly, murine vimentin 
transcription at 24 hr of differentiation decreased only slightly to 56% of control 
levels, and transcription of this gene was maintained at -40% through 96 hr of 
differentiation. Similar results were obtained with Faprt-585-S cells; in two 
independent experiments, murine vimentin transcription decreased to only 40% of 
control levels at 96 hr of DMSO-induced differentiaton (Figure 8b and Table IV). 
Blot analysis of cytoplasmic RNA from the same cell preparations used in these 
experiments confirmed the extensive decline ( 10-20 fold) in vimentin mRNA 
steady state levels in both MEL-Fl and Fapart-585-S cells at 96 hr of 
differentiation (data not shown). The induction of 6-globin transcription was only 
3.5-5 fold in Faprt-585-S cells; this is due to the high level of 6mmor globin 
expression in the undifferentiated state (see Figure 3a, lanes 3 and 4). 
In two independent experiments using MELCV-26 nuclei, transcription of the 
introduced chicken vimentin gene increased 2.5-4 fold (Figure 8c and Table IV), 
roughly paralleling the steady-state RNA levels (see Table I). Aprt and 6-globin 
transcription both increased -2-3 fold, approximating the increases in the 
respective steady-state amounts (Table I). Transcription of the mouse vimentin 
gene in differentiated MELCV-26 cells apparently decreased to only -70-90% of 
control levels. This value is an overestimate, however, as the combination of high 
levels of chicken vimentin transcription and limited (<10-15%), but variable cross-
hybridization with the mammalian DNA sequences obscured the relatively lower 
mouse-specific signal. Based on these in vitro transcription experiments, we 
61 
conclude that the induction of chicken vimentin RNA in transfected MEL cells is 
due primarily to an increase in transcription, in contrast to a lesser change in the 
transcription of the endogenous vimentin gene relative to murine vimentin RNA 
levels. Actin transcription rates increased 2-3 fold in Faprt-585-S and MELCV-26 
cells; in separate experiments, the former accumulated -2-fold more actin RNA 
during differentiation, and the latter maintained actin RNA at constant levels 
(Table I). As the determinations of actin transcription were only performed once, 
and steady-state actin mRNA was not measured within the same experiment, the 
observed disparity in MELCV-26 actin transcription and accumulation may not be 
significant. 
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DISCUSSION 
Divergence of Vimentin Expression in Avian and Mammalian Erythropoiesis Is 
Manifested in the Expression of Transfected Vimentin Genes in Differentiating 
MEL Cells 
The differentiation of MEL cells in vitro has long served as a model system for 
mammalian erythropoiesis (Friend et al., 1971; reviewed by Marks and Rifkind, 
1978). The induction of globin gene expression and stabilization of globin mRNAs 
in erythropoiesis have been examined intensively in this system (Ross et al., 1972; 
Orkin et al., 1975; Aviv et al., 1976; Orkin and Swerdlow, 1977; Nude! et al., 1977; 
Lowenhaupt and Lingrel, 1978; Lowenhaupt et al., 1978; Volloch and Houseman, 
1981; Shaul et al., 1982). Studies of exogenous glob in genes introduced into MEL 
cells have delineatd the cis-acting regulatory regions responsible for the induction 
of globin genes during erythropoiesis (Chao et al., 1983; Wright et al., 1983, 1984; 
Charnay et al., 1984, 1985). In the present study, we have undertaken MEL cell 
transfection experiments as an approach to understanding the molecular basis for 
divergent vimentin gene regulation in avian and mammalian erythropoiesis. 
Two simple alternative mechanisms can explain the observed differences in 
vimentin regulation in avian and mammalian erythropoiesis. For both 
mechanisms, we presume that the expression of vimentin genes is regulated by an 
interaction of trans-acting regulatory factors with cis-linked sequences. In the 
first mechanism, a divergence in trans-acting regulatory factors is responsible for 
the differences in expression. In avian erythroid cells, the vimentin gene is either 
activated or derepressed by a trans-acting factor during terminal differentiation. 
In mammals, however, this activating factor either is absent, or has been replaced 
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or overridden by the activity of a new factor, resulting in the repression of 
vimentin RNA levels during erythropoiesis. If vimentin cis-acting regulatory 
sequences have been conserved, we predict that transfected chicken vimentin 
genes would be negatively regulated in differentiating MEL cells. In the second 
mechanism, divergent cis-acting vimentin regulatory elements are responsible for 
activation (or derepression) in avian erythropoiesis and repression (or de-
activation) in mammalian erythropoiesis. The observed differences in gene 
expression therefore would be attributable to changes in the target vimentin 
sequence itself. This mechanism predicts that a transfected chicken vimentin 
gene would not be regulated in a manner appropriate for the differentiating host 
murine erythropoietic cell. Furthermore, if positively acting factors that activate 
the vimentin gene in chicken erythroid cells have been conserved in mammals as 
part of the general erythropoietic program (as we would expect them to be if they 
regulate the expression of a number of genes), then we would predict transf ected 
chicken vimentin genes to be activated or derepressed in differentiating MEL 
cells. 
Our results are consistent with the second mechanism described above. 
Chicken vimentin RNA levels either increased significantly (2-10 fold) or 
remained constant in the majority of chicken vimentin-expressing MEL cell lines 
undergoing DMSO-mediated differentiation. The increased accumulation of 
chicken vimentin RNA juxtaposed with the decline in mammalian vimentin RNA in 
I 
differentiating MEL cells suggest that the two sequences are responding to 
different regulatory signals, and that this differential response is mediated by a 
difference in cis-acting regulatory sequences. The increased transcription of the 
chicken vimentin gene in these differentiating cells further suggests a 
conservation of positively-acting factors which are capable of interacting with 
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similarly conserved chicken vimentin regulatory elements. It appears that 
transfected chieken vimentin sequences respond to these putative factors in a 
manner appropriate for chicken vimentin sequences in an erythropoietic 
environment. A similar situation, in which an apparent divergence of target gene 
sequences is juxtaposed with a functional conservation of trans-acting regulatory 
factors, has been described for the avian and mammalian lens crystallins (Kondoh 
et al., 1983, 1987; Piatigorsky, 1984). Although mammalian genomes contain no 
6-crystallin genes, chicken 6-crystallin genes are appropriately regulated in a 
lens-specific fashion when microinjected directly into murine cell nuclei (Kondoh 
et al., 1983) or expressed in transgenic mice (Kondoh et al., 1987). Hence, both 
chicken 6-crystallin and vimentin genes are appropriately expressed in murine 
xenogeneic environments according to the specificity of the species from which 
the genes originated. 
The divergence of vimentin gene expression m avian and mammalian 
erythropoiesis, as mediated by cis-acting sequences, contrasts with the mechanism 
of fetal recruitment of embryonic globin genes in simian primates (Chada et al., 
1986). In simian primates, the modern y-globin genes exhibit a fetal pattern of 
expression, but are believed to have evolved from an ancestral "proto-y" gene 
which exhibited an embryonic pattern of expression (Efstratiadis et al., 1980). In 
most non-primate mammals, the descendants of this proto-y gene have maintained 
an embryonic pattern of expression. By studying the behavior of a cloned human 
Gy-globin gene during embryogenesis of transgenic mice, Chada et al. (l 986) 
observed an embryonic, rather than a fetal pattern of Gy-globin gene expression. 
Their results suggested that the fetal recruitment of embryonic globin genes in 
simian primates is due to a temporal change in the expression of trans-acting 
factors specific for y-like globin genes, rather than a divergence of cis-acting y-
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glob in regulatory elements (Chada et al., 1986). Moreover, these results suggested 
that the trans-acting factors governing y-like globin gene expression, as well as 
the sequences with which they interact, have been conserved from rodents to man 
(Chada et al., 1986). 
It is formally possible that increased accumulation of chicken vimentin RNA 
m differentiating MEL cells is a manifestation of gene transfection. Exogenous 
vimentin genes may be released from appropriate regulation by virtue of their 
aberrant chromosomal locations (assumed to be random), the exclusion of 
regulatory sequences in the plasmid DNA constructs used for transfection, or the 
proximity of vector sequences. For example, transfected cloned a-globin genes 
are expressed at inappropriately high levels in non-erythroid cells (Mellon et al., 
1981; Humphries et al., 1982; Treisman et al., 1983) and also appear to be 
maximally expressed in both undifferentiated and differentiated MEL cells 
(Charnay et al., 1984). In contrast, a-globin genes introduced into MEL cells by 
chromosome-mediated transfer are appropriately regulated during differentiation 
(Deisseroth and Hendrick, 1978, 1979; Deisseroth et al., 1980; Charnay et al., 
1984), suggesting that chromatin configuration and/or local chromosome position 
effects play a key role in the regulated expression of a-globin gene expression. 
Several lines of evidence argue against these possibilities for transfected vimentin 
gene expression. Transfected hamster vimentin genes were found to be 
appropriately regulated. In three MEL cell lines expressing hamster vimentin 
genes, all exhibited significantly reduced levels of hamster vimentin RNA after 
DMSO-mediated differentiation. It is therefore unlikely that the observed 
patterns of chicken vimentin expression in differentiating MEL cells are due to 
the absence of regulatory influences particular to the murine vimentin 
chromosomal locus. The hamster vimentin gene construct used for these 
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transfections is similar to the construct used for the chicken gene transfections, 
except that the vimentin gene is surrounded by -0.5 kb more 5' flanking and 
-0.5 kb more 3' flanking sequences in the hamster gene construct, as compared to 
the chicken gene construct. However, we have obtained one MEL cell line 
containing vimentin sequences transferred on a genomic A. recombinant, A. V8 
(Capetanaki et al., 1983), which contains the entire chicken vimentin gene, plus 
6 kb 5' flanking and 5 kb 3' flanking sequences. This cell line expresses chicken 
vimentin at increased levels subsequent to DMSO-induced differentiation, albeit 
at low levels (data not shown). We therefore believe that both vimentin plasmid 
constructs used in this study contain sufficient flanking sequences to confer 
appropriately regulated expression, and that the differences observed are not due 
to an artificial exclusion of regulatory elements or an interference by cis-linked 
vector or aprt sequences. Rather, the increased accumulation of chicken vimentin 
RNA and decreased accumulation of hamster vimentin RNA in differentiating 
MEL cells accurately reflect the phylogenetic class-specific differences of the 
transfected gene sequences. Lastly, our results from in vitro nuclear run-on 
transcription experiments suggest that the differences in murine and chicken 
vimentin RNA accumulation in differentiating MEL cells is mediated in part by 
posttranscriptional mechanisms (see below for further discussion), which are 
independent of the above mentioned transcriptional effects. 
Non-Discriminatory Utilization of Chicken Vimentin Polyadenylation Signals m 
MEL Cells 
The tissue-specific and developmentally-regulated utilization of chicken 
vimentin RNA 3' termini suggests an important, albeit unknown biological role for 
the differential e xpression of vimentin 3' noncoding sequences (Capetanaki et al., 
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1983). We therefore examined the patterns of chicken vimentin transcript 
polyadenylation in transfected MEL cell lines to determine if the mechanisms 
responsible for the differential utilization of vimentin polyadenylation sites in 
chicken definitive erythroid cells have been conserved in mammalian 
erythropoietic cells. The data of Figure 4 demonstrate that the chicken vimentin 
3' termini are not utilized in a pattern distinctive of chicken definitive erythroid 
cells. It is possible that our DNA construct used for transfections lacks sufficient 
DNA sequence information to confer erythroid-specific transcript cleavage and 
polyadenylation. However, all three chicken vimentin 3' termini are generated at 
the appropriate sites, indicating that sufficient downstream sequences indeed are 
present to direct proper transcript cleavage and polyadenylation (reviewed by 
Birnstiel et al., 1985). Our data suggest that although the factors responsible for 
chicken vimentin gene activation have been functionally conserved in avian and 
mammalian erythropoiesis, the mechanism by which the chicken erythroid-specif ic 
pattern of polyadenylation site utilization occurs has diverged. 
The Role of Transcriptional and Posttranscriptional Mechanisms in the Regulation 
of Vimentin mRNA Levels in Differentiating MEL Cells 
DMSO-mediated differentiation of MEL cells leads to a 25-fold reduction in 
endogenous mouse vimentin mRNA levels at 4 days of incubation (Ngai et al., 
1984; this paper). In this study, we have performed in vitro nuclear run-on 
transcription experiments to determine the contribution of altered vimentin gene 
transcription rates to the changes in both endogenous and transfected vimentin 
mRNA steady state levels. In two untransfected MEL cell lines, we have found 
that transcription of the mouse vimentin gene reproducibly decreases to -40% of 
control levels after 96 hr of DMSO-mediated differentiation. This -2-fold 
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reduction in vimentin transcription in vitro contrasts with a corresponding 25-fold 
decrease in steady state vimentin mRNA. The apparent quantitative disparity in 
changes of vimentin transcription rates and steady state vimentin mRNA levels 
suggests that the decline in murine vimentin mRNA in differentiating MEL cells is 
due in part to posttranscriptional mechanisms. However, vimentin gene 
transcription in isolated nuclei may not accurately reflect the quantitative 
changes in transcription in vivo. Although it is widely assumed that reinitiation 
does not occur in these transcription reactions (e.g., Groudine et al., 1981 ), an 
overestimate of vimentin gene transcription during MEL cell differentiation could 
have been obtained. For example, the repression might be mediated by the 
induction of a labile or diffusible transcription factor, whose activity is lost during 
the purification of nuclei. It should be noted, however, that the disparity in the 
rate of transcriptional decrease in vitro (56% of control levels at 24 hr, -40% at 
48 hr, and - 40% at 96 hr) and the rate of steady state mRNA level decrease (30% 
of control levels at 24 hr, 10% at 48 hr, and 4% at 96 hr) argues against such a 
possibility. Nevertheless, direct in vivo measurements of vimentin gene 
transcription rates and RNA decay kinetics will be necessary to quantitate the 
absolute contributions of transcriptional and posttranscriptional regulation to the 
decline in steady state vimentin mRNA levels in differentiating MEL cells. 
Indeed, a combination of changes in transcription rate and posttranscriptional 
RNA processing, resulting in an overall greater change in mRNA steady state 
levels, has been demonstrated for the cell cycle regulation of cellular thymidine 
kinase (Stewart et al., 1987; Merrill et al., 1984; Lewis and Matkovich, 1986) and 
histone (Schumperli, 1986) mRNAs, as well as for the induction of hormonally-
responsive RNAs (Brock and Shapiro, 1983; Robins et al., 1982; Paek and Axel, 
1987). Transcriptional (Santiago et al., 1984; Farnam and Schimke, 1985) and 
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posttranscriptional (Leys et al., 1984) mechanisms also mediate the cell cycle 
regulation of dihydrofolate reductase mRNA levels. 
A comparison of chicken and mouse vimentin gene transcription rates with 
the corresponding steady state mRNA levels in differentiating MEL cells suggests 
that the divergent expression of these two genes in avian and mammalian 
erythropoiesis is effected at both the transcriptional and posttranscriptional 
levels. The increase in chicken vimentin RNA levels during differentiation of one 
transfected cell line, MELCY-26, apparently is due to an increase in the rate of 
transcription, as the increase in steady state chicken RNA levels approximated 
the increase in transcription. The data suggest that mammalian vimentin cis-
acting sequences have diverged from chicken sequences in such a way as to 
respond to both a transcriptional repression (or deactivation) as well as a 
differentiation-induced RNA destabilization. 
Expression and Persistence of Filamentous Chicken Vimentin m Differentiating 
MEL Cells 
Our studies show that differentiating MEL cells expressing chicken vimentin 
RNA accumulate vimentin filaments in the absence of endogenous mouse vimentin 
expression. Inappropriate expression of stable intermediate filaments in cultured 
cells by DNA transfection or microinjection of mRNA has been reported for the 
keratins and for desmin (Kreis et al., 1983; Giudice and Fuchs, 1987; Quax et al., 
1985). Together these results suggest that intermediate filament proteins can 
polymerize in vivo in the absence of accessory proteins; however, the presence of 
heterologous intermediate filament-associated proteins has not been ruled out in 
any of these cases. 
We presume that chicken and mouse vimentins copolymerize when they are 
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coexpressed in undifferentiated cells; although our antibodies react with both 
chicken and mouse vimentin, and hence are not capable of discriminating between 
the two molecules by immunofluorescence microscopy, copolymerization of 
vimentin and desmin, vimentin and glial fibrillary acidic protein, and vimentin and 
neurofilament protein has been described (Steinert et al., 1981; Quinlan and 
Franke, 1982, 1983; Sharp et al., 1982; Granger and Lazarides, 1983; Quax et al., 
1985). As chicken vimentin-expressing MEL cells differentiate, the composition 
of intermediate filaments probably changes gradually from a mouse-chicken 
vimentin heteropolymer to a chicken vimentin homopolymer. The accumulation of 
chicken vimentin filaments in differentiating MEL cells argues against the 
possibility that endogenous murine vimentin filaments are normally removed from 
the cytoplasm by accelerated protein turnover, for example by an activation of a 
Ca 2+ -dependent vimentin-specific protease (Nelson and Traub, 1981, l 982b) in 
response to an influx of Ca 2+ ions (Chapman, 1980; Levenson et al., 1980; Bridges 
et al., 1981). The functionally conserved specificity of the vimentin-desmin-
specific Ca2+ -activated protease from fish to man (Nelson and Traub, l 982b) 
suggests that if such an activity were activated in differentiating MEL cells, 
chicken vimentin also would be degraded. Since a MEL cell line expressing low 
levels of chicken vimentin during differentiation also accumulates filaments in the 
absence of endogenous murine vimentin (data not shown), we believe that the 
accumulation of filaments is not due to an excess of protease substrate. Our 
results support a previous contention that the accumulation of vimentin filaments 
is determined primarily by the levels of newly-synthesized vimentin (Blikstad and 
Lazarides, 1983; Moon and Lazarides, 1983), which in turn are regulated at the 
level of mRNA abundance (Capetanaki et al., 1983; Ngai et al., 1984). 
The experimentally induced expression of vimentin filaments in MEL cells 
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had no obvious effects on MEL cell differentiation. In the MEL cell lines 
described here, s-globin mRNA levels accumulated normally, and cells exhibited 
patterns of growth kinetics and reductions in cell volume typical of MEL cell 
differentiation (data not shown) (Marks and Rifkind, 1978). We have speculated 
previously that the removal of vimentin filaments in mammalian erythropoiesis 
facilitates the enucleation process (Ngai et al., 1984). The experiments described 
here do not address this issue, as enucleation occurs subsequent to the period of 
MEL cell differentiation studied, and furthermore, the maintenance of 
differentiating MEL cells to the anucleate reticulocytic stage is inherently 
problematical (Volloch and Houseman, 198 l, 1982). 
EXPERIMENT AL PROCEDURES 
Construction of Plasmid DNAs 
Manipulations of DNA were carried out according to standard protocols (Maniatis 
et al., 1982). For the transfection of aprt- cells with chicken vimentin sequences, 
a plasmid containing the entire chicken vimentin gene, with 2.5 kb 5' and 3' 
flanking sequences, plus the hamster aprt gene was constructed in pUC 18. A 
3.7 kb HincII-BamHI fragment from a "- genomic chicken vimentin recombinant, 
"- V8 (Capetanaki et al., 1983), containing the 5' end of the gene plus 2.5 kb 
upstream sequences, was inserted into the polylinker region of pUC18 cleaved 
with HincII and BamHI. The resulting plasmid was then linearized with HincII, and 
this site was replaced by the ligation of Xhol linkers, yielding plasmid 
p5'VIMXB-l. The remaining 3' end of the vimentin gene sequences, plus 3.8 kb 3' 
flanking sequences contained in a 11.3 kb BamHI fragment of A V8, were ligated to 
the BamHI site of p5'VIMXB-l, yielding plasmid pVIMXBB. A l.3 kb fragment at 
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the 3' end of the chicken genomic insert was removed by digestion with Asp718 (an 
isoschizomer of KpnI), and hamster aprt sequences were inserted on a 4.0 kb BglII-
Asp7l8 DNA fragment (Lowy et al., 1980) by successive ligation of Asp718-
generated cohesive ends, blunting of the remaining non-homologous Asp7 l 8 and 
BglII ends with DNA polymerase I large fragment, and blunt-end ligation. The 
final 20 kb plasmid, pAV21 (Figure la), typically was linearized at the single 
Asp718 site for introduction into mammalian cell lines. 
The hamster vimentin gene was isolated on a 14.5 kb BamHI fragment (Quax 
et al., 1983) from a A. EMBL3 genomic library prepared from size-fractionated, 
BamHI-digested BHK-21 DNA (not shown). pAV21 was digested with HindIII and 
BamHI, BamHI linkers were ligated to the polymerase-blunted ends (corresponding 
to the polylinker HindIII site and hamster aprt 5' flanking BamHI site) of the 6.7 kb 
fragment containing hamster aprt plus pUC18, and the DNA was circularized to 
yield pUC-APRT. The 14.5 kb BamHI fragment carrying hamster vimentin 
sequences was then ligated to the BamHI ends of pUC-APRT. The resulting 
plasmid, pAHV3, is shown in Figure lb. 
Cell Culture and Transfections 
An adherent aprt- MEL cell line, FaprC585-S (Deisseroth and Hendrick, 1978; 
Chao et al., 1983) was maintained at 37°C and 5% co2 in Dulbecco's modified 
eagle medium (DMEM) supplemented with 15% heat-inactivated fetal calf serum 
and penicillin/streptomycin, plus 50 µg/ml 2,6-diaminopurine (OAP medium) to 
continually select for the aprt- phenotype. Cells were cultured in the absence of 
OAP ("neutral" medium) for several days prior to DNA transfection. Two methods 
were used to introduce DNA into MEL cells. Poly-1-ornithine-mediated 
transfections were carried out as described previously (Bond and Wold, 1987). 
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Sixteen to twenty hours prior to DNA transfection, cells were plated at a density 
of l-2.5xl06 cells per 100 mm tissue culture dish. At the time of transfection, 
plates were washed once with Earle's balanced salt solution (EBSS), and once with 
Tris-buffered saline (TBS; 25 mm Tris-Cl, 137 mM NaCl, 5 mM KC!, 1.4 mM 
Na2HP04, 10 mM CaC12, 5 mM MgC12, pH 7.5). One milliliter of a TBS solution 
containing either 8 µg/ml Asp718-cleaved pAV21 DNA plus 28 µg/ml 
poly-1-ornithine or 4 µg/ml DNA plus 10 µg/ml poly-1-ornithine was added to each 
drained plate, and cells were incubated with the DNA-poly-1-ornithine solutions at 
37°C for 3 hr with occasional rocking of the plates. The DNA-poly-1-ornithine 
solutions were removed, and the plates were washed twice with TBS. Neutral 
medium was then added, and the cells were allowed to recover and express aprt 
activity for 18 hr. Aprt+ transformants were then selected by incubation with 
medium containing 4 µg/ml azaserine and 15 µg/ml adenine (AZA-AD medium). 
Individual MEL cell colonies were isolated in cloning cylinders and expanded for 
further analysis. The frequency of DNA transfer into Faprt-585-S cells by this 
method is difficult to assess, since the concentrations of DNA and poly-1-ornithine 
used here are toxic to the cells, and an undetermined number of cells were lost 
(~50%) when plates were washed after incubation with DNA-poly-1-ornithine. 
Nevertheless, we have observed aprt + colonies in approximately one out of every 
two-three plates, yielding a transfection frequency of one aprt + transformant per 
initial -4-10xl06 cells. We also introduced DNA into Faprt-585-S cells by calcium 
phosphate precipitation, as described (Wigler et al., 1979). Briefly, cells were 
plated in 10 ml neutral medium on 100 mm tissue culture dishes at a density of 
6xl05 cells per plate 18 hr prior to the addition of the calcium phosphate-DNA 
precipitate. One milliliter of precipitate containing 30 µg Asp718-cleaved pAV21 
or pAHV3 DNA was added to each plate. Medium containing the calcium 
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phosphate-DNA precipitate was removed after a 20-22 hr incubation at 37°C, and 
replaced with neutral medium for 24 hr. Aprt + transformants were then selected 
as described above. We observed aprt + trans formants at an approximate 
frequency of one per 2-5xl06 cells. Cells transfected with pAY21 by the poly-1-
ornithine protocol described above were designated MELCVO (chicken 
vimentin/ornithine), whereas calcium phosphate-generated transformants were 
designated MELCV. The hamster vimentin construct was introduced into MEL 
cells only by calcium phosphate precipitation, and the resulting cells were 
designated MELAHV. 
Analysis of aprt + MEL Transformants and Isolation of RNA 
+ Aprt clones were grown and tested for the presence of exogenous vimentin 
sequences by genomic DNA blotting (Southern, 197 5), using appropriate vimentin-
specific probes (data not shown). Cells containing either the entire chicken 
genomic portion of pAY21 or the entire 14.5 kb BamHI hamster genomic fragment 
of pAHV3 were studied further. Cells were adapted to growth in bacterial dishes 
to facilitate differentiation (Chao et al., 1983) and cultured in AZA-AD medium 
("undifferentiated" cells), or induced to differentiate in AZA-AD medium plus 
1.8% DMSO for 4-5 days (Friend et al., 1971). Faprt-585-S cells were induced to 
differentiate for 4 days in OAP medium plus 1.8% DMSO. Cells were harvested 
and total cellular RNA was prepared by the method of Chirgwin et al. (1979), as 
modified (Ngai et al., 1984). Spinal cord RNA from l week old chickens was 
isolated as described (Capetanaki et al., 1983), and cytoplasmic RNA was prepared 
from 15 day old chicken embryo erythroid cells (Moon et al., 1985). Poly(At RNA 
was purified by oligo(dT)-cellulose chromatography, essentially according to the 
method of Aviv and Leder (1972). 
75 
Determination of RNA Levels by Quantitative RNase Protection Mapping 
Steady state mRNA levels of chicken and murine vimentin, hamster aprt, mouse 
8-globin and mouse y-actin were assayed by protection of in vitro-synthesized 
complementary 32P-labeled RNAs from RNase digestion by cellular RNAs (Zinn 
et al., 1983; Melton et al., 1984). Several plasmids were constructed in pT7SP6 
(Axelrod and Kramer, 1985) for the synthesis of 32P-RNA probes (see below). For 
the detection of chicken vimentin 5' sequences, the 3.7 kb HincII-BamHI fragment 
of A. V8, containing the first and second exons (see Figure la) was inserted into the 
respective polylinker sites in pT7SP6. For probe synthesis, the template was 
cleaved with HindIII, and a 1.9 kb 32P-labeled complementary RNA was 
generated, using T7 phage polymerase (see Figure 2b). A l kb chicken vimentin 3'-
specific probe was synthesized from a template consisting of 3' untranslated 
sequences 143 nt downstream of the translation termination codon through 0.6 kb 
of 3' flanking sequences (Figure 4b). For 8-globin RNA analysis, the 5' 1. 9 kb 
EcoRI-BamHI fragment from the mouse 8maJor 8-globin genomic insert of 
pMB9-8G2 (Konkel et al., 1978) was subcloned (p85'). A BstN !-cleaved p85' 
template was transcribed with SP6 phage polymerase, yielding 32P-labeled RNA 
complementary to IVS I and exon II (Figure 3b). A hamster aprt-specif ic probe 
was synthesized using SP6 phage polymerase from a BamHI-cleaved recombinant 
containing a 0.9 kb hamster aprt fragment (p5'APRT, Figure 3d). This probe is 
protected by the first and second exons of aprt, and also contains IVS I and a 
portion of IVS II sequences (Nalbantoglu et al., 1986, 1987). Mouse y-actin RNA 
was detected using a probe synthesized from a human y-actin template cloned in 
pSP64 (Enoch et al., l 986). 
32P-labeled complementary RNA probes were synthesized with SP6 or T7 
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phage polymerases, using the above-mentioned templates, essentially under 
conditons described by Green et al. (1983) and Zinn et al. ( 1983). a-[ 32P]CTP 
(3000 Ci/mmole) was diluted with unlabeled CTP and included in the transcription 
reactions at the following final concentrations and specific activities: 50 µM at 
200 Ci/mmole for 5' vimentin, 50 µM at 50 Ci/mmole for B-globin, and 100 µM at 
100 Ci/mmole for aprt, y-actin, and 3'-vimentin. 
Typically, lxl05 - 2xl05 cpm 32P-RNA was hybridized to 10 µg MEL cell 
total RNA at 45°C for 14-17 hr in 30 µl 80% formamide, 40 mM PIPES, 400 mM 
NaCl, l mM EDTA, pH 6.4. The hybridization reactions were then diluted with 
300 µl 20 mM Tris-Cl, pH 7.5, 300 mM NaCl, 5 mM EDT A, 50 µg/ml RNase A, 
900 U/ml RNase T 1, and incubated at 30°C for 1 hr. Ten microliters of 20% SOS 
and 100 µg of Proteinase K were added, and samples were digested at 37°C for 
30-60 min. Following phenol extraction, 10 µg carrier beef liver tRNA was added, 
and RNA was precipitated with ethanol. Protected 32P-RNA fragments were 
resolved on 0.25 mm-thick, 5% polyacrylamide/8 M urea denaturing gels (Maxam 
and Gilbert, 1980) and exposed to Kodak XAR-5 film with intensifying screens. 
For quantitation, 32P-radioactivity in gel slices was assayed by Cerenkov 
radiation, as detected in the 3H channel of a Beckman 1801 liquid scintillation 
counter; each sample was counted for 20 min. Liquid scintillation counting of gel 
slices immersed in fluor gave similar results. The following gel slices were 
excised for quantitation: the 632 nt exon I fragment for chicken vimentin; the 
209 nt and 81 nt fragments for BmaJor and Bmmor globins, respectively; the 111 nt 
exon II fragment for hamster aprt; and the 80 nt fragment for mouse y-actin. 
Radioactivity in gel slices was directly proportional to the amount of RNA 
hybridized, as determined by serial dilution of cellular RNAs (data not shown). In 
cases where radioactivity was too low to be determined accurately (less than 2 a 
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above background + 2 a), autoradiograms using pre-flashed film (Laskey and Mills, 
1975) were scanned with a densitometer, and peak areas were integrated. The 
data of Table I were derived from the gels shown in Figures 2 and 3. Results 
qualitatively similar to the ones shown here were obtained in separate, multiple 
determinations (data not shown). 
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Metabolic Labeling with [35s}-Methionine and Immunofluorescence Microscopy 
MEL cells cultured in the absence or presence of 1.8% OMSO for 4 days were 
labeled with [35s]-methionine for l hr as described previously (Ngai et al., 1984). 
Equivalent amounts of protein-incorporated [35s] radioactivity in Triton X-100-
insoluble residues from each sample (Blikstad and Lazarides, 1983; Moon and 
Lazarides, 1983) were loaded on two-dimensional isoelectric focusing/SDS-
polyacrylamide gels (O'Farrell, 1975); gels were stained with Coomassie blue to 
visualize total protein, and then impregnated with 2,5-diphenyloxazole for 
fluorography (Bouves and Laskey, 1974). Immunof luorescence microscopy using an 
anti-chicken vimentin antiserum (Granger and Lazarides, 1979) was performed 
exactly as described previously (Ngai et al., 1984). 
Detection of Hamster Vimentin mRNA by Quantitative Primer Extension Analysis 
An oligonucleotide with the sequence 5'-TGCGAACCGCGGGAGTGCTG- 3' 
(synthesized at the Caltech Microchemical Facility) was labeled with T4 
polynucleotide kinase in the presence of y-[32P]-A TP and used for primer 
extension analysis, essentially as described by Jones et al. ( 1985). This 
oligonucleotide is complementary to hamster vimentin mRNA in the 5' non-coding 
region, between positions 37 through 56 relative to the RNA initation site (Quax 
et al., 1983). One-tenth of a picomole 32P-labeled oligonucleotide primer was 
hybridized to total cellular RNA for 2 hr at 55°C in 10 µl 10 mM Tris-Cl, pH 8, 
250 mM NaCl, 2 mM EDTA. Samples were diluted with 25 µl 50 mM Tris-Cl, 
pH 8.7, 10 mM MgC12, 5 mM OTT, 350 µM dATP, TTP, dCTP, dGTP, 10 µg/ml 
actinomycin D, 600 units/ml RNasin, 330 U/ml AMV reverse transcriptase (FPLC-
purified, Pharmacia), and incubated for l hr at 42°C. Following phenol extraction 
and ethanol precipitation, extension products were separated on 0.25 mm-thick 8% 
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polyacrylamide/8 M urea gels and visualized by exposure to Kodak XAR-5 film in 
the presence of an intensifying screen. The 53-57 nt extension products, 
corresponding to correctly initiated hamster vimentin mRNA, were quanitated by 
Cerenkov radiation determination of excised gel slices. Serial dilution of BHK-21 
RNA (a source of high levels of hamster vimentin RNA) over a 20-fold range 
yielded a commensurate decrease in radioactive extension products (data not 
shown). Tripling the amount of 32P-labeled oligonucleotide primer m 
hybridizations had no effect on the amount of extension product synthesized (data 
not shown). 
In Vitro Nuclear Run-On Transcriptions 
Transcription in isolated nuclei was performed by an amalgam of several published 
procedures (McKnight and Palmiter, 1979; Groudine et al., 198 l; Greenburg and 
Ziff, 1984; Linial et al., 1985; Carey et al., 1986). MEL cells were cultured for up 
to 4 days in the presence or absence of 1.8% DMSO. Cells were washed several 
times in phosphate-buffered saline, and lysed in ice cold reticulocyte standard 
buffer (RSB: 10 mM Tris-Cl, 10 mM NaCl, 5 mM MgC12, pH 7.4) plus 0.5% NP-40, 
l mM OTT, and 50-100 uni ts/ ml RNasin. All subsequent steps were carried out at 
0°C, unless otherwise noted. Nuclei were pelleted by centrifugation at 1000 xg 
for 4 min, and post-nuclear supernatants were saved for preparation of 
cytoplasmic RNA by phenol:chloroform extraction. Nuclear pellets were rinsed 
gently in RSB alone, repelleted and resuspended in nuclear freezing buffer (50 mM 
Tris-Cl, pH 8.0, 5 mM MgC12, 0.1 mM EDTA, 40% (w/v) glycerol) at an 
approximate density of 107 nuclei per 100 µl. Nuclei either were frozen and stored 
at -70°C and thawed prior to use (Experiment I), or used immediately 
(Experiment lI and MEL-Fl transcriptions). 
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Each transcription reaction was carrie<j out with -107 nuclei. Nuclei were 
preincubated at 0°C for 5-10 min in nuclear freezing buffer, pelleted for 8-10 sec 
in a variable speed Eppendorf microcentrifuge (setting 5), and resuspended in 50 µl 
nuclear freezing buffer. Fifty microliters of 2X run-on buffer (lo mM Tris-Cl, 
pH 8, 300 mM KCl, 5 mM MgC12, l mM DTT, 10 mM creatine phosphate, 
0.1 mg/ml creatine phosphokinase, l mM each ATP, CTP, and GTP) containing 
320 µCi a-[32P]UTP (-3000 Ci/mmol, dried down to a volume of -5 µl) was added to 
each sample, and transcription was allowed to proceed for 15 min at 30°C. We 
have determined that incorporation of a-[32P]UTP into RNA is linear for this 
duration at 30°C, in both uninduced and induced nuclei (data not shown). Nuclei 
were iced, pelleted, resuspended in 200 µl 20 mM Tris-Cl, pH 7 .5, 10 mM MgC12, 
2 mM CaC12, plus 40 µg carrier beef liver tRNA, and high molecular DNA was 
digested with 75 units DNase (FPLC-purified, Pharmacia) at 30°C for 15 min. 
Samples were digested by the addition of l 0 µ l 20% SDS, 100 µg Prate inase K and 
incubation at 42°C for 45-60 min. RNA was isolated by extraction with 300 µl 
phenol, back-extraction of the organic phase with 100 µl 10 mM Tris-Cl, pH 8, 
1 mM EDT A (TE), pooling the aqueous phases, and re-extraction with 400 µl 
phenol:SEVAG (l:l; SEVAG is chloroform:isoamyl/alcohol, 24:1). Samples were 
adjusted to 0.2 M NH40Ac, and RNA was precipitated with 2 volumes of ethanol, 
and washed once with 80% ethanol. RNA was resuspended in 50 µl TE, and RNA 
was separated from unincorporated a-[32P]UTP by chromatography on l ml 
Sephadex G-50 (medium) spin columns. Within a given experiment, equivalent 
amounts of radioactivity (3.5x 106 cpm m Experiment I, 7.Ox106 cpm m 
Experiment II, and lxl07 cpm in MEL-Fl transcriptions) were hybridized to 
nitrocellulose filters in l ml of solution. 
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Plasmid DNAs Jere linearized and immobilized on nitrocellulose according 
to Kafatos et al. (1979), using a Schleicher and Schuell dot blot apparatus. Ten 
micrograms of each plasmid was applied to each dot. The plasmids used were: 
pVIMXBB for detection of chicken vimentin gene transcription; pSThvim, a 
pT7SP6 recombinant containing the 14.5 kb BamHI hamster vimentin genomic 
fragment, for mouse viment in; pB5' for B-globin; pSP64y-actin for mouse y-actin, 
p5'APRT for hamster aprt, and pT7SP6 as a negative control. Filters were 
pre hybridized at 65°C for 2 hr in 20 mM Tris-Cl, pH 7 .5, l 0 mM EDT A, 0.3 M 
NaCl, 0.2% SOS (2X TESS), plus 0.25 mg/ml beef liver tRNA and lX Denhardt's 
solution (Denhardt, l 966). 32P-labeled RNA in TE was heated to 65°C for 
2-3 min, iced, and added to l ml 2X TESS, 0.1 mg/ml beef liver tRNA, lX 
Denhardt's solution preheated to 65°C, and hybridized in microcentrifuge tubes at 
65°C for 45 hr (Experiment I), 61 hr (Experiment II), or 66 hr (MEL-Fl 
transcriptions). Filters were washed three times with 2X SSC (lX SSC is 0.15 M 
NaCl, 0.015 M Na citrate, pH 7.0) at 65°C for 30 min each, once with 2X SSC at 
room temperature, and digested with 5 µg/ml RNase A and 25 units/ml RNase T 1 
in 2X SSC at 37°C for 30 min. Filters were washed finally in 3-4 changes of 2X 
SSC, 0.2% SOS at 65°C for 30 min each, air-dried, and exposed to preflashed 
Kodak XAR-5 film with intensifying screens. Radioactivity in each dot was 
quantitated by Cerenkov radiation, as described above. For each individual filter, 
the radioactivity in the pT7SP6 dot (18-20 cpm, less than 1-2 cpm over machine 
background) was subtracted from the gross radioactivity of each of the other 
dots. Dilution of input radioactivity in the hybridization yielded· comparable 
decreases in hybridized RNA. The inclusion of 2 µg/ml a-amanitin in nuclear pre-
incubations and transcriptions abolished all detectable radioactivity bound to the 
above-described plasmid dots, indicating that the transcription as assayed by our 
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plasmids was due to RNA polymerase II activity (Kedinger et al., 1979; Lindell 
et al., 1970). 
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FIGURE LEGENDS 
Figure 1. Plasmid DNA constructs used for transfection of MEL cells. a) 
Structure of pA V2 l, a chicken vimentin-hamster aprt plasmid. b) Structure of 
pAHV3, a hamster vimentin-hamster aprt plasmid. Solid bars indicate gene coding 
regions. Open bars indicate vimentin flanking sequences, whereas hatched bars 
show aprt flanking sequences. 
Figure 2. Analysis of chicken vimentin RNA levels in undifferentiated and 
differentiated transfected MEL cells. a) A 32P-labeled RNA probe 
complementary to the first and second exons of chicken vimentin mRNA (panel b) 
was hybridized to cellular RNAs and subjected to RNase digestion as described in 
Experimental Procedures. Protected fragments were resolved on denaturing 
polyacrylamide gels. M, 32P-labeled pBR322-HpaII DNA markers. tRNA, 
protection of probe from RNase digestion after hybridization with l 0 µg tRNA. 
CEF, protection of 2 µg chick embryo fibroblast total RNA. Fragments 
corresponding to the 632 nt first exon and 61 nt second exon are protected. 
Lanes 3-24, protection from 10 µg MEL cell RNA, from cells cultured in the 
absence (-) or presence (+) of 1.8% DMSO for 4-5 days. Note the protection of a 
70 nt fragment by mouse vimentin RNA. The upper portion of lanes 1-18 was 
exposed for 1.5 days. To facilitate visualization of 60-70 nt fragments (- 10-fold 
lower specific activity than the 632 nt exon I fragment), the lower portion of the 
same gel was exposed for 4.5 days. Lanes 19-24 were exposed for 4 days. Lower 
panel, the upper region of lanes 1-18 was exposed for 4.5 days to show lower 
intensity bands. 
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Figure 3. Analysis of 8-globin, hamster aprt, and mouse y-actin RNA levels in 
MEL cells. a) 8-globin RNA analysis. A 32P-labeled RNA probe for mouse 8major 
globin (panel b) was used for RNase protection and electrophoretic analysis as 
described in Experimental Procedures and the legend of Figure 2. The 8major 
globin probe is protected by both Bmaior globin mRNA (209 nt fragment), as well 
as by 8minor globin mRNA (81 nt fragment). M, 32P-labeled pBR322-Hpall 
markers. tRNA, tRNA (10 µg) control. Lanes 2-19, protection from 10 µg RNA 
isolated from uninduced (-) and induced (+) MEL cells. The RNAs used in this 
assay, as well as the assay in panel c, were from the same preparations as were 
used for the experiments shown in Figure 2. c) Hamster aprt and mouse y-actin 
RNA analysis. A mixed 32P-labeled RNA probe consisting of a complementary y-
actin RNA (Enoch et al., 1986) and a complementary hamster aprt RNA (panel d) 
was used, as described above. Protection of the aprt probe generates fragments 
of 111 nt (exon II) and 95 nt (exon I); protection of the y-actin probe yields an 
80 nt fragment. M, pBR322-Hpall markers. tRNA, protection of mixed probe 
after hybr idiza ti on with l 0 µg tRNA. Lanes 2 and 3, protection of l 0 µg 
MELCV0-16 (induced) RNA with the aprt probe only or actin probe only, 
respectively. Lanes 4-19, protection of the mixed probe with 10 µg MEL cell RNA, 
from DMSO-induced (+)or uninduced (-)cells. 
Figure 4. Analysis of chicken vimentin RNA 3' termini. The utilization of chicken 
vimentin RNA 3' termini was determined by protection of the 32P-labeled RNA 
probe shown in panel b. The positions of the consensus polyadenylation signal 
(5'-AATAAA-3') are indicated (Zehner and Paterson, l 983a). The sites are 
numbered l through 4, in a 5' to 3' direction. The expected sites of 3' termini, 
together with the predicted sizes of protected probe fragments (170, 410, 430 nt) 
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are shown. a) Protected probe fragments resolved on a denaturing polyacrylamide 
gel. M, pBR322-HpaII markers. tRNA and Faprt-585-S, negative controls showing 
probe protection after hybridization with l 0 µg tRNA or l 0 µg Faprt-585-5 
(uninduced) RNA. Lane 3, protection by 2 µg 15 day-old chick embryo erythroid 
total cytoplasmic RNA. Lanes 4-7, protection using 10 µg MELCV-26 and 
MELCV-29 RNA, from uninduced cells (-) or cells induced with 1.8% DM50 for 
4 days (+). Lanes 8 and 9, protection by 10 µg total RNA and l µg poly(A)+ RNA, 
respectively, from MELCV-26 cells cultured in 1.8% DM50 for 3 days. Lanes 10 
and 11 show protection patterns using l µg 15 day-old chick embryo erythroid 
cytoplasmic poly(A)+ RNA, and l µg l week-old chick spinal cord poly(A)+ RNA, 
respectively. Lanes 1-7 were exposed for 48 hr and lanes 8-11 were exposed for 
7 hr. 
Figure 5. Analysis of newly assembled vimentin by two-dimensional 
electrophoresis. MEL cells were grown in the absence or presence of 1.8% DM50 
for 4 days, labeled for l hr with [355] methionine, and fractionated with Triton 
X-100. Equivalent amounts of protein-incorporated radioactivity from insoluble 
residues were electrophoresed and fluorographed (panels a-d). a) Uninduced 
parental Faprt-585-5 MEL cells. b) Induced Faprt-585-5 cells. c) Uninduced 
MELCV-26 cells. d) Induced MELCV-26 cells. Migrations of mouse vimentin (m) 
and chicken vimentin (c) are indicated. e) and f), portions of Coomassie blue 
stained gels whose fluorographs are shown in panels c and d, respectively. 
Figure 6. Vimentin-specific immunofluorescence microscopy. MEL cells were 
cultured in the absence (panels a, b, e, and f) or presence (panels c, d, g, and h) of 
1.8% DM50 for 4 days and prepared for immunof luorescence microscopy using a 
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vimentin-specific antibody. Cells were visualized with phase contrast (a, c, e, g) 
and epifluorescence (b, d, f, h) optics. Vimentin filaments in parental Faprt-585-S 
cells (panel b) are lost subsequent to differentiation (panel d). MELCV-26 cells 
contain vimentin filaments both before (panel f) and after (h) DMSO-mediated 
differentiation. Bar, 10 µm. 
Figure 7. Quantitative primer extension analysis of hamster vimentin RNA. 
Extension products generated from a hamster vimentin-specific 32P-labeled 
oligonucleotide primer using 5 µg total cellular RNA templates were resolved on 
an 8% polyacrylamide/8 M urea gel. One-half of each sample was loaded on the 
gel. The position of 54-57 nt products, corresponding to correctly initiated 
hamster vimentin mRNA, is indicated. M, pBR322-HpaII markers. Lane 1, 
BHK-21 RNA. Lanes 2-9, MEL cell line RNAs, from cells grown in the absence(-) 
or presence (+)of DMSO for 4 days. Lane 1 was exposed for 1 day; lanes 2-9 were 
exposed for 7 days. The radioactivity in the extension products in lanes 4 or 6 
represent -5% of the radioactivity in the products in lane 1, as determined by 
Cerenkov radiation of excised gel slices (data not shown). 
Figure 8. In vitro nuclear run-on transcription analysis. Plasmid DNA dots 
immobilized to nitrocellulose were hybridized to 32P-labeled RNA synthesized in 
isolated MEL cell nuclei, washed, and exposed to x-ray film. V m' detection of 
endogenous mouse vimentin gene transcription with pSThvim, a hamster vimentin 
DNA plasmid. A strong signal is readily obtained, due to the high sequence 
homology among mammalian vimentin sequences (Ferrari et al., 1986). 6, 6-
globin; Ac, actin; V c' chicken vimentin; aprt, hamster aprt; (-), pT7SP6 vector 
DNA. a) Transcription in isolated nuclei from MEL-Fl cells cultured in the 
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absence or presence of 1.8% DMSO, as indicated. b) and c), Transcription in 
nuclei from parental Faprt-585-S cells or MELCV-26 cells (respectively) grown in 
the absence or presence of DMSO for 4 days. The data of panels band care from 
Experiment II (see text). 
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CHAPTER 5: 
Regulated Expression of Multiple Chicken Erythroid Membrane 
Skeletal Protein 4. 1 Variants Is Governed by Differential 
RNA Processing and Translational Control 
(In press, Proceedings of the National Academy of Sciences, USA, 1987) 
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ABSTRACT Protein 4.1 is an extrinsic membrane protein that facilitates 
the interaction of spectrin and actin in the erythroid membrane skeleton, 
and exists as a multiplet of structurally-related polypeptides in chickens. 
Previous studies have shown that the ratio of protein 4.1 variants is 
developmentally regulated during terminal differentiation of chicken 
erythroid and lenticular cells. To examine the mechanisms by which 
multiple chicken protein 4.1 variants are differentially expressed, we have 
isolated cDNA clones specific for chicken erythroid protein 4.1. We 
demonstrate that a single protein 4.1 gene gives rise to multiple 6.6 kilobase 
mRNAs by differential RNA processing. Furthermore, the ratios of protein 
4.1 mRNAs change during chicken embryonic erythropoiesis. We observe a 
quantitative difference in variant ratios when protein 4.1 is synthesized 
in vivo or in a rabbit reticulocyte lysate in vitro. Together our results 
demonstrate that the expression of multiple protein 4.1 polypeptides is 
regulated both translationally and at the level of RNA processing. 
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INTRODUCTION 
A network based on the proteins spectrin and actin lines the cytoplasmic 
surface of the mammalian erythrocyte plasma membrane, and is believed to 
confer upon this cell membrane its properties of strength and elasticity 
( 1,2). Protein 4.1 facilitates the interaction of spectrin and act in by forming 
a ternary complex with these components, and also has been shown to 
interact directly with two intrinsic membrane proteins, glycophorin and the 
anion transporter, and membrane phospholipid (2). Protein 4.1 therefore 
plays a key role in the maintenance of the membrane skeleton. Protein 4.1 
exists as a set of structurally related polypeptides in avian erythroid cells 
(3). In chicken erythrocytes, seven major protein 4.1 variants of 77, 87, 100, 
115, 150, 160, and 175 kDa are expressed, with the 100 and 115 kDa 
polypeptides found in highest abundance (3,4). However, in immature 
mitotic erythroblasts, the 77 and 87 kDa protein 4.1 variants predominate, 
and as the cells undergo terminal differentiation, the 100 and 115 kDa forms 
are found at higher levels (4,5). Protein 4.1 and protein 4.1 analogues also 
have been localized in nonerythroid tissues (3,4,6-11 ). 
In order to define the mechanism(s) by which multiple protein 4.1 
variants are generated, we have isolated cDNA clones encoding chicken 
protein 4.1. Partial DNA sequence analysis demonstrates 86% homology 
with human protein 4.1 cDNA sequences (12) over a 270 bp portion of a 
chicken protein 4.1 cDNA. We find that the gene encoding protein 4.1 exists 
as a single copy in the haploid chicken genome, and gives rise to one 6.6 kb 
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size-class RNA. By S 1 nuclease mapping experiments, we demonstrate that 
this single size RNA consists of multiple, distinct mRNAs, whose expression 
is developmentally regulated during chicken embryonic erythropoiesis. 
Hence, a heterogeneity of protein 4.1 mRNAs appears tq underlie the 
diversity of protein 4.1 polypeptides. A comparison of protein 4.1 polypep-
tides synthesized in vitro and in vivo demonstrates that the relative 
abundances of protein 4.1 variants is further regulated at the translational 
level. 
MATERIALS AND METHODS 
Isolation of protein 4.1 cDNAs. Protein 4.1-specific cDNAs were 
isolated from a ;\.gtl l expression library constructed from 14-15 day old 
chick embryo erythroid poly(A)+ RNA ("M" library of ref. 13). The library 
was screened with a protein 4.1-specific antiserum (3), and positive plaques 
were isolated and rescreened several times, as described ( 13). 
Complementary DNA inserts of candidate protein 4.1 clones were isolated 
after digestion of recombinant phage DNA with EcoRI and subcloned into 
pT7SP6 (a gift of Dr. V. Axelrod) (14) or ml3mp 19. DNA sequence analysis 
was performed by the dideoxynucleotide chain termination procedure (15). 
RNA preparation. Total cellular or cytoplasmic poly(A)+ RNA was 
prepared from chicken embryonic erythroid cells as described previously 
(13). To enrich for protein 4.1 mRNA, cytoplasmic poly(A)+ RNA was 
fractionated on a formamide-sucrose gradient, as described previously (13). 
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Fractions were collected, RNA was concentrated by ethanol precipitation, 
and fractions containing protein 4.1 translational activity in a rabbit 
reticulocyte lysate (16) were pooled. 
In vitro translation and hybridization-selected translation. Poly(A)+ 
RNA was translated in vitro for 90 min at 30°C in a high activity nuclease-
treated rabbit reticulocyte lysate containing 35[S]methionine ( 13, 16). 
Complete translation reactions or immunoprecipitates using a protein 4.1 
antiserum (3) were resolved on 12.5% polyacrylamide NaDodS04 gels ( 17). 
For an in vivo protein 4.1 standard, 15-day old chick embryo erythroid cells 
were metabolically labeled with 35[S]methionine for 30 min at 37°C, 
fractionated with Triton X-100, and immunoprecipitated with the protein 4.1 
antiserum, as described (3). Labeled protein bands were visualized by 
fluorography of gels impregnated with 2,5-diphenyloxazole (18). Plasmid 
DNA was bound to nitrocellulose and subjected to positive hybridization-
selected translation, as described (13,19). RNA selected from 10 µg of 
gradient enriched poly(A)+ RNA was translated in 15 µl of rabbit reticulocyte 
lysate. 
DNA and RNA analysis. DNA was digested with restriction 
endonucleases, electrophoresed, blotted to nitrocellulose, and protein 4.1 
sequences were detected with 32[P] nick translated cDNA inserts (20,21). 
RNA blots were performed as described previously (22,23). S 1 nuclease 
protection (24) of a protein 4.1 cDNA was performed by hybridizing RNA 
with an end-labeled 3.1 kb Xhol-Pvul fragment of pFP020, as described in 
the legend of Fig. 5. 
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RESULTS 
Isolation of chicken protein 4.1 cDNAs. We identified cDNA clones coding 
for protein 4.1 from a >..gtl 1 expression library (13) by screening with an 
antiserum specific for chicken protein 4.1 (3). DNA sequence analysis of the 
5' 270 nt of one cDNA, pFP020, reveals 86% nucleotide homology with a 
human reticulocyte protein 4.1 cDNA (12), rendering 98% amino acid 
sequence conservation from chicken to human protein 4.1 in this region 
(Fig. la). A restriction endonuclease map of representative protein 4.1 
cDNAs is shown in Fig. lb; we conclude from the above data that the cDNAs 
shown are specific for protein 4.1. 
In vitro translation of chicken protein 4.1 and positive hybridization-
selected translation. To examine the mRNA(s) encoding the protein 4.1 
polypeptides, we commenced by analyzing 35[S]methionine-labeled 
translation products synthesized in vitro in a rabbit reticulocyte lysate 
(13,16), using cytoplasmic poly(A)+ RNA isolated from circulating erythroid 
cells of 15-day old chick embryos. The seven major protein 4.1 variants of 
77, 87, 100, 115, 150, 160, and 175 kDa all are immunoprecipitated from an 
in vitro translation reaction, with the 160 and 175 kDa polypeptides in 
greatest abundance (Fig. 2a, lane 2). However, when protein 4.1 is 
immunoprecipitated from cytoskeletal extracts of 15-day old embryo 
erythroid cells metabolically labeled with 35[S]methionine, the 100 and 
115 kDa polypeptides are the predominant forms, and the 77, 87, 150, 160, 
and 175 kDa variants are found in lower relative amounts (3-5) (see Fig. 2a, 
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lane l and Fig. 2b, lane 8). As the protein 4.1 polypeptides are rapidly 
stabilized in the membrane skeleton with equivalent efficiencies shortly 
after their synthesis (3-5), the pattern of protein 4.1 variants identified after 
labeling in vivo, shown in Fig. 2, closely approximates their ratios of 
synthesis, as well as the steady state ratios (3). The relative rates of 
synthesis of protein 4.1 variants in vitro and in vivo therefore differ 
significantly. 
Protein 4.1 is a mmor product of in vitro translations, and is not 
identifiable in the total translation reaction (compare Fig. 2a, lanes 2 and 
3). To increase the relative abundance of protein 4.1 mRNA, we 
fractionated 15-day old embryo erythroid poly(A)+ RNA on a denaturing 4-
20% sucrose gradient, and pooled RNA fractions with protein 4.1 
translational activity. Translation of this material in vitro shows that this 
preparation is substantially depleted of glob in mRNA (Fig. 2b, lane l; 
compare with Fig. 2a, lane 3), and directs the translation of the protein 4.1 
polypeptides (Fig. 2b, lane 2). The 87, 100, and 115 kDa variants are more 
visible over a reduced background in the immunoprecipitation of the 
gradient-enriched RNA translation, as compared to translation of 
unfractionated RNA (Fig. 2a, lane 2). We therefore used gradient-enriched 
RNA for subsequent hybridization-selected translation experiments. 
We performed hybridization-selected translations to further determine 
the structural relatedness of the protein 4.1 polypeptides. Fig. 2b 
demonstrates that a representative cDNA, pFP02a, hybridizes to RNA which 
directs the synthesis of protein 4.1 polypeptides (lane 5). In contrast, the 
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plasmid vector alone does not hybridize to any detectable protein 4.1 RNA 
(lane 4). The hybridization-selected translation products of lane 5 are 
specifically immunoprecipitated by an anti-protein 4.1 antiserum (lane 7), 
whereas a similar immunoprecipitation of the plasmid vector-mediated 
selection is completely negative (lane 6). Positive hybridization-selected 
translation was repeated using pFP02a, pFP02b, and pFP020, with results 
similar to those shown in Fig. 2 (data not shown). We conclude that the 
cDNAs described here, together representing -3.5 kb, or 55% of protein 4.1 
mRNA (see below), are complementary to the mRNA(s) encoding all the 
major protein 4.1 variants found in 15-day old embryo erythroid RNA. 
Representation of protein 4.1 sequences in the chicken genome. Blot 
analysis of chicken genomic DNA using 32P-labeled protein 4.1 cDNA probes 
demonstrates that the multiple protein 4.1 polypeptides are encoded by a 
single gene (Fig. 3). pFP02a hybridizes to several genomic DNA bands 
generated by digestion with BamHI, HindIII, EcoRI, or Xbal (Fig. 3a). When 
the 5' 1.7 kb EcoRI-BamHI fragment or the 3' 0.7 kb BamHI-EcoRI fragment 
of pFP02a is used as probe (see Fig. la), each hybridizes to a subset of the 
genomic bands obtained with the entire cDNA insert (Fig. 3b,c). A similar 
hybridization using pFP02b as probe identifies the same BamHI-, HindIII-, 
and XbaI-genomic fragments detected by the pFP02a 3' probe (Fig. 3c,d, 
lanes 1-3), but since pFP02a and pFP02b share a common terminal EcoRI 
site, pFP02b hybridizes to a genomic EcoRI fragment which is not detected 
by pFP02a (Fig. 3a-d, lanes 4). The hybridization patterns shown in 
Fig. 3a-d, in conjunction with a preliminary analysis of overlapping 
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protein 4.1 genomic DNA phage recombinants (unpublished observations) 
indicate that the multiple bands detected in protein 4.1 genomic DNA blots 
are contiguous; pFP02a and pFP02b hybridize to overlapping cloned genomic 
sequences spanning over 40 kb (unpublished observations). To determine the 
copy number of the protein 4.1 gene(s) in the chicken genome, known 
amounts of genomic DNA or DNA of a protein 4.1 genomic clone, A4. l-l 9, 
were digested with EcoRI, and the relative hybridization of the 1.8 kb EcoRI 
fragment (an internal restriction fragment in the A4.l-19 insert; data not 
shown) with 32P-labeled pFP02a was used to determine gene copy number 
(see Fig. 3, legend). The autoradiogram of Fig. 3e shows that the 1.8 kb 
EcoRI band detected (arrowhead) is found at one copy per haploid genome 
(compare lanes l and 6 or lanes 2 and 5). Since pFP02a is complementary to 
RNA(s) encoding all the major protein 4.1 polypeptides (Fig. 2b, lanes 5 and 
7), we conclude that multiple protein 4.1 variants arise from a single gene. 
Multiple protein 4.1 mRNAs of indistinguishable sizes encode multiple 
chicken protein 4.1 polypeptides. The experiments shown in Figs. 2 and 3 
together suggest that multiple protein 4.1 variants arise by translationally 
regulated expression of one or several mRNA(s) encoded by a single gene. 
RNA blot analysis of gradient-enriched 15-day old embryo erythroid poly(A)+ 
RNA using 32P-labeled pFP02a as probe reveals a single major 6.6 kb RNA 
(Fig. 4b, lane I). Several minor bands smaller than the 6.6 kb RNA are also 
detected amidst a trail of degradation (Fig. 4b, lane I), in a pattern similar 
to that found in unfractionated poly(A)+ RNA (data not shown). To 
determine if these minor species are protein 4.1 mRNAs or stable 
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degradation intermediates, we separated the gradient-enriched RNA on a 
preparative methylmercury hydroxide agarose gel, and analyzed gel-
fractionated RNA by in vitro translation or by RNA blot analysis (Fig. 4). 
The autoradiograms of Fig. 4a and b demonstrate that translation of each 
major protein 4.1 variant co-fractionates in gel slices 4-7 (Fig. 4a), which 
corresponds to the major 6.6 kb protein 4.1 RNA peak (Fig. 4b). Within this 
peak, the ratios of the protein 4.1 polypeptides remain constant from 
fraction to fraction. The resolution of this experiment is sufficient to 
separate the streak of degraded protein 4.1 RNA, as well as the minor RNA 
species, from the protein 4.1 mRNA peak in slices 4-7. Hence, multiple 
protein 4.1 polypeptides are derived from a single size-class mRNA. 
Although a single size mRNA appears to give rise to multiple 
protein 4.1 products, we could not rule out the existence of multiple 
protein 4.1 mRNAs with indistinguishable electrophoretic mobilities. We 
therefore performed S 1 nuclease digestions on hybrids formed between 
erythroid protein 4.1 RNA and an end-labeled protein 4.1 cDNA. For this 
purpose, a probe was prepared which consisted of a pFP020 fragment end-
labeled at the Xhol site (see Fig. la). Figure 5, lane 2 shows that the 
pFP020 probe is protected by four distinct RNA species from erythroid cells 
of 15-day old chick embryos. The 1700 nt protected fragment identifies an 
RNA species complementary to pFP020 from the Xhol site to the 3' 
terminus of the insert. Additional fragments are present at 730 nt, 580 nt, 
and 470 nt (barely visible in this exposure; see below), and represent RNAs 
which are derived from DNA containing this Xhol site, but are divergent 730, 
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580, and 470 nt downstream. S 1 nuclease analysis of RNA fractionated on 
the same methylmercury hydroxide agarose gel described in Fig. 4 
demonstrates that the multiple protein 4.1 RNAs co-electrophorese at 6.6 kb 
(Fig. 4c), precluding the possibility that the multiplicity of protected 
fragments arises from RNA precursors or degradation products. A greater 
het~rogeneity of protein 4.1 mRNA may well exist, as other putative RNAs 
which do not contain sequences both complementary to and continuous with 
the XhoI site within this 1.7 kb cDNA would not be detected. 
Expression of multiple protein 4.1 mRNAs is developmentally 
regulated. Circulating erythroid cells of 4-day old embryos are "early" 
mitotic erythroblasts of the primitive series, whereas circulating red cells of 
15-day old embryos are "late" post-mitotic definitive series cells (25). 
Previous studies have shown that the pattern of protein 4.1 variant 
expression in embryonic erythroid cells changes both during ontogeny as well 
as within the primitive series and definitive series lineages (4). To compare 
a "late" pattern of protein 4.1 mRNA expression (Fig. 5, lane 2) with a 
pattern from "early" cells, we performed S 1 nuclease analysis on RNA from 
4-day old embryos. Using the 32P-end-labeled probe described above, we 
find protection of only the 470 nt and 580 nt fragments by the 4-day old 
embryo erythroid RNA (Fig. 5, lane 3). Blot analysis of this RNA detects a 
single 6.6 kb protein 4.1-specific band (data not shown). We interpret the 
results described above to indicate that the generation of multiple 
protein 4.1 mRNAs is developmentally regulated. 
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DISCUSSION 
We have examined the mechanisms by which multiple chicken protein 4.1 
polypeptides are generated, using cloned cDNA probes specific for 
protein 4.1. Our protein 4.1 cDNAs are complementary to RNAs encoding 
all the major chicken erythroid protein 4.1 polypeptides, as shown by 
hybridization-selected translations. Quantitative genomic DNA blotting 
reveals that multiple protein 4.1 variants arise from a single gene. By RNA 
blot analysis and S 1 nuclease mapping, we have determined that the single 
protein 4.1 gene generates multiple mRNAs with indistinguishable sizes. The 
observation of multiple 6.6 kb mRNAs exhibiting sequence discontinuit ies at 
distances of up to -1 kb apart indicates that alternative pathways of pre-
mRNA splicing (e.g., see refs. 26-28) play a key, but not necessarily 
exclusive role in the genesis of multiple protein 4.1 mRNAs. Different sites 
of transcription initiation, as well as termination and/or transcript cleavage 
and polyadenylation may also occur, and indeed may determine the selection 
of splicing patterns, as shown for other transcription units (e.g., see 
refs. 29-31). 
In this study we demonstrate that the differential expression of 
multiple protein 4.1 mRNAs is developmentally regulated, as the mRNAs 
detected switch from "early" primitive cells to "late" definitive cells. This 
switch is paralleled by changes in protein 4.1 polypeptide synthesis and 
accumulation (4). Translational and/or co-translational processes also 
regulate the pattern of protein 4.1 expression, as demonstrated by the 
quantitative difference in protein 4.1 polypeptide synthesis in vivo and 
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in vitro. The relative amounts of protein 4.1 variants may be controlled by 
preferential translation of certain protein 4.1 mRNAs. Alternatively, 
limited co-translational or rapid post-translational processing of the larger 
protein 4.1 polypeptides may give rise to the smaller variants (see 
refs. 3,5). Hence, although expression of protein 4.1 polypeptides is 
specified initially at the mRNA level by RNA processing, the relative 
abundance, or perhaps even the presence or absence of each variant is 
further determined by translational or co-translational mechanisms. 
Our data regarding the expression of multiple protein 4.1 mRNAs from 
a single gene may be applicable to the observed occurrence of protein 4.1 
and protein 4.1 analogues in non-erythroid tissues (3,4,6-9,11). For example, 
in developing chick lens, protein 4.1 variants similar to those found m 
chicken erythroid cells are present (3,4). A 6.6 kb protein 4.1 mRNA is 
detected in chick lens by RNA blotting (data not shown), suggesting that lens 
protein 4.1 is specified by the same gene that encodes erythroid 
protein 4.1. The signiticance of producing multiple protein 4.1 mRNAs and 
polypeptides in a developmentally-regulated and tissue-specific manner 
remains to be determined. It is possible that differential splicing of protein 
4.1 exons facilitates the expression of alternative functional domains, which 
would affect or mediate the interactions of protein 4.1 with other membrane 
skeletal components. Future studies employing full-length protein 4.1 
cDNAs should facilitate our understanding of both the structural and 
regulatory features of the differential expression of multiple protein 4.1 
mRNAs and polypeptides. 
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Mammalian erythroid protein 4.1 exists as two structurally related 
polypeptides with molecular masses of 80 kDa (4.la) and 78 kDa (4.lb) 
(32,33); protein 4. la and 4. lb differ at their carboxy-termini, but appear to 
be functionally equivalent (33). Mammalian lens generally expresses a minor 
125-145 kDa protein 4.1-related polypeptide in addition to the protein 4.la/b 
doublet (3,6, 11) Hence, mammalian protein 4.1 is expressed as a number of 
related variants, but the extent of heterogeneity is lesser, or perhaps more 
subtle than that found in avian species. 
We thank Ors. Bruce Granger, Barbara Wold and John Cox for helpful 
discussions during the course of this study. This work was supported by 
grants from the NIH, NSF, and Muscular Dystrophy Association of America. 
J.N. was also supported by a Gordon Ross Foundation Fellowship, J.H.S by a 
training grant from the National Institutes of Health (T32 GM07616), and 
R. T .M. by an American Cancer Society postdoctoral fellowship. 
133 
References 
1. Branton, 0., Cohen, C. M. & Tyler, J. (1981) Cell 24, 24-32. 
2. Marchesi, V. T. (1985) Ann. Rev. Cell Biol. 1, 531-561. 
3. Granger, B. L. & Lazar ides, E. ( 1984) Cell 37, 595-607. 
4. Granger, B. L. & Lazarides, E. (1985) Nature 313, 238-241. 
5. Staufenbiel, M. & Lazarides, E. (1986) J. Cell Biol. 102, 1157-1163. 
6. Aster, J.C., Welsh, M. J., Brewer, G. J., & Maisel, H. (l 984) Biochem. 
Biophys. Res. Comm. 119, 726-734. 
7. Cohen, C. M., Foley, S. F. & Korsgren, C. (1982) Nature 299, 648-650. 
8. Goodman, S. R., Casoria, L. A., Coleman, D. B., & Zagon, I. S. ( 1984) 
Science 224, 1433-1436. 
9. Spiegel, J. E., Beardsley, D. S., Southwick, F. S., & Lux, S. E. (1984) J. 
Cell Biol. 99, 886-893. 
10. Baines, A. J. & Bennett, V. (1985) Nature 315, 410-413. 
11. Aster, J. C., Brewer, G. J., & Maisel, H. (1986) J. Cell Biol. 103, 115-
122. 
12. Conboy, J., Kan, Y. W., Shohet, S. B., & Mohandas, N. (1986) Proc. natn. 
Acad. Sci. USA 83, 9512-9516. 
13. Moon, R. T., Ngai, J., Wold, B. J., & Lazarides, E. (1985) J. Cell Biol. 
100, 152-160. 
14. Axelrod, V. D. & Kramer, F. R. (1985) Biochemistry 24, 5716-5723. 
15. Sanger, F ., Nicklen, S., & Coulson, A. (1977) Proc. natn. A cad. Sci. USA 
74, 5463-5476. 
134 
16. Jackson, R. L. & Hunt, T. (1983) in Methods in Enzymology (S. Fleisher 
& B. Fleisher, eds.). Academic Press Inc., New York. 
17. Laemmli, U. K. (1970) Nature 227, 680-685. 
18. Bouves, W. M. & Laskey, R. A. (1974) Eur. J. Biochem. 46, 83-88. 
19. Ricciardi, R. P., Miller, J. S. & Roberts, B. E. (1979) Proc. natn. Acad. 
Sci. USA 76, 4927-4931. 
20. Southern, E. M. ( 197 5) J. Mol. Biol. 98, 503-517. 
21. Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) J. Mol. 
Biol. ll3, 237-251. 
22. Capetanaki, Y. G., Ngai, J., Flytzanis, C., & Lazarides, E. (1983) Cell 
35, 411-420. 
23. Goldberg, D. A. ( 1980) Proc. natn. Acad. Sci. USA 77, 5794-5798. 
24. Berk, A. J. & Sharp, P.A. (1977) Cell 12, 721-732. 
25. Bruns, G. A. P. & Ingram, V. M. (1973) Phil. Trans. Roy. Soc. (Land.) B 
266, 225-305. 
26. Crabtree, G. R. & Kant, J. A. (1982) Cell 31, 159-166. 
27. Amara, S. G., Jonas, V ., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. 
(1982) Nature 298, 240-244. 
28. Breitbart, R. E.,Nguyen, H. T., Medford, R. M., Destree, A. T., Mahdavi, 
V., & Nadal-Ginard, B. (1985) Cell 41, 67-82. 
29. Early, P., Rogers, J., Davis, M., Calame, K., Bond, M., Wall, R., & Hood, 
L. (1980) Cell 20, 313-319. 
30. Young, R. A., Hagenblichle, 0. & Schibler, U. (1981) Cell 23, 451-458. 
135 
31. Periasamy, M., Strehler, E. E., Garfinkel, L. I., Gubits, R. M., Ruiz-
Opazo, N., & Nadal-Ginard, B. (1984) J. Biol. Chem. 259, 13595-13604. 
32. Goodman, S. R., Yu, J., Whitfield, C. F., Culp, E. N., & Posnak, E. J. 
(1982) J. Biol. Chem. 257, 4564-4569. 
33. Leto, T. L. & Marchesi, V. T. (1984) J. Biol. Chem. 259, 4603-4608. 
34. Young, R. A. & Davis, R. W. ( 1983) Proc. natn. Acad. Sci. USA 80, 
1194-1198. 
35. Dodgson, J.B., Strommer, J. & Engel, J. D. (l 979) Cell 17, 879-887. 
36. Bailey, J. M. & Davidson, N. (1976) Anal. Biochem. 70, 75-85. 
136 
Figure Legends 
FIG. l Protein 4.1 cDNAs. a) DNA sequence analysis of the 5' 270 nt of 
pFP020. Top row: sequence of a human protein 4.1 cDNA from nucleotide 
1324 to 1593, according to Conboy et al. (12). Middle row: sequence of 
pFP020, determined by Jeffrey Stack. Dots indicate non-homologous 
nucleotides. Bottom row: Amino acid sequence derived from the chicken 
protein 4.1 cDNA. Non-homologous human protein 4.1 residues are indicated 
in parentheses. b) Restriction endonuclease map of protein 4.1 cDNAs. 
pFP02a and pFP02b were isolated from the same Agtl l recombinant 
(AFP0-2). EcoRI sites in parentheses are from synthetic linkers, whereas the 
EcoRI site shared by pFP02a and pFP02b occurs naturally. The direction of 
transcription of pFP02a and pFP02b was determined by their orientation 
within the B-galactosidase gene of Agtl l (34). pFP020 was isolated 
subsequent to back-screening of the A cDNA library with the pFP02a insert. 
FIG. 2. Synthesis of protein 4.1 in vivo and in vitro and identification of 
protein 4.1-specific cDNAs. a) NaDodS04 polyacrylamide gel electro-
phoretic analysis of protein 4.1 synthesis. Lane 1, immunoprecipitate of 
protein 4.1 from cytoskeletal extracts of 15-day old embryo erythroid cells 
labeled in vivo. Lane 2, immunoprecipitation from 10 µl rabbit reticulocyte 
lysate in which of 15-day old embryo erythroid cytoplasmic poly(A)+ RNA 
was translated. Lane 3, one microliter of the complete in vitro translation 
reaction used in lane 2. The high molecular weight triplet in lane 3 is 
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ankyr in, a-spectr in, and s-spectrin, m descending order. Bars indicate 
positions of protein 4.1 variants (from top to bottom): 175 kDa, 160 kDa, 
150 kDa, 115 kDa, 100 kDa, 87 kDa, and 77 kDa. Asterisk marks the position 
of the 70 kDa heat shock protein, which is a major translation product of 15-
day-old embryo red cell RNA, and is immunoprecipitated non-specifically 
from the in vitro translation reaction. Lanes l and 2 were f luorographed for 
8 days, whereas lane 3 was exposed for 16 hr. b) NaDodS04-polyacrylamide 
gel analysis of gradient-enriched erythroid poly(A)+ RNA translation and 
hybridization-selected translation. Lane 1, 0.5 µl of an in vitro translation of 
gradient-enriched 15-day-old embryo erythroid poly(A)+ RNA. Lane 2, 
immunoprecipitation from 10 µl of the in vitro translation reaction shown in 
lane 1. Lane 3, endogenous translational activity from 5 µl lysate with no 
added RNA. Lane 4, hybridization-selected translation using plasmid vector 
(5 µl of a 15 µl reaction). Lane 5, hybridization-selected translation mediated 
by pFP02a (5 µl). Lanes 6,7, protein 4.1-specific immunoprecipitation from 
10 µl lysate of lanes 4 and 5, respectively. Lane 8: Immunoprecipitate of 
metabolically-labeled protein 4.1, as in a, lane l. Bars indicate positions of 
protein 4.1 polypeptides, as in a. Lanes 1-8 represent consecutive lanes from 
the same gel, but were fluorographed for l day (lane 1), 3 days (lanes 2-5), 
and 6 days (lanes 6-8). 
FIG. 3. Blot analysis of chicken genomic DNA using protein 4.1 cDNA 
probes. a-d) One microgram of chicken liver DNA was digested with BamHI 
(lane 1), HindlII (lane 2), EcoRI (lane 3), or Xbal (lane 4) electrophoresed on a 
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0.9% agarose gel, and blotted to nitrocellulose. Blots were hybridized to the 
following 32P-labeled nick-translated cDNA sequences: a) pFP02a insert, b) 
1.7 kb pFP02a 5' EcoRI-BamHI fragment, c) 0.7 kb pFP02a 3' BamHI-EcoRI 
fragment, and d) pFP02b insert. The autoradiograms in panels a-d were 
from adjacent strips of nitrocellulose blotted to the same gel. The positions 
of >.. DNA digested with HindIII is shown (23, 9.4, 6.6, 2.3, 2.0, and 0.56 kb). 
e) Determination of protein 4.1 gene copy number. A recombinant phage, 
;i..4.1-19, containing chicken protein 4.1 gene sequences was isolated from a ;x. 
Charon 4A genomic library (35) and used to quantitate protein 4.1 DNA 
hybridization. Chicken liver DNA (l.O µg and 0.5 µg) and ;x. 4.1-19 DNA were 
digested with Eco RI, separated on a 0. 9% agarose gel, blotted to nitro-
cellulose, and hybridized to 32P-labeled pFP02a. The 1.8 kb EcoRI band 
(arrowhead) was used to calibrate the hybridization signals. Lane 1, 10 µg 
chicken liver DNA. Lane 2, 0.5 µg chicken liver DNA. Lanes 3-8, \4.1-19 
DNA corresponding to 0.25, 0.5, 1.0, 2.0, and 4.0 copies per haploid genome 
(C = 1.5 pg) per µg chicken DNA, respectively. Bars denote ;x. HindIII DNA 
size markers. 
FIG. 4. Fractionation of 15-day-old embryo erythroid RNA on a 
methylmercury hydroxide agarose gel and analysis by in vitro translation, 
RNA blotting, and S 1 nuclease protection. Gradient-enriched poly(A)+ RNA 
was electrophoresed in the presence of methylmercury hydroxide (36) on a 
preparative 0.9% low gelling temperature agarose gel. The gel was sliced in 
0.5 mm thick sections perpendicular to the axis of electrophoresis, and RNA 
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was isolated as described previously (22). a) In vitro translation of 
fractionated RNA. RNA was translated in a rabbit reticulocyte lysate 
containing 35[S]methionine, immunoprecipitated with protein 4.1 antiserum, 
and analyzed on a 12.5% polyacrylamide-NaDodS04gel. C, immunopre-
cipitate of protein 4.1 from 15-day-old embryo erythroid cells labeled with 
35[S]methionine. I, immunoprecipitation from reticulocyte lysate in which 
gradient-enriched poly(A)+ RNA ("input") was translated. Lanes 1-15, 
immunoprecipitates from translations of fractionated RNA from gel slices 
1-15, respectively. Bars indicate 175, 150, 115, 100, and 87 kDa protein 4.1 
variants. b) RNA blot of fractionated RNA. RNA was electrophoresed in 
the presence of formaldehyde, blotted to nitrocellulose, and probed with 
32P-labeled pFP02a cDNA insert. I, gradient-enriched RNA ("input"). 
Lanes 1-15, RNA from slices 1-15. c) s1 nuclease analysis of fractionated 
RNA. S 1-nuclease mapping was performed using a 
32P-end-labeled pFP020 
cDNA probe (see Fig. 5 legend). Protected fragments were separated on a 
l.5 mm-thick 7 M urea-5% polyacrylamide gel. tRNA, 32P-labeled DNA 
protected after incubation with tRNA. I, fragments protected by gradient-
enriched poly(A)+ RNA ("input"). Lanes 2-9, fragments protected by RNA in 
slices 2-9. 
FIG. 5. S 1 nuclease protection of protein 4.1 cDNA by chick erythroid 
RNA. pFP020 was cleaved with Xhol and end-labeled by filling out with 
DNA polymerase I large fragment in the presence of a-32[P]dNTPs (see 
Fig. lb), digested with Pvul, and the 3.1 kb fragment containing 1.7 kb insert 
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plus 1.4 kb vector sequences was isolated and hybridized with RNA in 80% 
formamide, 40 mM PIPES, 0.4 M NaCl, l mM EDT A at 50°C for 15 hr. 
Samples were digested with S 1 nuclease (24), and fragments were resolved on 
0.3 mm-thick denaturing 7 M urea-5% polyacrylamide gels. Lane 1, 
undigested probe. Lane 2, fragments protected by 2 µg cytoplasmic poly(At 
RNA of 15-day-old embryo erythroid cells. Lane 3, fragments protected by 
2 µg total cellular poly(A)+ RNA of 4-day old embryo erythroid cells. Lane 4, 
S 1 nuclease digestion following hybridization with 2 µg tRNA. Bars indicate 
mobilities of end-labeled DNA markers (1856, 1060, 929, 622, 527, 404, 383, 
309, 242, 238, and 217 nt). 
HU
M
AN
; 
CH
IC
KE
N:
 
CH
IC
KE
N 
AA
: 
HU
M
AN
: 
CH
IC
KE
N:
 
CH
IC
KE
N 
AA
: 
HU
M
AN
; 
CH
IC
KE
N;
 
CH
IC
KE
N 
AA
: 
13
24
 G
AG
 T
TT
 C
TT
 G
AG
 A
AT
 G
CC
 A
AA
 A
AG
 T
TG
 T
CT
 A
TG
 T
AT
 G
GA
 G
TT
 G
AT
 C
TT
 C
AT
 A
AA
 G
CA
 A
AG
 G
AC
 T
TG
 G
AA
 G
GA
 G
TA
 G
AT
 A
TC
 A
TC
 C
TA
 G
GT
 
GA
G 
TT
C 
CT
C 
GA
G 
AA
T 
GC
A 
AA
G 
AA
A 
CT
G 
TC
T 
AT
G 
TA
T 
GG
A 
GT
T 
GA
C 
CT
T 
CA
C 
CA
C 
GC
C 
AA
G 
GA
C 
TT
G 
GA
A 
GG
A 
GT
G
 G
AT
 A
TC
 A
CT
 C
TG
 G
GA
 
gl
u 
ph
e 
le
u 
gl
u 
a
a
n
 
a
la
 l
ya
 l
ya
 l
eu
 a
e
r 
m
et
 
ty
r 
gl
y 
v
a
l 
a
sp
 l
eu
 h
ia
 h
is
 a
la
 l
ya
 a
sp
 l
eu
 g
lu
 g
ly
 v
a
l 
a
sp
 i
le
 t
hr
 l
eu
 g
ly
 
O
ya
) 
(i
le
) 
14
4 
GT
C 
TG
C 
TC
T 
AG
T 
GG
C 
CT
T 
CT
G 
GT
T 
TA
C 
AA
A 
GA
T 
AA
G 
CT
G 
AG
A 
AT
T 
AA
C 
CG
C 
TT
C 
CC
T 
TG
G 
CC
C 
AA
A 
GT
G 
CT
G 
AA
G 
AT
T 
TC
T 
TA
T 
AA
A 
CG
T 
91
 G
TC
 T
GT
 T
CC
 A
GT
 G
GC
 C
TT
 C
TT
 G
TT
 T
AC
 A
AA
 G
AT
 A
AG
 C
TG
 A
GA
 A
TC
 A
AC
 C
GC
 T
TC
 C
CT
 T
GG
 C
CC
 A
AA
 G
TC
 C
TG
 A
AG
 A
TT
 T
CC
 T
AC
 A
AA
 C
GC
 
v
a
l 
c
ys
 s
e
r 
s
e
r 
gl
y 
le
u 
le
u 
v
a
l 
ty
r 
ly
s 
a
sp
 l
ys
 l
eu
 a
rg
 i
le
 a
sn
 
a
rg
 p
he
 p
ro
 t
rp
 p
ro
 l
ye
 v
a
l 
le
u 
ly
a 
il
e 
se
r 
ty
r 
ly
a 
a
rg
 
15
04
 A
GT
 A
GC
 T
TT
 T
TC
 A
TC
 A
AG
 A
TT
 C
GG
 C
CT
 G
GA
 G
AG
 C
AA
 G
AG
 C
AG
 T
AT
 G
AA
 A
CT
 A
CC
 A
TC
 G
GA
 T
TC
 A
AA
 C
TT
 C
CC
 A
GT
 T
AC
 C
GA
 G
CA
 G
CT
 A
AG
 
lB
l 
AG
C 
AG
C 
TT
C 
TT
T 
AT
T 
AA
G 
AT
T 
CC
C 
CC
A 
GG
G 
GA
G 
CA
A 
GA
G 
CA
G 
TA
C 
CA
A 
AC
T 
AC
A 
AT
T 
GG
A 
TT
C 
AA
G 
CT
A 
CC
A 
AC
T 
TA
C 
CG
G 
GC
A 
GC
A 
AA
G 
s
e
r 
e
e
r 
ph
e 
ph
e 
il
e 
ly
e 
il
e 
a
rg
 p
ro
 g
ly
 g
lu
 g
ln
 g
lu
 g
ln
 t
yr
 g
lu
 e
e
r 
th
r 
il
e 
gl
y 
ph
e 
ly
s 
le
u 
pr
o 
e
e
r 
ty
r 
a
rg
 a
la
 a
la
 l
ye
 
F
ig
u
re
 l
a
 
.
i::- ,_
 
1-rj 
I-'· 
<..O 
s:: 
t-'i 
CD 
f-' 
t1 
~I "O 
'O .,, 
.,, 
0 
~ 
(Eco RJ) 
Xhol/AvaI 
Hine JI 
Pvu II 
Xbal 
Pvu II 
Ava I 
Hincil 
(Eco RI) 
'O .,, 
cg 
I\) 
C" 
Eco RI 
XbaI 
(Eco RI) 
Zt7l 
'O .,, 
.,, 
0 
~ 
(Eco RI) 
Ui 
i v., 
Pvu II 
Xbal 
Pvu II 
Aval 
Hine Il 
Barn HI 
.. 
Pvu Il 
XhoI/Aval 
Ava I 
Eco RI 
143 
a b 
1 2 . 3 1 2 3 4 5 6 7 8 
* 
Figure 2 
a
· 
b 
c 
d 
23
.1
 
-
9
.4
2
-,
 
6
.5
6
-
4
.3
6
-
2
.3
2
-
2
.0
3
-
0
.5
6
-
1
2
3
4
 
1
2
3
4
 
1
2
3
4
 
1
2
3
4
 
-
-
F
ig
u
re
 
3 
e 
1
2
3
4
5
6
7
8
 
..
..
.
.
 
-
-
.
i::-
.
i::-
145 
a 2 4 6 s 10 12 14 
C I I 3 5 7 9 11 13 15 
b 2 4 6 8 10 12 14 
6.6 kb -
c 
1700 nt -
I I 3 5 7 9 11 13 15 
2 4 6 8 
3 5 7 9 
730 nt - .. 
·- -580 nt -
Figure 4 
146 
1 2 3 4 
..... 
Figure 5 
,PROBE 
_ 1700 nt 
_ 730 nt 
- 580 nt 
_ 470 nt 
147 
CHAPTER 6: 
Conclusions 
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The study of vimentin expression during cellular differentiation has 
revealed several interesting aspects of the regulation of the gene encoding 
this intermediate filament protein. The chicken vimentin gene produces 
three distinct mRNAs which differ in the lengths of their 3' untranslated 
regions (Zehner and Paterson, l 983a,b). Size heterogeneity of 3' 
untranslated sequences has also been demonstrated for a number of other 
mRNAs, for example, mouse dihydrofolate reductase (Setzer et al., 1980), 
mouse Brmicroglobulin (Parnes and Robinson, 1983), mouse a-amylase (Tosi 
et al., 1981), and eel calmodulin (Legace et al., 1983) mRNAs. Although 
the effects of variations in the lengths of chicken vimentin RNA 3' 
untranslated regions is not known, the cell- and tissue-specific utilization of 
chicken vimentin polyadenylation sites (Capetanaki et al., 1983 [Chapter 2]) 
implies that the resulting differences are functionally significant. The 
differential utilization of polyadenylation sites may affect the relative 
stabilities or posttranscriptional processing of chicken vimentin mRNAs. It 
is also possible that chicken vimentin 3' untranslated sequences may affect 
subcellular compartmentation differentially. Lawrence and Singer (1986) 
have shown by in situ hybridization that vimentin RNA exhibits a 
preferential nuclear or peri-nuclear localization in primary chick embryo 
fibroblasts. However, in these experiments vimentin RNA was detected 
using a probe complementary to all three mRNAs, and so discrimination of 
the localization of any specific mRNA species was not possible. The 
contribution of chicken vimentin 3' untranslated sequences to subcellular 
mRNA localization remains an interesting possibility to be explored. It 
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should again be noted that mammalian cells express only one vimentin 
mRNA species; a comparison of hamster and chicken vimentin mRNAs 
demonstrates 83% nucleotide sequence homology in the 3' untranslated 
regions, with the single hamster polyadenylation signal corresponding to the 
second chicken vimentin signal (Quax et al., 1983). Any explanation for the 
importance of cell-specific expression of multiple vimentin mRNAs with 
different 3' untranslated regions therefore must be reconciled with the 
presence of only one vimentin mRNA in mammals. However, it is possible 
that a functional requirement for multiple vimentin mRNAs in mammals has 
been lost or altered since the divergence of birds and mammals, as suggested 
by the differences in posttranscriptional regulation of mouse and chicken 
vimentin mRNAs in differentiating MEL cells (Chapter 4). 
The developmental and tissue-specific expression of vimentin is 
complex. During terminal differentiation, vimentin may be completely 
repressed, as in chick spinal cord neurons (Tapscott et al., 1983a,b), 
mammalian erythropoiesis (Dellagi et al., 1983; Ngai et al., 1984 
[Chapter 3]), and mammalian B lymphocyte development (Dellagi et al., 
1983; McTavish et al., 1983; Traub et al., 1983); partially repressed or 
constitutively expressed, as in myogenesis (Granger and Lazarides, 1979; 
Gard and Lazarides, 1980), astrocytes (Tapscott et al., 1981b; Yen and 
Fields, 1981; Schnitzer et al., 1981), and certain retinal neurons (Drager, 
1983); or induced, as in avian erythropoiesis (Capetanaki et al., 1983 
[Chapter 2]). How is vimentin differentially regulated in such a diverse 
variety of cells? Perhaps there are multiple tissue-specific cis-linked 
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regulatory sequences that are responsible for the positive or negative 
regulation in these differentiating cell lineages. For example, multiple 
tissue-specific regulatory elements have been demonstrated to be 
responsible for the expression of the mouse a-fetoprotein gene in yolk sac 
visceral ectoderm, fetal liver, or gut (Godbout et al., 1986; Hammer et al., 
1987). A preliminary indication of a multiplicity of vimentin regulatory 
sequences is implied by the differences in both transcriptional and post-
transcriptional regulation of chicken and mouse vimentin RNA levels in 
differentiating MEL cells (Chapter 4). The divergence of mammalian and 
avian vimentin gene expression in erythropoiesis should continue to be useful 
in delineating the cis-linked regulatory sequences responsible for the 
developmental regulation of this gene. For example, the expression of 
hybrid hamster-chicken vimentin fusion genes in differentiating MEL cells 
may help to identify such putative positively- and negatively-responding 
sequences. 
In Chapter 5 I have presented evidence for differential RNA processing 
and translational regulation as mechanisms governing the expression of 
multiple chicken membrane skeletal protein 4.1 polypeptides. Although the 
functional significance of multiple protein 4.1 variants is at present 
unknown, the future isolation and characterization of full-length protein 4.1 
cDNAs will aid in the elucidation of protein 4.1 isoform structure. 
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INTRODUCTION 
Patterns of intermediate filament protein expression have provided several model 
systems in which to study the regulation of both gene expression and morphogenesis 
during cell differentiation. In a variety of cell types, a specific intermediate filament 
subunit is induced as part of a terminal differentiation program. For example, vimentin 
is expressed as the major intermediate filament protein in the avian erythrocyte' and 
lens fiber cell.2·3 In other cases, vimentin is present during immature stages and precedes 
the appearance of the cell type-specific subunit. During terminal differentiation, the 
particular subunit may partially or completely replace vimentin as the major inter-
mediate filament protein. In developing chick spinal cord, neurofilament protein is 
expressed in lieu of vimentin during the terminal differentiation of neurons ... , In 
chicken myogenesis, vimentin is coexpressed with desmin, whose synthesis is induced 
following fusion of myoblasts in the formation of multinucleate myotubes; 6•7 the 
coexpression of vimentin and desmin persists in adult chicken skeletal muscle.' Het-
erogeneity of intermediate filament composition within a cell type is also seen in certain 
mouse retinal neurons, where vimentin coexists with neurofilament protein,9 and in 
astrocytes, where glial fibrillary acidic protein (GFAP) and vimentin are both pres-
ent.'·10·11 Interestingly, the 70,000 dalton core neurofilament polypeptide (NF70) has 
been found in sub-stoichiometric quantities relative to vimentin in erythrocytes from 
chicken embryos and young chicks. 12 Intermediate filament proteins therefore represent 
a class of proteins whose expression is differentially regulated both within and between 
specific cell lineages. Furthermore, the changing composition of intermediate filaments 
a This work was supported by grants from the National Institutes of Health, National Science 
Foundation, Muscular Dystrophy Association of America and a Grant-in-Aid from the American 
Heart Association, Greater Los Angeles Affiliate. J.N. was also supported by a Gordon Ross 
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and Gamble postdoctoral fellowships. E.L. is the recipient of a Research Career Development 
Award from the National Institutes of Health. 
b Correspondence to: Dr. Elias Lazarides, Division of Biology 156-29, California Institute of 
Technology, Pasadena, CA 91125. 
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in some differentiating cells suggests changing functional requirements for these fil-
aments. 
To examine the regulation of intermediate filament proteins and their genes, we 
have begun by studying vimentin and desmin expression during avian and mammalian 
erythropoiesis and during myogenesis in vitro. Recently we have approached these 
systems at the molecular level using recombinant DNA clones for chicken vimentin 
and desmin. 13-is In this paper we will review the results from these studies and will 
attempt to place them in the broader context of intermediate filament expression to 
help define their modes of regulation. 
Expression of the Chicken Vimentin Gene 
We have shown that two mRNA size classes arise from the single vimentin gene16 
with cell- and tissue-specific modes of expression.13 Vimentin mRNAs with lengths 
of 2.0 and 2.3 kilobases (kb) are both present in chicken skeletal muscle, lens, spinal 
cord, cultured embryo fibroblasts and myogenic cells, and at low levels in gizzard 
and 4-day embryonic erythroid cells. 13 The ratios of the two mRNA classes vary, 
however; for example, there are roughly equal amounts of 2.0 and 2.3 kb vimentin 
mRNAs in skeletal muscle, whereas in spinal cord, the 2.3 kb RNA is 1.5-2 times 
FIGURE 1. Tissue-specific expression of the two 
chicken vimentin mRNAs. Polyadenylated RNA 
was separated by electrophoresis in the presence of 
formaldehyde, transferred to nitrocellulose, and 
hybridized to a "P-labeled vimentin probe." Lane 
l, 3 µ.g spinal cord RNA; lane 2, 3 µ.g 4-day em-
bryonic erythroid RNA; lane 3, 3 µ.g 10-day em-
bryonic erythroid RNA; lane 4, 3 µ.g 15-day 
embryonic erythroid RNA; lane 5, same as lane 2, 
but exposed for a sevenfold longer period of time. 
Note differences in the relative ratios of the 2.3 kb 
and 2.0 kb RNAs (see text). 
2.3kb- . 
2.0 kb - -
2 3 4 5 
.;.,t Jill. ~ 
·-· 
as prevalent, and in 4-day embryonic erythrocytes, the 2.0 kb RNA is approximately 
twice as abundant as the 2.3 kb RNA. In contrast to the abovementioned cases, 
erythroid cells from 10- and 15-day embryos express predominantly the 2.0 kb mRNA 
species13 (FIGURE 1). Furthermore, there is a -20-fold greater accumulation of vi-
mentin mRNA in erythrocytes from 10-day-old embryos as compared to erythrocytes 
from 4-day-old embryos, and a further -twofold increase from 10-day to 15-day 
embryonic erythroid cells (FIGURE 1). 
Variations in the lengths of 3' untranslated regions appear to be primarily re-
sponsible for the - 300 nucleotide (nt) difference between the two chicken vimentin 
mRNA classes. 13· 16•11 Sequence data of the 3' end of the gene have revealed two pairs 
of putative polyadenylation sites (sequence: 5'-AATAAA-3') within the 3' untranslated 
region separated by -250 nt. 16 These findings suggest that different 3' termini of 
vimentin mRNAs account for all or most of the length discrepancies observed between 
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the two mRNA classes. We have shown directly by hybridizing different restriction 
fragments of the cloned vimentin gene to RNA blots that the 2.0 and 2.3 kb RNAs 
indeed differ at their 3' ends.13 Hence, a probe generated from the 3' terminal region 
of the vimentin gene hybridizes only to the 2.3 kb mRNA, whereas sequences upstream 
hybridize to both RNA classes (FIGURE 2). Preliminary S1 nuclease mapping at the 
S' end of the gene has revealed no differences between the two RNAs at our level of 
resolution (-SO bp) (Capetanaki, Ngai, and Lazarides, unpublished results). Si nu-
clease mapping experiments by Zehner and Paterson have confirmed the utilization 
of three of the four possible poly(A) addition sites in chicken embryonic muscle 
vimentin mRNA. 17 From the available sequence data16 and the experiments described 
above, '3•11 the usage of differential splicing patterns to generate multiple 3' terminal 
sequences is unlikely. Moreover, it appears that the vimentin mRNA species share 
common protein-coding sequences, and the differences observed reside in the lengths 
of 3' untranslated regions. These differences may be generated either by transcription 
termination at each of the poly(A) addition sites or by post-transcriptional cleavage 
of a larger precursor transcript to reveal the correct 3' termini. Transcription beyond 
the poly(A) addition site(s), with subsequent cleavage of the primary transcript and 
polyadenylation, has been demonstrated in other systems, such as J3-globin,1&-20 SV40 
late,21•22 and adenovirus early and major late2'-" transcription units. In the case of 
vimentin RNA processing, it is also possible that a transcript that is cleaved and/ or 
polyadenylated at one of the downstream sites may be further processed, ultimately 
to yield a 2.0 kb mRNA. Experiments involving rapid labeling and detection of 
vimentin primary transcripts should help define the limits of the vimentin gene tran-
scription unit and the processing steps necessary to generate the observed 3' termini. 
The role of 3' untranslated sequences in mRNA is currently unknown. However, 
in addition to chicken vimentin mRNA, size heterogeneity of 3' untranslated regions 
is also observed in mRNAs coding for mouse dihydrofolate reductase (four mRNAs),26 
a-amylase (two mRNAs),27 j32-microglobulin (two mRNAs),28 and eel calmodulin (at 
least two of three mRNAs). 29 The cell- and tissue-specific expression of the vimentin 
mRNA species implies that variations in the lengths of the 3' untranslated region are 
functionally significant. Perhaps these sequences affect the subcellular compartmen-
tation of the mRNAs, the relative stability of the two messages, or both. In this 
regard, it is puzzling that mammalian cells express only one vimentin mRNA 
species30•3 ' whose 3' untranslated sequences are highly homologous (83%) to those of 
the chicken vimentin mRNA;31 the mammalian mRNA's 3' terminus appears to 
coincide with a position near the second polyadenylation signal of the chicken mol-
ecule. 31 Any explanation for the importance of cell-specific expression of two mRNAs 
with different 3' untranslated regions therefore must take into account the presence 
of only one vimentin mRNA in mammals. 
Vimentin Gene Expression in Chicken Embryonic Erythroid Cells 
As described above and shown in FIGURE 1, circulating erythroid cells from 10-
and IS-day chick embryos express predominantly the 2.0 kb vimentin mRNA, whereas 
erythroid cells from 4-day-old embryos express both mRNA classes.' 3 Furthermore, 
the levels of vimentin mRN A in 10- and 1 S-day cells are - 20 and - SO times higher 
than in 4-day cells, respectively. Circulating blood cells from 4-day-old embryos are 
a mixture of early and late polychromatophilic primitive erythroblasts, whereas cells 
from 10-day-old embryos are -2S% primitive cells, -3S% mid to late polychro-
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matophilic definitive erythroblasts, and - 35% mature definitive erythrocytes." At 15 
days of embryonic development, 60-70% of the erythroid cells are mature definitive 
erythrocytes, with late polychromatophilic erythroblasts making up the remaining 
fraction . 32 Since primitive series and definitive series erythroid cells represent different 
cell lineages, the accumulation of the 2.0 kb vimentin mRNA between 4 and 10 days 
of development should be considered to be lineage specific. Only a slight proportion 
of vim en tin mRNA from 10- and 15-day cells can possibly derive from primitive series 
cells, as these cells represent a small percentage of the 10-day population and are 
virtually absent in 15-day-old embryo blood. Hence, the - twofold increase in erythroid 
vimentin mRNA levels observed between 10 and 15 days of embryogenesis can be 
ascribed to an induction of expression solely within the definitive series lineage. 
A 
VIMENTIN GENE: 
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FIGURE 2. Variations in the lengths at the 3' end are responsible for the size differences of 
the chicken vimentin mRNAs. Schematic representation of the vimentin gene, showing the 
positions of the stop codon (STOP) and the putative poly( A) addition signals (5' -AA TAAA-3') 
(arrows) as determined by DNA sequencing(A).16 Asterisks denote the poly(A) addition sites, 
which are utilized in chick embryonic skeletal muscle. 17 When a 32 P-labeled probe, which includes 
amino acid coding sequences as well as 3' -untranslated sequences, is hybridized to RNA con-
taining both vimentin mRNAs, both the 2.0 kb and 2.3 kb species are detected(B)." However, 
a 32 P-labeled probe derived from the 3' end of the gene only hybridizes to the 2.3 kb RNA(C)." 
The increase in vimentin mRNA abundances during chicken embryonic eryth-
ropoiesis appears to underlie the pattern of vimentin protein expression. In 4-day 
embryos, primitive series cells synthesize low levels of vimentin (Blikstad, I. and 
Lazarides, E., unpublished results). In contrast, blood cells from 10- and I 5-day 
embryos display an increased level of vimentin synthesis and vimentin filament ac-
cumulation .11·3• The expression of vimentin filaments therefore appears to be regulated 
primarily transcriptionally or by RNA stabilization. 
The factors that regulate both the induction and selection of the 2.0 kb vimentin 
mRNA in definitive versus primitive cells remain to be elucidated. Different hemo-
poietic microenvironments may influence the expression of the vimentin gene. The 
pattern and level of expression also may be genetically determined within each eryth-
roid lineage. Further studies using more defined populations of cells and cultured cell 
systems3s·3• should help delineate the factors relevant to this phenomenon. 
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Repression of Vimentin Gene Expression during Mammalian Erythropoiesis 
in Vitro 
The dramatic change of vimentin mRNA levels during chicken embryonic eryth-
ropoiesis led us to search for a well defined culture system in which to study the 
regulation ofvimentin gene expression during differentiation. For over a decade, Friend 
murine erythroleukemia (MEL) cells have provided an excellent model system for 
studying the molecular events in mammalian erythropoiesis. 37 Chemical induction of 
MEL cell differentiation evokes a series of events that resemble those occurring in 
mammalian erythropoiesis in vivo, such as a change from a basophilic erythroblastic 
to an orthochromatophilic normoblastic phenotype,38 cessation of cell proliferation,39·40 
induction of heme synthetic enzyme activities,•1·•2 elevation in iron uptake and heme 
synthesis,38 induction of globin mRNAs,43_., and accumulation of hemoglobin. 38 A 
variety of membrane-associated alterations are also induced, including changes in 
surface antigen expression,46-48 an increase in transferrin receptor levels,49 induction 
of the membrane skeleton protein spectrin46·'° and the transmembrane anion trans-
porter," and a decrease in Na,K (ATPase) activity.'2·'3 We therefore sought to de-
termine if any changes in vimentin expression occur during MEL cell maturation, 
and if so, to establish where in the developmental program such changes may reside. 
We have found that in striking contrast to the pattern of vimentin expression in 
chicken erythroid cells, MEL cells rapidly repress the expression of vimentin upon 
induction with dimethyl sulfoxide (DMS0), 14 a potent inducer of MEL cell differ-
entiation.38 lmmunofluorescence microscopy using an anti-vimentin antiserum shows 
that vimentin filaments are present in untreated MEL cells, but are lost rapidly upon 
induction with DMS014 (FIGURE 3). [3' S]methionine labeling experiments have re-
vealed that synthesis and assembly of cytoskeletal vimentin is significantly reduced 
by 24 hr of induction. 1• Hence, the loss of vimentin filaments from differentiating 
MEL cells may be facilitated by a shutdown of vimentin synthesis with a concomitant 
dilution of existing filaments by cytokinesis. 
To investigate the mechanisms underlying the decline of vimentin synthesis in 
differentiating MEL cells, we performed quantitative RNA blots using a chicken 
vimentin cDNA as probe. 14 In uninduced cells, this cDNA recognizes a single 2.1 kb 
RNA band 14 that represents the mature vimentin mRNA, as reported by others.30·3' 
By 12 hr of DMSO-mediated differentiation, the level of vimentin mRNA falls to 
FIGURE 3. Differentiation of MEL cells induced by DMSO causes the loss ofvimentin filaments. 
MEL cells were cultured in the presence of 1.8% DMSO for 72 hr or maintained in control 
medium, as indicated. Cells were prepared for indirect immunofluorescence microscopy using 
an anti-vimentin antiserum as described previously. 14 Bar, 10 µ.m. 
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FIGURE 4. Vimentin mRNA levels 
during MEL cell differentiation. 
Poly(A)+ RNA was prepared from cells 
cultured for various periods in the pres-
ence of 1.8% DMSO or in control me-
dium, and subjected to quantitative 
RNA blot analysis using a vimentin-
specific probe.,. Autoradiograms were 
scanned and peak areas were deter-
mined. The values shown are normal-
ized to total cellular poly(Ar RNA 
content and are expressed as a per-
centage of the control levels (100%). 
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- 70% of control amounts and rapidly thereafter to - 30% at 24 hr, - 10% at 48 
hr, and -4% at 96 hr14 (FIGURE 4). For comparison, a significant increase in 
,B-globin mRNA accumulation does not occur in these cells until 24-36 hr of differ-
entiation.14 The repression of vimentin mRNA levels in DMSO-treated MEL cells 
therefore represents an early and rapid process in this developmental program. More-
over, our results demonstrate that, as in chicken erythroid cells, vimentin filament 
expression in this system is regulated by the abundance of vimentin mRNA. 
Although the precipitous decrease in vimentin mRNA occurs early in MEL cell 
differentiation, this event appears to be associated with the subsequent commitment 
to terminal differentiation. 14 Commitment to terminal differentiation represents the 
capacity of MEL cells to continue irreversibly in their differentiation program in the 
absence of chemical inducer.39 '40 During induction by DMSO, a significant percentage 
of committed cells appears in the population after a lag period of 20 -24 hr, and the 
number of committed cells attains a plateau level by -48 hr.39 From FIGURE 4 we 
see that the decline in vimentin mRNA levels precedes the major onset of commitment; 
by 24 hr of induction, vimentin mRNA levels have fallen -threefold, and -10-fold 
at 48 hr. Hexamethylenebisacetamide (HMBA), another potent inducer of MEL cell 
terminal differentiation,54 like DMSO also causes a dramatic reduction in vimentin 
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mRNA levels.•• On the other hand, hemin, an agent that effects a rapid increase in 
globin mRNA levels,45""'0 but does not induce other events characteristic of terminal 
differentiation,'6 causes only a -twofold reduction in vimentin mRNA.14 Together 
these results suggest that repression of vimentin mRNA expression is a component 
of the MEL cell terminal differentiation program, although the decline temporally 
precedes commitment. 
It should be noted that we have not assayed for commitment in our MEL cell 
culture system. However, the kinetics of globin induction we observed14 are similar 
to those found in the studies that did assay for commitment.39 In the latter studies, 
globin accumulation appeared to parallel or slightly precede the onset of commitment.39 
Hence, given that vimentin mRNA levels begin to decrease significantly by 12 hr, we 
feel confident that this event indeed precedes absolute commitment. 
Our interpretation that the changes in vimentin expression are associated with 
MEL cell commitment is consistent with observations that indicate that development 
of the committed phenotype is a multistep process. A multistep process is demonstrated 
by the growth of mixed benzidine-positive and -negative colonies during cloning in 
the absence of inducer.39 The existence of mixed colonies indicates that a series of 
events can occur subsequent to and distinct from earlier events that were evoked in 
the presence of inducer. Experiments using inhibitors of MEL cell terminal differ-
entiation have further shown the multistep nature of the acquisition of commitment." 
A definitive answer regarding the relationship between vimentin expression and com-
mitment can be established by studying the effects of inhibitors of MEL cell 
differentiation'S-<;7 and the use of hypersensitive or non-inducible MEL cell lines.68 
Vimentin Expression in Avian and Mammalian Erythropoiesis: Functional 
Implications and Future Prospects 
The biological function(s) of intermediate filaments remains elusive. However, a 
structural role for these filaments has been inferred from morphological observa-
tions.69·70 For example, nucleated chicken erythrocytes possess a vimentin filament 
network that attaches to the plasma membrane, spans the cytoplasm, and appears to 
anchor the centrally located nucleus.34 In contrast, intermediate filaments have never 
been observed in the mature, anucleate mammalian erythrocyte. Furthermore, Dellagi 
and co-workers have shown by immunoftuorescence microscopy that vimentin expres-
sion is lost during the erythroblastic stages of human erythropoiesis in vivo.71 Although 
this loss of vimentin could not be correlated with a particular stage in differentiation,71 
our studies utilizing MEL cells have demonstrated that the disappearance of vimentin 
filaments is a rapidly inducible event during erythropoiesis in vitro•• (FIGURES 3 and 
4). 
Considering the different patterns of vimentin expression observed in chicken and 
mammalian erythroid development, it is possible that enucleation during mammalian 
erythropoiesis is facilitated by the loss of vimentin filaments. The cessation of vimentin 
synthesis during mammalian erythropoiesis may allow the dilution of existing filaments 
(by cell division), which otherwise might physically inhibit enucleation.72 The loss of 
vimentin filaments during mammalian red cell development also may reflect the chang-
ing state of the plasma membrane.46-" Indeed, a dramatic morphological change occurs 
as the round, nucleated erythroblastic cell gives rise to the smaller, biconcave disc-
shaped anucleate erythrocyte. In any case, the dynamic positive and negative regulation 
of the vimentin gene in avian and mammalian erythropoiesis suggests that the presence 
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or absence of vimentin filaments represents an essential feature in each of these 
differentiation programs. 
MEL cell differentiation provides an excellent model system for investigating the 
regulation and consequences of vimentin gene expression during erythropoiesis. The 
similarity in patterns of vimentin expression during mammalian erythropoiesis in vivo11 
and in vitro14 strongly suggests that the mechanisms for vimentin gene regulation in 
MEL cells reflect or are identical to those operative in vivo. One limitation of the in 
vitro system, however, is that MEL cells rarely differentiate to or beyond the reti-
culocyte stage.73 We are now carrying out experiments involving the transformation 
of MEL cells with foreign vimentin genes in an attempt to investigate further vimentin 
gene regulation. Additionally, manipulation of vimentin gene expression may yield 
valuable information regarding the function of vimentin filaments during red blood 
cell maturation. 
Noncoordinate Regulation of Vimentin and Desmin Genes During Myogenesis 
in Vitro 
Desmin is the intermediate filament subunit that is specifically expressed in skeletal, 
cardiac, and most smooth muscles.69·'0 Previous studies have shown an induction of 
desmin synthesis and accumulation upon fusion of chicken myoblasts into multinu-
cleate myotubes during myogenesis in vitro.' This induction is manifested by the 
appearance of cytoplasmic desmin-containing filaments.6·' During later stages of dif-
ferentiation, desmin redistributes from a cytoplasmic filamentous pattern to a sarco-
meric Z-line association at a time when adjacent sarcomeres become aligned.6•7 In 
adult chicken skeletal muscle, desmin is localized at the peripheries of Z-discs.74 One 
interpretation of the above observations is that desmin or desmin-containing filaments 
both facilitate and maintain the cross-striated appearance in skeletal muscle by re-
distributing to the Z-disc peripheries and interlinking adjacent myofibrils across the 
myocyte cytoplasm.1·•·74 Vimentin follows the same redistribution as desmin during 
myogenesis, but is present in mitotic and post-mitotic myoblasts, as well as in fusing 
and post-fusion myotubes.' 
The mechanism by which intermediate filament redistribution occurs during my-
ogenesis is presently unknown. Desmin and vimentin may associate preferentially with 
Z discs due to the de nova appearance of binding sites at these structures. Another 
possibility involves the developmentally regulated expression of Z-disc-specific desmin 
and vimentin mRNAs, whose products would only localize at Z discs. Post-transla-
tional modifications of desmin and vimentin also may affect their subcellular locali-
zations and interactions. Lastly, the ratio of vimentin to desmin may influence 
intermediate filament distribution. To distinguish which of the above possibilities are 
plausible, and to determine the means of regulating the levels of vimentin and desmin 
in myogenesis, we have analyzed RNA from this system using recombinant DNA 
clones for vimentin and desmin. '"" From FIGURE 5(A), we see that the levels of the 
2.4 kb desmin mRNA increase, beginning at 24-36 hr after plating, and eventually 
level off by 3-4 days of culture. 15 In this system, the major onset of fusion occurs 
between 24 and 48 hr after plating, and approximately 50% of the nuclei are present 
in syncytial myotubes at 30 hr. The large induction of desmin mRNA therefore 
coincides with the observed increase in desmin synthesis.' Hence, the specific expression 
of this intermediate filament protein during and subsequent to fusion appears to be 
regulated primarily at the mRNA level. The induction of desmin mRNA levels and 
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desmin synthesis parallels the induction of other muscle-specific mRNAs (with the 
concomitant increase in synthesis of these proteins) at the time of fusion.7'-77 
Neither the amount nor the size of the desmin mRNA changes significantly between 
4 and 8 days of culture, a time at which the rearrangement of intermediate filaments 
is observed.6·1 Since the desmin gene appears to exist as a single copy in the haploid 
chicken genome," it therefore seems unlikely that a switching of desmin mRNAs 
A 2 a 4 s s 1 s 9 10 
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--···· 
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<~1··~ 
" ~ . 
FIGURE 5. RNA blot analysis of desmin and vimentin mRNA levels duriri.g myogenesis in 
vitro. (A) Total RNA was isolated from cultured chick myogenic cells, subjected to electropho-
resis, blotted to nitrocellulose and hybridized to a " P-labeled desmin cDNA probe." Lane I, 
RNA obtained from cells 6 hr after plating; lane 2, 12 hr; lane 3, 24 hr; lane 4, 36 hr; lane 5, 
48 hr; lane 6, 60 hr; lane 7, 84 hr; lane 8, 108 hr; lane 9, 132 hr; lane 10, 192 hr. D indicates 
the position of the 2.4 kb desmin mRNA band. (B) An RNA blot similar to the one shown in 
(A) hybridized to a " P-labeled vimentin cDNA probe. Lane I, RNA from cells 6 hr after 
plating; lane 2, 12 hr; lane 3, 24 hr; lane 4, 48 hr; lane 5, 64 hr. Vimentin mRNA levels remain 
essentially constant through 8 days (192 hr) of culture (data not shown). Y denotes the positions 
of the 2.0 kb and 2.3 kb vimentin mRNAs. 
occurs. However, we cannot rule out the possibility that desmin transcripts are dif-
ferentially processed to yield distinct mRNAs with indistinguishable electrophoretic 
mobilities. Structural analysis of the desmin gene and its transcript(s) will render a 
definitive answer to this possibility . 
As the single vimentin gene gives rise to two mRNAs with the same amino acid 
coding region, 13· 16· 11 the redistribution of vimentin-containing filaments cannot be 
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caused by the appearance of a Z-disc-specific vimentin gene product.13 Both vimentin 
mRNAs are present throughout myogenesis, and there is a slight increase in the 
amount of the 2.0 kb RNA relative to the 2.3 kb RNA as differentiation proceeds 
(FIGURE 5, B). At present, we cannot ascribe any importance to this latter observation. 
Our analysis ofvimentin mRNA during myogenesis indicates that there is no significant 
change in its abundance through 8 days of culture (FIGURE 5, B and unpublished 
results). This result contrasts with the observed two- to threefold increase in vimentin 
synthesis that we have reported previously.7 The discrepancy may be due to differences 
in standardization (normalization to total RNA versus total protein synthesis) or 
variations in culturing conditions. Zehner and Paterson have observed a -threefold 
increase in vimentin mRNA during myogenesis,17 but this difference again may be 
due to dissimilar methods of culture. Nevertheless, it is clear that the genes coding 
for desmin and vimentin are noncoordinately regulated during myogenesis in vitro. 
The relatively constant levels of vimentin and desmin expression during the re-
organization of intermediate filaments (at - 8 days) renders unlikely the possibility 
that changing ratios of subunit composition affect localization. By default, we are left 
with the conclusion that the transition of vimentin- and desmin-containing filaments 
to Z discs is effected either by the appearance of specific Z-disc receptors or filament-
binding proteins, or by modification of the subunits themselves. Both vimentin and 
desmin are substrates for cAMP-dependent protein kinases,'"· 79 and at the time of 
filament redistribution, the sensitivities and sites of phosphorylation for these kinases 
change.79 Furthermore, Danto and Fischman have characterized a monoclonal anti-
body that recognizes desmin in adult cardiac and skeletal muscle, but not in cultured 
cardiac muscle cells or certain regions of embryonic myocardium.80 The differential 
reactivity to this antibody presumably reflects conformational differences or differential 
masking, which only allows this epitope to be reactive in adult muscle.80 The roles of 
covalent modifications (such as phosphorylation) or protein-protein interactions in 
this process remain to be elucidated. 
Generalized Model for Intermediate Filament Protein Expression 
The data discussed in this review show that the expression of vimentin and desmin 
filaments is regulated primarily at the levels of transcription or RNA stabilization, 
and not at the level of translation.13- 1' In the case of vimentin, a dramatic change in 
vimentin mRNA levels during chicken embryonic erythropoiesis is correlated with a 
similar change at the protein level.13 The loss of vimentin filaments in differentiating 
MEL cells also occurs as a result of a rapid and extensive decline in vimentin mRNA.14 
During myogenesis in vitro, the rates of desmin synthesis and accumulation increase 
significantly upon fusion, whereas vimentin levels change to a lesser degree; 1 these 
alterations in expression are correlated with similar changes in the respective mRNA 
abundances.1'· 1' The large change in magnitude of vimentin mRNA levels during 
erythropoiesis and desmin mRNA levels during myogenesis suggest similar changes 
in transcription rates of these genes in the systems studied. However, the effects of 
variable RNA turnover, as well as transcription, can only be ascertained definitively 
by direct measurement of these two processes. 
During terminal differentiation of certain cells, vimentin may be partially or com-
pletely replaced by the cell type-specific subunit. The regulation of vimentin expression 
in MEL cells by mRNA abundance suggests a similar type of control for vimentin 
during the replacement of vimentin by specific intermediate filament subunits in other 
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differentiating cells. Our findings concerning vimentin and desmin regulation during 
myogenesis further suggest that the ratios of intermediate filament subunits within a 
cell reflect the ratios of the respective mRNAs. This is further supported by the 
observations that relative abundances of vimentin correlate with the levels of mRNA 
in different tissues, 13 and desmin mRNA is present only in tissues or cells that express 
the desmin polypeptide." Similarly, we have shown by RNA blot analysis using a 
GFAP cDNA probe that GFAP mRNA is present in the centq1l nervous system, but 
is not detectable in any of the non-nervous tissues examined." The differential expres-
sion of keratin polypeptides in various epithelial cells has also been shown to be due 
to differences at the mRNA level.81 '82 We extrapolate the results discussed above to 
conclude that in general, the expression of intermediate filament subunits is determined 
by the presence and abundance of the corresponding mRNAs. A notable exception 
is presented by mouse squamous cell carcinomas, wherein the mRNA coding for a 
67,000 dalton keratin is specifically masked, preventing its expression.83 Determination 
of the prevalence ofmRNA masking in the regulation of intermediate filament protein 
expression awaits further experimentation using other cell types. 
MODEL FCR INTERMEDIATE FILAMENT EXPRESSION 
RAPID SELF 
TRANSCRIPTION) TRANSLATION ASS£ME:l..Y 
PROCESSING ~ mRNA --- A\ALABLE SUBUNITS ~ FILAMENTS .____ FlLAMENT LOCALIZATION 
TRANSPORT (\ i {SLOW) I 
TUROOVER t 
OEGRADATICN 
PRIMAR'Y R£GlJ..ATION FOR SUlUNIT REGULATED 
EXPRESSION ANO f"-AMOIT AO:l..MU..ATIOO POST-TRANSLATIONALLY 
FIGURE 6. A general model for the regulation of intermediate filament expression. Rapid self-
assembly of intermediate filaments is facilitated by the availability of soluble subunits. The 
availability of subunits in turn is determined primarily at the mRNA level. The intracellular 
localization of filaments may be influenced by post-translational modification of the subunits 
themselves or by protein-protein interactions (see text). 
The presence of intermediate filaments comprising two different subunits has been 
observed in a number of systems. Chemical cross-linking studies have demonstrated 
that intermediate filament heteropolymers occur in vivo and that non-identical subunits 
can exist as nearest neighbors.84'8s Reconstitution studies have also shown that vimentin 
and desmin can assemble to form heteropolymers in vitro. 86 A uniformly sparse dec-
oration of intermediate filaments in chicken erythrocytes with an anti-neurofilament 
(NF70) antibody has been observed by immunoelectron microscopy; 12 these cells 
contain substoichiometric amounts of NF70 as compared to vimentin.12 The simplest 
explanation for these results is that the observed antibody decoration reflects the 
random co-polymerization of NF70 and vimentin.12 Similarly, there is a punctate 
distribution of desmin in intermediate filaments of fibroblasts ,81 where only a very low 
amount of desmin is present.88 Studies from this laboratory have demonstrated the 
rapid post-translational assembly of vimentin filaments from a saturable pool of soluble 
vimentin in chicken erythroid cells. 33 '89 The kinetics of assembly suggest that the 
formation of filaments within the cell is determined primarily by the availability of 
soluble subunits and is not regulated or limited post-translationally.33·89 The formation 
of heteropolymers with a random distribution of subunits is consistent with the inter-
pretation that assembly of imermediate filaments is dependent mainly on the availa-
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bility of the subunits themselves. However, the existence of microdomains of 
homologous subunits within a co-polymer is neither demonstrated nor ruled out by 
the above experiments. It is possible that subunits are incorporated into growing 
filaments as small oligomeric homopolymers, which would appear to be soluble by 
conventional fractionation techniques.33•89 
The availability of intermediate filament subunits for assembly appears to be 
regulated transcriptionally or post-transcriptionally, but not translationally (with the 
above noted exception83) or post-translationally. "-1'·33•89 Since intermediate filaments 
have been shown to be stable cellular constituents,90 we propose the general conclusion 
that regulation of intermediate filament subunit abundances at the mRNA level directly 
regulates the expression of intermediate filaments (FIGURE 6). Although the major 
point of regulation appears to precede translation, we cannot discount other influences 
on intermediate filament expression. Such influences include those that determine the 
localization of filaments within the cell. For example, some post-translational (e.g. 
phosphorylation) or allosteric mechanism must exist to alter the form and localization 
that desmin and vimentin filaments assume during their redistribution during my-
ogenesis.13·" ·79 Other subtle translational and/ or post-translational mechanisms may 
exist to fine-tune the assembly and the ultimate expression of intermediate filaments. 
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